<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- RRD ActiveDisclosure(SM) XBRL Instance Document - http://www.financial.rrd.com/ -->
<!-- Creation Date      : 2013-12-17T16:56:19.1832234+00:00 -->
<!-- Version            : 1.6.3.3 -->
<!-- Package ID         : 6D2B5E1F85DCE143089E656DF8930062-0000879407-001309 -->
<!-- Copyright (c) 2013 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2012-01-31" xmlns:arwr="http://www.arrowheadresearch.com/20130930" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:us-roles="http://fasb.org/us-roles/2012-01-31" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2012-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:utr="http://www.xbrl.org/2009/utr">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="arwr-20130930.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <unit id="U_shares">
    <measure>shares</measure>
  </unit>
  <unit id="U_iso4217USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="U_iso4217USD_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="U_arwrEmployee">
    <measure>arwr:Employee</measure>
  </unit>
  <unit id="U_pure">
    <measure>pure</measure>
  </unit>
  <unit id="U_iso4217USD_arwrWarrant">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>arwr:Warrant</measure>
      </unitDenominator>
    </divide>
  </unit>
  <context id="C_0000879407_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20131216">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2013-12-16</instant>
    </period>
  </context>
  <context id="C_0000879407_20130331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2013-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20030501_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2003-05-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EquityIssuedInBusinessCombinationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTwoDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtFifteenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirtyFiveDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20020930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20020930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20020930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20020930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20020930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20020930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20020930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2002-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20021001_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2002-10-01</startDate>
      <endDate>2003-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:StockIssuanceCostChargedToAdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EquityIssuedInBusinessCombinationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EquityIssuedInBusinessCombinationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EquityIssuedInBusinessCombinationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EquityIssuedInBusinessCombinationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTwoDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTwoDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTwoDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTwoDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20031001_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-10-01</startDate>
      <endDate>2004-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtFifteenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtFifteenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtFifteenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtFifteenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20041001_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2005-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirtyFiveDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirtyFiveDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirtyFiveDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirtyFiveDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20051001_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-10-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtZeroPointZeroOneDollarsPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20030930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForMarketableSecuritiesAtTenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForCashAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAsGiftForTenDollarAndNinetyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTwoDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20040930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtFifteenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ExercisedAtTenDollarPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_20050930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFortyEightDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirtyEightDollarsAndFortyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirtyFiveDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiftyNineDollarsAndTenCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtSixDollarsAndThirtyFourCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFourDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtSixDollarsAndTwentyThreeCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiveDollarsAndElevenCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwoDollarsAndSeventySixCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwoDollarsAndTwentySixCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwoDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFourDollarsAndFortyNineCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtOneDollarAndEightyThreeCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtSixDollarsAndThirtyFourCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFourDollarsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtSixDollarsAndTwentyThreeCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiveDollarsAndElevenCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwoDollarsAndSeventySixCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedUnderCommittedCapitalAgreementMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedUnderCommittedCapitalAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EquityIssuedInBusinessCombinationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFourDollarsAndFortyNineCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwoDollarsAndTwentySixCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwoDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtOneDollarAndEightyThreeCentsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2006-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiftySevenDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20061001_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-10-01</startDate>
      <endDate>2007-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20070930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2007-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtApproximatelyEighteenDollarPerShareNetMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwentyOneDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20071001_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ArrowheadsIncreaseInProportionateShareOfCalandosEquityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20081001_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2009-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtSixDollarsAndThirtyFourCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtSixDollarsAndThirtyFourCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtSixDollarsAndThirtyFourCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThirteenDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToUnidymStockholdersInExchangeForUnidymsSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20091001_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-10-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuanceOfCommonStockForSubscriptionMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuanceOfCommonStockForSubscriptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuanceOfCommonStockForSubscriptionMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuanceOfCommonStockForSubscriptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsAndEightyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtThreeDollarsAndSeventyCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFourDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFourDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtSixDollarsAndTwentyThreeCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtSixDollarsAndTwentyThreeCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiveDollarsAndElevenCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFiveDollarsAndElevenCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwoDollarsAndSeventySixCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwoDollarsAndSeventySixCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwoDollarsAndSeventySixCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedUnderCommittedCapitalAgreementMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedUnderCommittedCapitalAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EquityIssuedInBusinessCombinationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:EquityIssuedInBusinessCombinationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedToCalandoStockholdersInExchangeForCalandoSSharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">arwr:SubscriptionsReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFourDollarsAndFortyNineCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtFourDollarsAndFortyNineCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwoDollarsAndTwentySixCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwoDollarsAndTwentySixCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwoDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtTwoDollarsAndTwelveCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtOneDollarAndEightyThreeCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:IssuedAtOneDollarAndEightyThreeCentsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:PreferredStockIssuedAtThousandDollarsPerShareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrInsertTherapeuticsIncMember_20050323">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:InsertTherapeuticsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-03-23</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20060331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesEPreferredStockMember_20070420">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-04-20</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20080423">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-04-23</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrMsEnergyLlcMember_20080429">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:MsEnergyLlcMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-04-29</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20080808">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-08-08</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090611">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-06-11</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20090625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-06-25</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090922">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-22</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20090928">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-28</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090928">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-28</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20090928">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-28</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_arwrSeriesCOnePreferredStockMember_20090930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:SeriesCOnePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20091130">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-11-30</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20091130">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-11-30</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20100228">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-02-28</instant>
    </period>
  </context>
  <context id="C_0000879407_20100331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2010-03-31</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20111001_20111021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:RocheMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-21</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20111021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:RocheMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-10-21</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20120401_20120405">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:AlvosTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-04-01</startDate>
      <endDate>2012-04-05</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20121021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:RocheMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-10-21</instant>
    </period>
  </context>
  <context id="C_0000879407_20121001_20121021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-10-21</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonIncMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:RocheMadisonIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:AlvosTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">arwr:ExchangeRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesByTypeAxis_us-gaapBondsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesByTypeAxis">us-gaap:BondsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrWisePowerMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:WisePowerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesByTypeAxis_us-gaapBondsMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesByTypeAxis">us-gaap:BondsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131001_20131031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_20111021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2011-10-21</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRangeAxis_us-gaapMinimumMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRangeAxis_us-gaapMaximumMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapScheduleOfReceivablesWithImputedInterestNameOfReceivableWithImputedInterestAxis_arwrWisepowerMember_20110131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfReceivablesWithImputedInterestNameOfReceivableWithImputedInterestAxis">arwr:WisepowerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-01-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapScheduleOfReceivablesWithImputedInterestNameOfReceivableWithImputedInterestAxis_arwrWisepowerMember_20130124">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfReceivablesWithImputedInterestNameOfReceivableWithImputedInterestAxis">arwr:WisepowerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-01-24</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapScheduleOfReceivablesWithImputedInterestNameOfReceivableWithImputedInterestAxis_arwrWisepowerMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfReceivablesWithImputedInterestNameOfReceivableWithImputedInterestAxis">arwr:WisepowerMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">arwr:CommercialNotesDueWithinOneYearMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueAfterOneYearThroughTwoYearsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">arwr:CommercialNotesDueAfterOneYearThroughTwoYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">arwr:CommercialNotesDueWithinOneYearMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueAfterOneYearThroughTwoYearsMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">arwr:CommercialNotesDueAfterOneYearThroughTwoYearsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:RocheMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:RocheMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:AlvosTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20120405">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:AlvosTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-04-05</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_us-gaapRangeAxis_us-gaapMinimumMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:RocheMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_us-gaapRangeAxis_us-gaapMaximumMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:RocheMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20111001_20111021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-21</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:RocheMadisonMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:AlvosTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:RocheMadisonMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:AlvosTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapPatentsMember_us-gaapRangeAxis_us-gaapMinimumMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapPatentsMember_us-gaapRangeAxis_us-gaapMaximumMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapPatentsMember_20130630">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-06-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapPatentsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20080417">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-04-17</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20081126">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-11-26</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20090623">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-06-23</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:AblarisTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20101001_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:AblarisTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrLeonardoBiosystemsIncMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:LeonardoBiosystemsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:AblarisTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_20081126">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2008-11-26</instant>
    </period>
  </context>
  <context id="C_0000879407_deiLegalEntityAxis_arwrCalandoMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">arwr:CalandoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantOneMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantTwoMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantThreeMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFourMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFiveMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantFiveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSixMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantSixMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSevenMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantSevenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantEightMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantEightMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantOneMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantTwoMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantTwoMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantThreeMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantThreeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFourMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantFourMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFiveMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantFiveMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSixMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantSixMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSevenMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantSevenMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantEightMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:WarrantEightMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandStockOptionPlanMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arwr:TwoThousandStockOptionPlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandFourEquityIncentivePlanMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arwr:TwoThousandFourEquityIncentivePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110901_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-09-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20111031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111004">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-10-04</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_us-gaapLimitedLiabilityCompanyMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_us-gaapLimitedLiabilityCompanyMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:LimitedLiabilityCompanyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_us-gaapStatementScenarioAxis_arwrSubscriptionAgreementMember_20111001_20111031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">arwr:SubscriptionAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20120229">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-02-29</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20111021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-10-21</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20111001_20111031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20120201_20120229">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-02-01</startDate>
      <endDate>2012-02-29</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementScenarioAxis_arwrSubscriptionAgreementMember_20111001_20111031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">arwr:SubscriptionAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111021">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-10-21</instant>
    </period>
  </context>
  <context id="C_0000879407_20120710_20120810">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2012-07-10</startDate>
      <endDate>2012-08-10</endDate>
    </period>
  </context>
  <context id="C_0000879407_20120810">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2012-08-10</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20111101_20111117">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">arwr:RocheMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-11-01</startDate>
      <endDate>2011-11-17</endDate>
    </period>
  </context>
  <context id="C_0000879407_20121201_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2012-12-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0000879407_20130101_20130131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-01-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_20130131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2013-01-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130501_20130531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-05-01</startDate>
      <endDate>2013-05-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-05-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrConvertiblePreferredStockSeriesBMember_20130501_20130531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ConvertiblePreferredStockSeriesBMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-05-01</startDate>
      <endDate>2013-05-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_arwrConvertiblePreferredStockSeriesBMember_20130531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arwr:ConvertiblePreferredStockSeriesBMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-05-31</instant>
    </period>
  </context>
  <context id="C_0000879407_20130531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <instant>2013-05-31</instant>
    </period>
  </context>
  <context id="C_0000879407_20130501_20130531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2013-05-01</startDate>
      <endDate>2013-05-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_20120801_20120831">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
    </entity>
    <period>
      <startDate>2012-08-01</startDate>
      <endDate>2012-08-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRangeAxis_us-gaapMinimumMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRangeAxis_us-gaapMaximumMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsStockOptionPlanMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arwr:TwoThousandsStockOptionPlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsFourEquityIncentivePlanMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arwr:TwoThousandsFourEquityIncentivePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsFourEquityIncentivePlanMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arwr:TwoThousandsFourEquityIncentivePlanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrCalandoPharmaceuticalsIncMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrArrowheadMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arwr:ArrowheadMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrCalandoPharmaceuticalsIncMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrArrowheadMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arwr:ArrowheadMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrCalandoPharmaceuticalsIncMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arwr:CalandoPharmaceuticalsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:DerivativeFinancialInstrumentsAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">arwr:ExchangeRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20110930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">arwr:ExchangeRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">arwr:ExchangeRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">arwr:ExchangeRightsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrUnidymIncMember_20110101_20110131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-01-31</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrUnidymIncMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arwr:UnidymIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandTenWarrantMember_20100630">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:TwoThousandTenWarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-06-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandTwelveWarrantMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:TwoThousandTwelveWarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandThirteenWarrantMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:TwoThousandThirteenWarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandTenWarrantMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:TwoThousandTenWarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandTwelveWarrantMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arwr:TwoThousandTwelveWarrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arwr:AblarisTherapeuticsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">arwr:TwoThousandTenWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">arwr:TwoThousandTenWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">arwr:TwoThousandsTwelveWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">arwr:TwoThousandsTwelveWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">arwr:TwoThousandThirteenWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20111001_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">arwr:TwoThousandThirteenWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_arwrDiscretionaryContributionsMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">arwr:DiscretionaryContributionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_arwrEmployeeContributionsUpToThreePercentMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">arwr:EmployeeContributionsUpToThreePercentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_arwrFiftyPercentageOfMatchingContributionMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">arwr:FiftyPercentageOfMatchingContributionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_arwrEmployeeContributionUpToFirstTwoPercentageMember_20121001_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">arwr:EmployeeContributionUpToFirstTwoPercentageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131001_20131011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-11</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131001_20131011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-11</endDate>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-10-11</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-10-11</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-10-11</instant>
    </period>
  </context>
  <context id="C_0000879407_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131001_20131011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000879407</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-11</endDate>
    </period>
  </context>
  <dei:DocumentType id="F_000000" contextRef="C_0000879407_20121001_20130930">10-K</dei:DocumentType>
  <dei:AmendmentFlag id="F_000001" contextRef="C_0000879407_20121001_20130930">false</dei:AmendmentFlag>
  <dei:DocumentPeriodEndDate id="F_000002" contextRef="C_0000879407_20121001_20130930">2013-09-30</dei:DocumentPeriodEndDate>
  <dei:DocumentFiscalYearFocus id="F_000003" contextRef="C_0000879407_20121001_20130930">2013</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus id="F_000004" contextRef="C_0000879407_20121001_20130930">FY</dei:DocumentFiscalPeriodFocus>
  <dei:TradingSymbol id="F_000005" contextRef="C_0000879407_20121001_20130930">ARWR</dei:TradingSymbol>
  <dei:EntityRegistrantName id="F_000006" contextRef="C_0000879407_20121001_20130930">ARROWHEAD RESEARCH CORP</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey id="F_000007" contextRef="C_0000879407_20121001_20130930">0000879407</dei:EntityCentralIndexKey>
  <dei:CurrentFiscalYearEndDate id="F_000008" contextRef="C_0000879407_20121001_20130930">--09-30</dei:CurrentFiscalYearEndDate>
  <dei:EntityWellKnownSeasonedIssuer id="F_000009" contextRef="C_0000879407_20121001_20130930">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:EntityCurrentReportingStatus id="F_000010" contextRef="C_0000879407_20121001_20130930">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityVoluntaryFilers id="F_000011" contextRef="C_0000879407_20121001_20130930">No</dei:EntityVoluntaryFilers>
  <dei:EntityFilerCategory id="F_000012" contextRef="C_0000879407_20121001_20130930">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityCommonStockSharesOutstanding id="F_000013" contextRef="C_0000879407_20131216" decimals="INF" unitRef="U_shares">38700363</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityPublicFloat id="F_000014" contextRef="C_0000879407_20130331" decimals="-6" unitRef="U_iso4217USD">38000000</dei:EntityPublicFloat>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000015" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">19114444</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000016" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">3377288</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:AccountsReceivableNetCurrent id="F_000017" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">75000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccountsReceivableNetCurrent id="F_000018" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">9375</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:OtherReceivables id="F_000019" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">8663</us-gaap:OtherReceivables>
  <us-gaap:OtherReceivables id="F_000020" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">9930</us-gaap:OtherReceivables>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="F_000021" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">615351</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="F_000022" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">618130</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:MarketableSecuritiesCurrent id="F_000023" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">9030261</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:MarketableSecuritiesCurrent id="F_000024" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">106500</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:NotesAndLoansReceivableNetCurrent id="F_000025" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">2446113</us-gaap:NotesAndLoansReceivableNetCurrent>
  <us-gaap:AssetsCurrent id="F_000026" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">28843719</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent id="F_000027" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">6567336</us-gaap:AssetsCurrent>
  <us-gaap:FurnitureAndFixturesGross id="F_000028" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">323376</us-gaap:FurnitureAndFixturesGross>
  <us-gaap:FurnitureAndFixturesGross id="F_000029" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">323376</us-gaap:FurnitureAndFixturesGross>
  <arwr:ResearchEquipment id="F_000030" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">3452013</arwr:ResearchEquipment>
  <arwr:ResearchEquipment id="F_000031" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">3319027</arwr:ResearchEquipment>
  <us-gaap:CapitalizedComputerSoftwareGross id="F_000032" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">69623</us-gaap:CapitalizedComputerSoftwareGross>
  <us-gaap:CapitalizedComputerSoftwareGross id="F_000033" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">69623</us-gaap:CapitalizedComputerSoftwareGross>
  <us-gaap:LeaseholdImprovementsGross id="F_000034" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">2749409</us-gaap:LeaseholdImprovementsGross>
  <us-gaap:LeaseholdImprovementsGross id="F_000035" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">2749409</us-gaap:LeaseholdImprovementsGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000036" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">6594421</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000037" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">6461435</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="F_000038" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">3081186</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="F_000039" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">1565783</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:PropertyPlantAndEquipmentNet id="F_000040" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">3513235</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet id="F_000041" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">4895652</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="F_000042" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">3240513</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross id="F_000043" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">4784569</us-gaap:FiniteLivedIntangibleAssetsGross>
  <arwr:DerivativeAssetAndOtherNonCurrentAssets id="F_000044" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">1732164</arwr:DerivativeAssetAndOtherNonCurrentAssets>
  <arwr:DerivativeAssetAndOtherNonCurrentAssets id="F_000045" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">280261</arwr:DerivativeAssetAndOtherNonCurrentAssets>
  <us-gaap:OtherAssetsNoncurrent id="F_000046" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">4972677</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent id="F_000047" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">5064830</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:Assets id="F_000048" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">37329631</us-gaap:Assets>
  <us-gaap:Assets id="F_000049" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">16527818</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent id="F_000050" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">1199632</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent id="F_000051" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">877986</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="F_000052" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">638884</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="F_000053" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">730775</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="F_000054" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">905771</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="F_000055" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">1127219</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:DeferredRevenueCurrent id="F_000056" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">103125</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredRevenueCurrent id="F_000057" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">37500</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DerivativeLiabilitiesCurrent id="F_000058" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">4096363</us-gaap:DerivativeLiabilitiesCurrent>
  <us-gaap:DerivativeLiabilitiesCurrent id="F_000059" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">647213</us-gaap:DerivativeLiabilitiesCurrent>
  <us-gaap:CapitalLeaseObligationsCurrent id="F_000060" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">221345</us-gaap:CapitalLeaseObligationsCurrent>
  <us-gaap:CapitalLeaseObligationsCurrent id="F_000061" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">214801</us-gaap:CapitalLeaseObligationsCurrent>
  <us-gaap:NotesPayableCurrent id="F_000062" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">971557</us-gaap:NotesPayableCurrent>
  <us-gaap:NotesPayableCurrent id="F_000063" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">100000</us-gaap:NotesPayableCurrent>
  <us-gaap:OtherLiabilitiesCurrent id="F_000064" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">588343</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesCurrent id="F_000065" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">1592394</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="F_000066" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">8725020</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="F_000067" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">5327888</us-gaap:LiabilitiesCurrent>
  <us-gaap:LongTermNotesPayable id="F_000068" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">50000</us-gaap:LongTermNotesPayable>
  <us-gaap:LongTermNotesPayable id="F_000069" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">839421</us-gaap:LongTermNotesPayable>
  <us-gaap:CapitalLeaseObligationsNoncurrent id="F_000070" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">1061113</us-gaap:CapitalLeaseObligationsNoncurrent>
  <us-gaap:CapitalLeaseObligationsNoncurrent id="F_000071" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">1282458</us-gaap:CapitalLeaseObligationsNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent id="F_000072" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">1758709</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent id="F_000073" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">269142</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:LiabilitiesNoncurrent id="F_000074" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">2869822</us-gaap:LiabilitiesNoncurrent>
  <us-gaap:LiabilitiesNoncurrent id="F_000075" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">2391021</us-gaap:LiabilitiesNoncurrent>
  <us-gaap:CommitmentsAndContingencies id="F_000076" xsi:nil="true" contextRef="C_0000879407_20130930" unitRef="U_iso4217USD" />
  <us-gaap:CommitmentsAndContingencies id="F_000077" xsi:nil="true" contextRef="C_0000879407_20120930" unitRef="U_iso4217USD" />
  <us-gaap:PreferredStockValue id="F_000078" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">10</us-gaap:PreferredStockValue>
  <us-gaap:CommonStockValue id="F_000079" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">124859</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue id="F_000080" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">108354</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="F_000081" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">193514766</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="F_000082" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">145917968</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock id="F_000083" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">1016000</us-gaap:ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="F_000084" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">-166140969</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="F_000085" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">-134997680</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity id="F_000086" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">27498666</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000087" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">10012642</us-gaap:StockholdersEquity>
  <us-gaap:MinorityInterest id="F_000088" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">-1763877</us-gaap:MinorityInterest>
  <us-gaap:MinorityInterest id="F_000089" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">-1203733</us-gaap:MinorityInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000090" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">25734789</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000091" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">8808909</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:LiabilitiesAndStockholdersEquity id="F_000092" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">37329631</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="F_000093" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">16527818</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000094" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000095" contextRef="C_0000879407_20120930" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="F_000096" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized id="F_000097" contextRef="C_0000879407_20120930" decimals="INF" unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="F_000098" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">9900</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued id="F_000099" contextRef="C_0000879407_20120930" decimals="INF" unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="F_000100" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">9900</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding id="F_000101" contextRef="C_0000879407_20120930" decimals="INF" unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare id="F_000102" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare id="F_000103" contextRef="C_0000879407_20120930" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="F_000104" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">145000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized id="F_000105" contextRef="C_0000879407_20120930" decimals="INF" unitRef="U_shares">145000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="F_000106" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">32489444</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="F_000107" contextRef="C_0000879407_20120930" decimals="INF" unitRef="U_shares">13579185</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="F_000108" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">32489444</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding id="F_000109" contextRef="C_0000879407_20120930" decimals="INF" unitRef="U_shares">13579185</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:Revenues id="F_000110" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">290266</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000111" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">146875</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000112" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">4429100</us-gaap:Revenues>
  <us-gaap:LaborAndRelatedExpense id="F_000113" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">6667669</us-gaap:LaborAndRelatedExpense>
  <us-gaap:LaborAndRelatedExpense id="F_000114" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">6414921</us-gaap:LaborAndRelatedExpense>
  <us-gaap:LaborAndRelatedExpense id="F_000115" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">33059799</us-gaap:LaborAndRelatedExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="F_000116" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">3488864</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="F_000117" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">6439323</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="F_000118" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">34842079</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="F_000119" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">8705627</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="F_000120" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">5391463</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="F_000121" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">51324375</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ShareBasedCompensation id="F_000122" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1536271</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000123" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1241404</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000124" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">15117739</us-gaap:ShareBasedCompensation>
  <us-gaap:DepreciationDepletionAndAmortization id="F_000125" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1751412</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="F_000126" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1748975</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="F_000127" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">9160698</us-gaap:DepreciationDepletionAndAmortization>
  <arwr:ImpairmentOfIntangibleAssets id="F_000128" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1308047</arwr:ImpairmentOfIntangibleAssets>
  <arwr:ImpairmentOfIntangibleAssets id="F_000129" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">1308047</arwr:ImpairmentOfIntangibleAssets>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability id="F_000130" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-1421652</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability id="F_000131" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-1421652</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability>
  <us-gaap:OperatingExpenses id="F_000132" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">24879542</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses id="F_000133" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">21236086</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses id="F_000134" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">146234389</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss id="F_000135" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-24589276</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="F_000136" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-21089211</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="F_000137" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-141805289</us-gaap:OperatingIncomeLoss>
  <us-gaap:IncomeLossFromEquityMethodInvestments id="F_000138" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-641141</us-gaap:IncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromEquityMethodInvestments id="F_000139" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-240154</us-gaap:IncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromEquityMethodInvestments id="F_000140" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-1604548</us-gaap:IncomeLossFromEquityMethodInvestments>
  <us-gaap:ImpairmentOfInvestments id="F_000141" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1642775</us-gaap:ImpairmentOfInvestments>
  <us-gaap:ImpairmentOfInvestments id="F_000142" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">1642775</us-gaap:ImpairmentOfInvestments>
  <arwr:GainOnAcquisition id="F_000143" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1576107</arwr:GainOnAcquisition>
  <arwr:GainOnAcquisition id="F_000144" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">1576107</arwr:GainOnAcquisition>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="F_000145" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-76388</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="F_000146" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-1079377</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="F_000147" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-1282853</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:MarketableSecuritiesGainLoss id="F_000148" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-58091</us-gaap:MarketableSecuritiesGainLoss>
  <us-gaap:MarketableSecuritiesGainLoss id="F_000149" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">62954</us-gaap:MarketableSecuritiesGainLoss>
  <us-gaap:InterestIncomeExpenseNet id="F_000150" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-97910</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:InterestIncomeExpenseNet id="F_000151" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">35966</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:InterestIncomeExpenseNet id="F_000152" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">2652534</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:UnrealizedGainLossOnDerivatives id="F_000153" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-5300389</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UnrealizedGainLossOnDerivatives id="F_000154" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">386892</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:UnrealizedGainLossOnDerivatives id="F_000155" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-2018985</us-gaap:UnrealizedGainLossOnDerivatives>
  <arwr:GainLossOnSaleOfStockInSubsidiary id="F_000156" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">2292800</arwr:GainLossOnSaleOfStockInSubsidiary>
  <us-gaap:OtherNonoperatingIncomeExpense id="F_000157" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-997975</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense id="F_000158" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-747975</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense id="F_000159" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-7113803</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense id="F_000160" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-1021432</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense id="F_000161" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-712741</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="F_000162" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-31703079</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="F_000163" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-22110643</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest id="F_000164" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-142518030</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeTaxExpenseBenefit id="F_000165" xsi:nil="true" contextRef="C_0000879407_20121001_20130930" unitRef="U_iso4217USD" />
  <us-gaap:IncomeTaxExpenseBenefit id="F_000166" xsi:nil="true" contextRef="C_0000879407_20111001_20120930" unitRef="U_iso4217USD" />
  <us-gaap:IncomeTaxExpenseBenefit id="F_000167" xsi:nil="true" contextRef="C_0000879407_20030501_20130930" unitRef="U_iso4217USD" />
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest id="F_000168" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-31703079</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest id="F_000169" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-22110643</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest id="F_000170" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-142518030</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax id="F_000171" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-354</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax id="F_000172" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-80</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax id="F_000173" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-47546996</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
  <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax id="F_000174" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">4708588</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax id="F_000175" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-354</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax id="F_000176" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-80</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax id="F_000177" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-42838408</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:ProfitLoss id="F_000178" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-31703433</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000179" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-22110723</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000180" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-185356438</us-gaap:ProfitLoss>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="F_000181" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-560144</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="F_000182" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-984795</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest id="F_000183" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-19379429</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLoss id="F_000184" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-31143289</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000185" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-21125928</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000186" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-165977009</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000187" contextRef="C_0000879407_20121001_20130930" decimals="2" unitRef="U_iso4217USD_shares">-1.30</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000188" contextRef="C_0000879407_20111001_20120930" decimals="2" unitRef="U_iso4217USD_shares">-1.90</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000189" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_shares">24002224</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000190" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_shares">11129766</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000191" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20021001_20030930" decimals="INF" unitRef="U_shares">300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000192" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20021001_20030930" decimals="INF" unitRef="U_shares">168000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SharesIssued id="F_000193" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20030930" decimals="INF" unitRef="U_shares">468000</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000194" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">7500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000195" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">47500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000196" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">50000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000197" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">660879</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000198" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">70553</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000199" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">15000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000200" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">35623</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000201" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">7500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000202" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="INF" unitRef="U_shares">600</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:SharesIssued id="F_000203" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20040930" decimals="INF" unitRef="U_shares">1363155</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000204" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="INF" unitRef="U_shares">1381289</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000205" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="INF" unitRef="U_shares">2500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000206" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="INF" unitRef="U_shares">50225</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000207" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="INF" unitRef="U_shares">1250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SharesIssued id="F_000208" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050930" decimals="INF" unitRef="U_shares">2798419</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000209" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="INF" unitRef="U_shares">11579</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000210" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="INF" unitRef="U_shares">20485</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000211" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="INF" unitRef="U_shares">1500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000212" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="INF" unitRef="U_shares">559000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000213" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="INF" unitRef="U_shares">2538</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000214" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="INF" unitRef="U_shares">20838</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000215" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20020930" unitRef="U_iso4217USD" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000216" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20020930" unitRef="U_iso4217USD" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000217" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20020930" unitRef="U_iso4217USD" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000218" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20020930" unitRef="U_iso4217USD" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000219" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20020930" unitRef="U_iso4217USD" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000220" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20020930" unitRef="U_iso4217USD" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000221" xsi:nil="true" contextRef="C_0000879407_20020930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000222" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000223" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20021001_20030930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000224" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20021001_20030930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000225" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000226" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">1680</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000227" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20021001_20030930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000228" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">1678320</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000229" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20021001_20030930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000230" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">1680000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000231" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20021001_20030930" unitRef="U_iso4217USD" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000232" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">168000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000233" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20021001_20030930" unitRef="U_iso4217USD" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000234" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">168000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:ProfitLoss id="F_000235" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20021001_20030930" unitRef="U_iso4217USD" />
  <us-gaap:ProfitLoss id="F_000236" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20021001_20030930" unitRef="U_iso4217USD" />
  <us-gaap:ProfitLoss id="F_000237" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20021001_20030930" decimals="0" unitRef="U_iso4217USD">-95238</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000238" contextRef="C_0000879407_20021001_20030930" decimals="0" unitRef="U_iso4217USD">-95238</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000239" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20030930" decimals="0" unitRef="U_iso4217USD">4680</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000240" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20030930" unitRef="U_iso4217USD" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000241" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20030930" decimals="0" unitRef="U_iso4217USD">1510320</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000242" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20030930" unitRef="U_iso4217USD" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000243" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20030930" decimals="0" unitRef="U_iso4217USD">-95238</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000244" contextRef="C_0000879407_20030930" decimals="0" unitRef="U_iso4217USD">1419762</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000245" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">75</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000246" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000247" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">14925</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000248" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000249" contextRef="C_0000879407_20031001_20040930" decimals="0" unitRef="U_iso4217USD">15000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000250" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">475</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000251" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000252" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">474525</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000253" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000254" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">475000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000255" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000256" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000257" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">499500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000258" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000259" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000260" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000261" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">-96500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000262" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000263" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrStockIssuanceCostChargedToAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">-96500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000264" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">6609</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000265" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000266" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">9906573</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000267" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000268" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">9913182</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000269" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">706</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000270" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000271" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">-151175</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000272" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000273" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">-150469</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000274" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">163</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000275" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000276" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">162587</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000277" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000278" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">162750</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000279" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">356</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000280" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000281" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">533988</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000282" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000283" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">534344</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000284" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000285" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">991318</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000286" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000287" contextRef="C_0000879407_20031001_20040930" decimals="0" unitRef="U_iso4217USD">991318</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000288" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">75</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000289" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000290" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">14925</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000291" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000292" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">15000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000293" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">6</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000294" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000295" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">5994</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000296" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000297" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">6000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000298" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000299" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">175653</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000300" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000301" contextRef="C_0000879407_20031001_20040930" decimals="0" unitRef="U_iso4217USD">175653</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ProfitLoss id="F_000302" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:ProfitLoss id="F_000303" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20031001_20040930" unitRef="U_iso4217USD" />
  <us-gaap:ProfitLoss id="F_000304" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">-2528954</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000305" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20031001_20040930" decimals="0" unitRef="U_iso4217USD">1777699</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000306" contextRef="C_0000879407_20031001_20040930" decimals="0" unitRef="U_iso4217USD">-751255</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000307" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20040930" decimals="0" unitRef="U_iso4217USD">13645</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000308" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000309" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20040930" decimals="0" unitRef="U_iso4217USD">12059997</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000310" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20040930" unitRef="U_iso4217USD" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000311" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20040930" decimals="0" unitRef="U_iso4217USD">-2624192</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000312" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20040930" decimals="0" unitRef="U_iso4217USD">1777699</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000313" contextRef="C_0000879407_20040930" decimals="0" unitRef="U_iso4217USD">11227149</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000314" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">13813</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000315" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20041001_20050930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000316" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">20705522</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000317" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20041001_20050930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000318" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">20719335</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000319" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">25</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000320" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20041001_20050930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000321" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">24975</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000322" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20041001_20050930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000323" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">25000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000324" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">502</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000325" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20041001_20050930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000326" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">1999498</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000327" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20041001_20050930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000328" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">2000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000329" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">12</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000330" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20041001_20050930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000331" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">49988</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000332" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20041001_20050930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000333" contextRef="C_0000879407_20041001_20050930" decimals="0" unitRef="U_iso4217USD">50000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000334" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20041001_20050930" unitRef="U_iso4217USD" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000335" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">508513</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000336" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20041001_20050930" unitRef="U_iso4217USD" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000337" contextRef="C_0000879407_20041001_20050930" decimals="0" unitRef="U_iso4217USD">508513</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000338" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20041001_20050930" unitRef="U_iso4217USD" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000339" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">230087</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000340" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20041001_20050930" unitRef="U_iso4217USD" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000341" contextRef="C_0000879407_20041001_20050930" decimals="0" unitRef="U_iso4217USD">230087</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:ProfitLoss id="F_000342" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20041001_20050930" unitRef="U_iso4217USD" />
  <us-gaap:ProfitLoss id="F_000343" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20041001_20050930" unitRef="U_iso4217USD" />
  <us-gaap:ProfitLoss id="F_000344" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">-6854918</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000345" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20041001_20050930" decimals="0" unitRef="U_iso4217USD">121491</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000346" contextRef="C_0000879407_20041001_20050930" decimals="0" unitRef="U_iso4217USD">-6733427</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000347" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20050930" decimals="0" unitRef="U_iso4217USD">27997</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000348" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20050930" unitRef="U_iso4217USD" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000349" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20050930" decimals="0" unitRef="U_iso4217USD">35578580</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000350" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20050930" unitRef="U_iso4217USD" />
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000351" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20050930" decimals="0" unitRef="U_iso4217USD">-9479110</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000352" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20050930" decimals="0" unitRef="U_iso4217USD">1899190</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000353" contextRef="C_0000879407_20050930" decimals="0" unitRef="U_iso4217USD">28026657</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000354" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">116</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000355" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000356" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">341421</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000357" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000358" contextRef="C_0000879407_20051001_20060930" decimals="0" unitRef="U_iso4217USD">341537</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000359" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">205</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000360" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000361" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">999795</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000362" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000363" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">1000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000364" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">15</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000365" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000366" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">57585</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000367" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000368" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">57600</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000369" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">5590</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000370" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000371" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">19539410</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000372" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000373" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">19545000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000374" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">25</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000375" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000376" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">149975</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000377" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000378" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">150000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000379" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">208</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000380" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000381" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">1077125</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000382" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000383" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">1077333</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000384" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000385" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">1369478</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000386" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000387" contextRef="C_0000879407_20051001_20060930" decimals="0" unitRef="U_iso4217USD">1369478</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ProfitLoss id="F_000388" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:ProfitLoss id="F_000389" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20051001_20060930" unitRef="U_iso4217USD" />
  <us-gaap:ProfitLoss id="F_000390" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">-18997209</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000391" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20051001_20060930" decimals="0" unitRef="U_iso4217USD">-964752</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000392" contextRef="C_0000879407_20051001_20060930" decimals="0" unitRef="U_iso4217USD">-19961961</us-gaap:ProfitLoss>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit id="F_000393" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtZeroPointZeroOneDollarsPerUnitMember_20030930" decimals="INF" unitRef="U_iso4217USD_shares">0.01</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit id="F_000394" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20030930" decimals="INF" unitRef="U_iso4217USD_shares">10.00</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit id="F_000395" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtTenDollarPerUnitMember_20040930" decimals="INF" unitRef="U_iso4217USD_shares">10.00</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit id="F_000396" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForMarketableSecuritiesAtTenDollarPerUnitMember_20040930" decimals="INF" unitRef="U_iso4217USD_shares">10.00</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit id="F_000397" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForCashAtFifteenDollarPerUnitMember_20040930" decimals="INF" unitRef="U_iso4217USD_shares">15.00</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit id="F_000398" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsGiftForTenDollarAndNinetyCentsPerShareMember_20040930" decimals="INF" unitRef="U_iso4217USD_shares">10.90</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit id="F_000399" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAsStockIssuanceCostAtFifteenDollarPerUnitMember_20040930" decimals="INF" unitRef="U_iso4217USD_shares">15.00</arwr:CommonStockAndWarrantsIssuedForCashPricePerUnit>
  <arwr:ExerciseOfStockOptionsPricePerShare id="F_000400" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTwoDollarPerShareMember_20040930" decimals="INF" unitRef="U_iso4217USD_shares">2.00</arwr:ExerciseOfStockOptionsPricePerShare>
  <arwr:ExerciseOfStockOptionsPricePerShare id="F_000401" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20040930" decimals="INF" unitRef="U_iso4217USD_shares">10.00</arwr:ExerciseOfStockOptionsPricePerShare>
  <arwr:ExerciseOfStockOptionsPricePerShare id="F_000402" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtFifteenDollarPerShareMember_20050930" decimals="INF" unitRef="U_iso4217USD_shares">15.00</arwr:ExerciseOfStockOptionsPricePerShare>
  <arwr:ExerciseOfStockOptionsPricePerShare id="F_000403" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrExercisedAtTenDollarPerShareMember_20050930" decimals="INF" unitRef="U_iso4217USD_shares">10.00</arwr:ExerciseOfStockOptionsPricePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000404" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseInsertTherapeuticsShareAtThirtyNineDollarsAndEightyCentsPerShareMember_20050930" decimals="2" unitRef="U_iso4217USD_shares">39.80</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000405" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFortyEightDollarsAndEightyCentsPerShareMember_20060930" decimals="2" unitRef="U_iso4217USD_shares">48.80</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000406" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyEightDollarsAndFortyCentsPerShareMember_20060930" decimals="2" unitRef="U_iso4217USD_shares">38.40</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000407" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirtyFiveDollarsPerShareMember_20060930" decimals="2" unitRef="U_iso4217USD_shares">35.00</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000408" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftyNineDollarsAndTenCentsPerShareMember_20060930" decimals="2" unitRef="U_iso4217USD_shares">59.10</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000409" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToPurchaseCalandoPharmaceuticalsIncAtFiftyOneDollarsAndSeventyCentsPerShareMember_20060930" decimals="2" unitRef="U_iso4217USD_shares">51.70</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000410" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_20070930" decimals="2" unitRef="U_iso4217USD_shares">57.80</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000411" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_20070930" decimals="2" unitRef="U_iso4217USD_shares">37.70</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000412" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_20080930" decimals="2" unitRef="U_iso4217USD_shares">18.00</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000413" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_20080930" decimals="2" unitRef="U_iso4217USD_shares">27.20</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000414" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_20080930" decimals="2" unitRef="U_iso4217USD_shares">28.30</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000415" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_20080930" decimals="2" unitRef="U_iso4217USD_shares">29.50</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000416" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_20080930" decimals="2" unitRef="U_iso4217USD_shares">21.90</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000417" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_20080930" decimals="2" unitRef="U_iso4217USD_shares">21.80</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000418" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_20090930" decimals="2" unitRef="U_iso4217USD_shares">5.50</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000419" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_20090930" decimals="2" unitRef="U_iso4217USD_shares">5.20</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000420" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_20090930" decimals="2" unitRef="U_iso4217USD_shares">3.00</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000421" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_20100930" decimals="2" unitRef="U_iso4217USD_shares">6.34</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000422" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_20100930" decimals="2" unitRef="U_iso4217USD_shares">13.12</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000423" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20110930" decimals="2" unitRef="U_iso4217USD_shares">3.80</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000424" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20120930" decimals="2" unitRef="U_iso4217USD_shares">3.80</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000425" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_20120930" decimals="2" unitRef="U_iso4217USD_shares">3.70</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000426" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_20120930" decimals="2" unitRef="U_iso4217USD_shares">4.00</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000427" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_20120930" decimals="2" unitRef="U_iso4217USD_shares">6.23</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000428" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_20120930" decimals="2" unitRef="U_iso4217USD_shares">5.11</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000429" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_20120930" decimals="2" unitRef="U_iso4217USD_shares">2.76</arwr:CommonStockIssuanceValuePerShare>
  <arwr:PreferredStockIssuanceValuePerShare id="F_000430" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20120930" decimals="0" unitRef="U_iso4217USD_shares">1000</arwr:PreferredStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000431" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_20130930" decimals="2" unitRef="U_iso4217USD_shares">2.26</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000432" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_20130930" decimals="2" unitRef="U_iso4217USD_shares">2.12</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000433" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_20130930" decimals="2" unitRef="U_iso4217USD_shares">4.49</arwr:CommonStockIssuanceValuePerShare>
  <arwr:CommonStockIssuanceValuePerShare id="F_000434" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_20130930" decimals="2" unitRef="U_iso4217USD_shares">1.83</arwr:CommonStockIssuanceValuePerShare>
  <arwr:PreferredStockIssuanceValuePerShare id="F_000435" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20130930" decimals="0" unitRef="U_iso4217USD_shares">1000</arwr:PreferredStockIssuanceValuePerShare>
  <us-gaap:SharesIssued id="F_000436" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060930" decimals="INF" unitRef="U_shares">3414359</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000437" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930" decimals="INF" unitRef="U_shares">18616</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000438" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930" decimals="INF" unitRef="U_shares">284945</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000439" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930" decimals="INF" unitRef="U_shares">143122</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SharesIssued id="F_000440" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070930" decimals="INF" unitRef="U_shares">3861042</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000441" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="INF" unitRef="U_shares">10536</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000442" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="INF" unitRef="U_shares">386398</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000443" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="INF" unitRef="U_shares">5000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000444" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="INF" unitRef="U_shares">7055</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000445" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="INF" unitRef="U_shares">10505</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000446" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="INF" unitRef="U_shares">11416</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000447" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="INF" unitRef="U_shares">1500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SharesIssued id="F_000448" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20080930" decimals="INF" unitRef="U_shares">4293452</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000449" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930" decimals="INF" unitRef="U_shares">205839</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000450" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930" decimals="INF" unitRef="U_shares">222222</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000451" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930" decimals="INF" unitRef="U_shares">919664</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SharesIssued id="F_000452" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090930" decimals="INF" unitRef="U_shares">5641177</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000453" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="INF" unitRef="U_shares">688</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000454" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="INF" unitRef="U_shares">508343</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000455" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="INF" unitRef="U_shares">659299</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000456" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="INF" unitRef="U_shares">122000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000457" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="INF" unitRef="U_shares">15318</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000458" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="INF" unitRef="U_shares">225189</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SharesIssued id="F_000459" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20100930" decimals="INF" unitRef="U_shares">7172014</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000460" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930" decimals="INF" unitRef="U_shares">8656</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000461" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930" decimals="INF" unitRef="U_shares">2700</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000462" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930" decimals="INF" unitRef="U_shares">1458916</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SharesIssued id="F_000463" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110930" decimals="INF" unitRef="U_shares">8642286</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000464" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">4583</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000465" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">138158</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000466" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">675000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000467" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000468" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">83211</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000469" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">97831</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000470" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">2260869</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000471" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedUnderCommittedCapitalAgreementMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">68926</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000472" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">1217159</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits id="F_000473" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">131</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000474" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">1015</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits id="F_000475" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">275782</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits id="F_000476" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">-1015</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000477" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="INF" unitRef="U_shares">15511</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SharesIssued id="F_000478" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120930" decimals="INF" unitRef="U_shares">13579185</us-gaap:SharesIssued>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000479" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">1182451</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000480" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">675</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <arwr:CancellationOfSharesRelatedToSubscriptionReceivables id="F_000481" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">267444</arwr:CancellationOfSharesRelatedToSubscriptionReceivables>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000482" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">239894</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000483" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">1825079</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000484" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">1667051</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000485" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">14262553</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000486" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">9900</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SharesIssued id="F_000487" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130930" decimals="INF" unitRef="U_shares">32489444</us-gaap:SharesIssued>
  <us-gaap:SharesIssued id="F_000488" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20130930" decimals="INF" unitRef="U_shares">9900</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000489" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20060930" decimals="0" unitRef="U_iso4217USD">34156</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000490" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20060930" decimals="0" unitRef="U_iso4217USD">59113369</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000491" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20060930" decimals="0" unitRef="U_iso4217USD">-28476319</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000492" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20060930" decimals="0" unitRef="U_iso4217USD">934438</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000493" contextRef="C_0000879407_20060930" decimals="0" unitRef="U_iso4217USD">31605644</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000494" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">186</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000495" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">434541</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000496" contextRef="C_0000879407_20061001_20070930" decimals="0" unitRef="U_iso4217USD">434727</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000497" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">2849</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000498" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20061001_20070930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000499" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">15149366</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000500" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiftySevenDollarsAndEightyCentsPerShareMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">15152215</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000501" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">2401394</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000502" contextRef="C_0000879407_20061001_20070930" decimals="0" unitRef="U_iso4217USD">2401394</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000503" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">1431</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000504" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20061001_20070930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000505" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">5398569</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000506" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedForPurchaseOfCarbonNanotechnologiesIncAtThirtySevenDollarsAndSeventyCentsPerShareMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">5400000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000507" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">2175544</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000508" contextRef="C_0000879407_20061001_20070930" decimals="0" unitRef="U_iso4217USD">2175544</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ProfitLoss id="F_000509" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">-29931118</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000510" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20061001_20070930" decimals="0" unitRef="U_iso4217USD">-781829</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000511" contextRef="C_0000879407_20061001_20070930" decimals="0" unitRef="U_iso4217USD">-30712947</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000512" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20070930" decimals="0" unitRef="U_iso4217USD">38622</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000513" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20070930" decimals="0" unitRef="U_iso4217USD">84672783</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000514" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20070930" decimals="0" unitRef="U_iso4217USD">-58407437</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000515" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20070930" decimals="0" unitRef="U_iso4217USD">152609</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000516" contextRef="C_0000879407_20070930" decimals="0" unitRef="U_iso4217USD">26456577</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000517" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">106</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000518" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">289921</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000519" contextRef="C_0000879407_20071001_20080930" decimals="0" unitRef="U_iso4217USD">290027</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000520" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">3867</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000521" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">6956718</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000522" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtApproximatelyEighteenDollarPerShareNetMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">6960585</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000523" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">1720962</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000524" contextRef="C_0000879407_20071001_20080930" decimals="0" unitRef="U_iso4217USD">1720962</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000525" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">50</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000526" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20071001_20080930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000527" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">135950</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000528" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentySevenDollarsAndTwentyCentsPerShareToRiceUniversityMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">136000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000529" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">71</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000530" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20071001_20080930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000531" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">199929</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000532" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyEightDollarsAndThirtyCentsPerShareToPurchaseSharesOfUnidymIncMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000533" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">105</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000534" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20071001_20080930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000535" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">309895</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000536" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyNineDollarsAndFiftyCentsPerShareToPurchaseMasaEnergyLlcMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">310000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000537" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">114</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000538" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20071001_20080930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000539" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">249886</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000540" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndNinetyCentsPerShareToUnidymForAcquisitionOfNanoconductionMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">250000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000541" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">15</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000542" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20071001_20080930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000543" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">32685</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000544" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwentyOneDollarsAndEightyCentsPerShareMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">32700</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000545" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">3187397</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000546" contextRef="C_0000879407_20071001_20080930" decimals="0" unitRef="U_iso4217USD">3187397</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ProfitLoss id="F_000547" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">-27089030</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000548" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20071001_20080930" decimals="0" unitRef="U_iso4217USD">-152609</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000549" contextRef="C_0000879407_20071001_20080930" decimals="0" unitRef="U_iso4217USD">-27241639</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000550" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20080930" decimals="0" unitRef="U_iso4217USD">42950</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000551" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20080930" decimals="0" unitRef="U_iso4217USD">97756126</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000552" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20080930" decimals="0" unitRef="U_iso4217USD">-85496467</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000553" contextRef="C_0000879407_20080930" decimals="0" unitRef="U_iso4217USD">12302609</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000554" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2059</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000555" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20081001_20090930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000556" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">1131617</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000557" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndFiftyCentsPerShareToUnidymStockholderInExchangeForUnidymSSharesMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">1133676</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000558" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2222</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000559" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20081001_20090930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000560" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">1156111</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000561" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndTwentyCentsPerShareToTelVenturesInExchangeForUnidymSSharesMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">1158333</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt id="F_000562" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt id="F_000563" contextRef="C_0000879407_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000564" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20081001_20090930" unitRef="U_iso4217USD" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000565" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2120250</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000566" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrArrowheadsIncreaseInProportionateShareOfCalandosEquityMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2120250</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000567" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">9197</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000568" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20081001_20090930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000569" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2749796</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000570" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsPerShareMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2758993</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000571" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">16297</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000572" contextRef="C_0000879407_20081001_20090930" decimals="0" unitRef="U_iso4217USD">16297</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000573" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2676170</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000574" contextRef="C_0000879407_20081001_20090930" decimals="0" unitRef="U_iso4217USD">2676170</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000575" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20081001_20090930" unitRef="U_iso4217USD" />
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000576" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">300000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000577" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">-300000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature id="F_000578" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">163960</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature id="F_000579" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">-163960</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <us-gaap:ProfitLoss id="F_000580" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20081001_20090930" decimals="0" unitRef="U_iso4217USD">-19308392</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000581" contextRef="C_0000879407_20081001_20090930" decimals="0" unitRef="U_iso4217USD">-19308392</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000582" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20090930" decimals="0" unitRef="U_iso4217USD">56428</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000583" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20090930" decimals="0" unitRef="U_iso4217USD">110070327</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000584" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20090930" decimals="0" unitRef="U_iso4217USD">-300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000585" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20090930" decimals="0" unitRef="U_iso4217USD">-104968819</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000586" contextRef="C_0000879407_20090930" decimals="0" unitRef="U_iso4217USD">4857936</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000587" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">7</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000588" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">7624</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000589" contextRef="C_0000879407_20091001_20100930" decimals="0" unitRef="U_iso4217USD">7631</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000590" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">300000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000591" contextRef="C_0000879407_20091001_20100930" decimals="0" unitRef="U_iso4217USD">300000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:MinorityInterestIncreaseFromStockIssuance id="F_000592" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">245345</us-gaap:MinorityInterestIncreaseFromStockIssuance>
  <us-gaap:MinorityInterestIncreaseFromStockIssuance id="F_000593" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">54655</us-gaap:MinorityInterestIncreaseFromStockIssuance>
  <us-gaap:MinorityInterestIncreaseFromStockIssuance id="F_000594" contextRef="C_0000879407_20091001_20100930" decimals="0" unitRef="U_iso4217USD">300000</us-gaap:MinorityInterestIncreaseFromStockIssuance>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000595" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">5083</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000596" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20091001_20100930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000597" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">3217813</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000598" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndThirtyFourCentsPerShareMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">3222896</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000599" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">6593</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000600" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20091001_20100930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000601" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">7861985</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000602" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThirteenDollarsAndTwelveCentsPerShareMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">7868578</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax id="F_000603" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">-4169907</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax id="F_000604" contextRef="C_0000879407_20091001_20100930" decimals="0" unitRef="U_iso4217USD">-4169907</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000605" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">1220</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000606" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20091001_20100930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000607" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">-160667</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000608" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">159447</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000609" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">153</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000610" xsi:nil="true" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20091001_20100930" unitRef="U_iso4217USD" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000611" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">-1435</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000612" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToUnidymStockholdersInExchangeForUnidymsSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">1282</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000613" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">1582149</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000614" contextRef="C_0000879407_20091001_20100930" decimals="0" unitRef="U_iso4217USD">1582149</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000615" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">2250</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000616" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">1063600</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000617" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">200</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000618" contextRef="C_0000879407_20091001_20100930" decimals="0" unitRef="U_iso4217USD">1066050</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:ProfitLoss id="F_000619" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">-5774048</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000620" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20091001_20100930" decimals="0" unitRef="U_iso4217USD">-1182990</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000621" contextRef="C_0000879407_20091001_20100930" decimals="0" unitRef="U_iso4217USD">-6957038</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000622" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20100930" decimals="0" unitRef="U_iso4217USD">71734</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000623" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20100930" decimals="0" unitRef="U_iso4217USD">119716834</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000624" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20100930" decimals="0" unitRef="U_iso4217USD">-110742867</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000625" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20100930" decimals="0" unitRef="U_iso4217USD">-967406</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000626" contextRef="C_0000879407_20100930" decimals="0" unitRef="U_iso4217USD">8078295</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000627" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">87</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000628" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">43192</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000629" contextRef="C_0000879407_20101001_20110930" decimals="0" unitRef="U_iso4217USD">43279</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000630" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">27</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000631" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">13857</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000632" contextRef="C_0000879407_20101001_20110930" decimals="0" unitRef="U_iso4217USD">13884</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:MinorityInterestIncreaseFromStockIssuance id="F_000633" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">254275</us-gaap:MinorityInterestIncreaseFromStockIssuance>
  <us-gaap:MinorityInterestIncreaseFromStockIssuance id="F_000634" contextRef="C_0000879407_20101001_20110930" decimals="0" unitRef="U_iso4217USD">254275</us-gaap:MinorityInterestIncreaseFromStockIssuance>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000635" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">1618509</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000636" contextRef="C_0000879407_20101001_20110930" decimals="0" unitRef="U_iso4217USD">1618509</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000637" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">-849707</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest id="F_000638" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">849707</us-gaap:AdjustmentsToAdditionalPaidInCapitalReallocationOfMinorityInterest>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000639" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">1404640</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000640" contextRef="C_0000879407_20101001_20110930" decimals="0" unitRef="U_iso4217USD">1404640</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000641" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">14574</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000642" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">4629110</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000643" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">4643684</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000644" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuanceOfCommonStockForSubscriptionMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">900000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000645" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuanceOfCommonStockForSubscriptionMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">-900000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:ProfitLoss id="F_000646" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">-3128885</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000647" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20101001_20110930" decimals="0" unitRef="U_iso4217USD">-363514</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000648" contextRef="C_0000879407_20101001_20110930" decimals="0" unitRef="U_iso4217USD">-3492399</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000649" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110930" decimals="0" unitRef="U_iso4217USD">86422</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000650" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110930" decimals="0" unitRef="U_iso4217USD">127476436</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000651" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20110930" decimals="0" unitRef="U_iso4217USD">-900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000652" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20110930" decimals="0" unitRef="U_iso4217USD">-113871752</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000653" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20110930" decimals="0" unitRef="U_iso4217USD">-226938</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000654" contextRef="C_0000879407_20110930" decimals="0" unitRef="U_iso4217USD">12564167</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000655" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">45</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000656" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">23788</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000657" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">23833</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000658" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1241404</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000659" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1241404</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000660" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1382</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000661" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">523618</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000662" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000663" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndEightyCentsPerShareMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">425000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000664" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">6750</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000665" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">2241000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000666" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtThreeDollarsAndSeventyCentsPerShareMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">2247750</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000667" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000668" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">399000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000669" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsPerShareMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">400000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000670" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">83</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000671" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">499918</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000672" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtSixDollarsAndTwentyThreeCentsPerShareMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">500001</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000673" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">98</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000674" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">499903</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000675" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFiveDollarsAndElevenCentsPerShareMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">500001</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000676" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">2261</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000677" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">5809979</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000678" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-16000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000679" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndSeventySixCentsPerShareMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">5796240</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000680" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedUnderCommittedCapitalAgreementMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">689</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000681" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedUnderCommittedCapitalAgreementMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-689</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000682" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">9332</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000683" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">6138498</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000684" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapEquityIssuedInBusinessCombinationMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">6147830</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000685" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000686" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1014999</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000687" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1015000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits id="F_000688" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">276</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits id="F_000689" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-1</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits id="F_000690" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-275</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000691" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000692" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedToCalandoStockholdersInExchangeForCalandoSSharesMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000693" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">16</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000694" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">50390</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000695" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">50406</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:ProfitLoss id="F_000696" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-21125928</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000697" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-984795</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000698" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120930" decimals="0" unitRef="U_iso4217USD">108354</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000699" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120930" decimals="0" unitRef="U_iso4217USD">145917968</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000700" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20120930" decimals="0" unitRef="U_iso4217USD">-1016000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000701" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20120930" decimals="0" unitRef="U_iso4217USD">-134997680</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000702" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20120930" decimals="0" unitRef="U_iso4217USD">-1203733</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000703" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1183</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000704" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">2053416</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000705" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">2054599</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000706" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000707" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">2578</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000708" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">2579</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000709" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1536271</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000710" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1536271</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <arwr:SubscriptionReceivable id="F_000711" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">16000</arwr:SubscriptionReceivable>
  <arwr:SubscriptionReceivable id="F_000712" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">16000</arwr:SubscriptionReceivable>
  <arwr:CancellationOfSubscriptionReceivables id="F_000713" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-2674</arwr:CancellationOfSubscriptionReceivables>
  <arwr:CancellationOfSubscriptionReceivables id="F_000714" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-997326</arwr:CancellationOfSubscriptionReceivables>
  <arwr:CancellationOfSubscriptionReceivables id="F_000715" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_arwrSubscriptionsReceivableMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1000000</arwr:CancellationOfSubscriptionReceivables>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000716" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">240</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000717" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">985809</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000718" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtFourDollarsAndFortyNineCentsPerShareMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">986049</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000719" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1825</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000720" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">3814643</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000721" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwentySixCentsPerShareMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">3816468</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000722" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1667</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000723" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">3255192</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000724" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtTwoDollarsAndTwelveCentsPerShareMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">3256859</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000725" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">14263</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000726" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">25445236</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000727" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrIssuedAtOneDollarAndEightyThreeCentsPerShareMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">25459499</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="F_000728" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1600989</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="F_000729" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1600989</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000730" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">10</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000731" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">9899990</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000732" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrPreferredStockIssuedAtThousandDollarsPerShareMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">9900000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:ProfitLoss id="F_000733" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-31143289</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss id="F_000734" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-560144</us-gaap:ProfitLoss>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000735" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130930" decimals="0" unitRef="U_iso4217USD">124859</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000736" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20130930" decimals="0" unitRef="U_iso4217USD">10</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000737" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130930" decimals="0" unitRef="U_iso4217USD">193514766</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000738" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDeficitDuringDevelopmentStageMember_20130930" decimals="0" unitRef="U_iso4217USD">-166140969</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="F_000739" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapNoncontrollingInterestMember_20130930" decimals="0" unitRef="U_iso4217USD">-1763877</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax id="F_000740" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-354</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax id="F_000741" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-80</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
  <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax id="F_000742" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-42838408</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
  <us-gaap:GainLossOnSaleOfInvestments id="F_000743" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">58091</us-gaap:GainLossOnSaleOfInvestments>
  <us-gaap:GainLossOnSaleOfInvestments id="F_000744" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-762954</us-gaap:GainLossOnSaleOfInvestments>
  <arwr:ProvisionForAllowanceForBadDebtsAndSalesRelatedAllowances id="F_000745" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">2497300</arwr:ProvisionForAllowanceForBadDebtsAndSalesRelatedAllowances>
  <arwr:ProvisionForAllowanceForBadDebtsAndSalesRelatedAllowances id="F_000746" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">2497300</arwr:ProvisionForAllowanceForBadDebtsAndSalesRelatedAllowances>
  <arwr:GainLossFromSaleOfSubsidiary id="F_000747" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">306344</arwr:GainLossFromSaleOfSubsidiary>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims id="F_000748" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">741632</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <us-gaap:ResearchAndDevelopmentInProcess id="F_000749" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">15851555</us-gaap:ResearchAndDevelopmentInProcess>
  <us-gaap:AmortizationOfDebtDiscountPremium id="F_000750" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">128406</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfDebtDiscountPremium id="F_000751" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">9390</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfDebtDiscountPremium id="F_000752" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">129858</us-gaap:AmortizationOfDebtDiscountPremium>
  <arwr:NonCashImpairmentCharges id="F_000753" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">2315721</arwr:NonCashImpairmentCharges>
  <arwr:NonCashImpairmentCharges id="F_000754" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1642775</arwr:NonCashImpairmentCharges>
  <arwr:NonCashImpairmentCharges id="F_000755" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">3958496</arwr:NonCashImpairmentCharges>
  <us-gaap:GainLossOnSaleOfEquityInvestments id="F_000756" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-240154</us-gaap:GainLossOnSaleOfEquityInvestments>
  <us-gaap:GainLossOnSaleOfEquityInvestments id="F_000757" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-963407</us-gaap:GainLossOnSaleOfEquityInvestments>
  <arwr:NoncontrollingInterest id="F_000758" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">560144</arwr:NoncontrollingInterest>
  <arwr:NoncontrollingInterest id="F_000759" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">984795</arwr:NoncontrollingInterest>
  <arwr:NoncontrollingInterest id="F_000760" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">19379429</arwr:NoncontrollingInterest>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="F_000761" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">65625</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="F_000762" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-162855</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="F_000763" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-34415</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInOtherReceivables id="F_000764" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-1080</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInOtherReceivables id="F_000765" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">938179</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInOtherReceivables id="F_000766" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">2542062</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInPrepaidExpense id="F_000767" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-44713</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:IncreaseDecreaseInPrepaidExpense id="F_000768" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">338531</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:IncreaseDecreaseInPrepaidExpense id="F_000769" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">436386</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="F_000770" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1811</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="F_000771" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">30600</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets id="F_000772" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">165566</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="F_000773" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">321647</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="F_000774" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">291876</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="F_000775" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">819957</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities id="F_000776" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">27920</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities id="F_000777" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">186369</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities id="F_000778" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">748829</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="F_000779" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-187910</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="F_000780" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">882296</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="F_000781" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">942251</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="F_000782" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-19032826</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="F_000783" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-15340090</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="F_000784" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-94910622</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="F_000785" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">296880</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="F_000786" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">479710</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="F_000787" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">4342189</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments id="F_000788" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1419079</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
  <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments id="F_000789" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">509009</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
  <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments id="F_000790" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">4732688</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment id="F_000791" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">89505</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment id="F_000792" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">290312</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment id="F_000793" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">522192</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquireMarketableSecurities id="F_000794" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">10732571</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:PaymentsToAcquireMarketableSecurities id="F_000795" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">29308486</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities id="F_000796" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">18888265</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <us-gaap:CashDivestedFromDeconsolidation id="F_000797" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-121033</us-gaap:CashDivestedFromDeconsolidation>
  <us-gaap:CashDivestedFromDeconsolidation id="F_000798" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">1579365</us-gaap:CashDivestedFromDeconsolidation>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired id="F_000799" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">250000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries id="F_000800" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">2000000</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
  <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates id="F_000801" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">10150000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
  <us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates id="F_000802" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">10529594</us-gaap:ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates>
  <us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries id="F_000803" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">359375</us-gaap:ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries>
  <us-gaap:PaymentsToAcquireIntangibleAssets id="F_000804" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">303440</us-gaap:PaymentsToAcquireIntangibleAssets>
  <us-gaap:IncreaseDecreaseInRestrictedCash id="F_000805" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-50773</us-gaap:IncreaseDecreaseInRestrictedCash>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations id="F_000806" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-9520867</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations id="F_000807" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">440644</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations id="F_000808" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-12850593</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations id="F_000809" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">214801</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
  <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations id="F_000810" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">196606</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
  <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations id="F_000811" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">411407</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000812" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">44506004</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000813" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">10958231</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000814" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">150759015</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt id="F_000815" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">2516467</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <arwr:ProceedsFromSaleOfStockInSubsidiary id="F_000816" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">8000</arwr:ProceedsFromSaleOfStockInSubsidiary>
  <arwr:ProceedsFromSaleOfStockInSubsidiary id="F_000817" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">20902100</arwr:ProceedsFromSaleOfStockInSubsidiary>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="F_000818" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">44291203</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="F_000819" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">10769625</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="F_000820" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">173766175</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations id="F_000821" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-354</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
  <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations id="F_000822" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-280</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
  <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations id="F_000823" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-46004141</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
  <us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations id="F_000824" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">790625</us-gaap:CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations>
  <us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations id="F_000825" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-1677000</us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations>
  <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations id="F_000826" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-354</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
  <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations id="F_000827" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-280</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
  <us-gaap:NetCashProvidedByUsedInDiscontinuedOperations id="F_000828" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">-46890516</us-gaap:NetCashProvidedByUsedInDiscontinuedOperations>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="F_000829" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">15737156</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="F_000830" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-4130101</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="F_000831" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">19114444</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000832" contextRef="C_0000879407_20110930" decimals="0" unitRef="U_iso4217USD">7507389</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:InterestPaid id="F_000833" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">42044</us-gaap:InterestPaid>
  <us-gaap:InterestPaid id="F_000834" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">42269</us-gaap:InterestPaid>
  <us-gaap:InterestPaid id="F_000835" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">322732</us-gaap:InterestPaid>
  <us-gaap:IncomeTaxesPaid id="F_000836" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">742500</us-gaap:IncomeTaxesPaid>
  <arwr:CommonStockPurchasedFromMinorityShareHolders id="F_000837" contextRef="C_0000879407_deiLegalEntityAxis_arwrInsertTherapeuticsIncMember_20050323" decimals="INF" unitRef="U_shares">7375000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <us-gaap:CommonStockSharesIssued id="F_000838" contextRef="C_0000879407_deiLegalEntityAxis_arwrInsertTherapeuticsIncMember_20050323" decimals="INF" unitRef="U_shares">50226</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000839" contextRef="C_0000879407_deiLegalEntityAxis_arwrInsertTherapeuticsIncMember_20050323" decimals="0" unitRef="U_iso4217USD">2000000</us-gaap:CommonStockValue>
  <arwr:CommonStockPurchasedFromMinorityShareHolders id="F_000840" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20060331" decimals="INF" unitRef="U_shares">964000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <us-gaap:CommonStockSharesIssued id="F_000841" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20060331" decimals="INF" unitRef="U_shares">20838</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000842" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20060331" decimals="0" unitRef="U_iso4217USD">1077333</us-gaap:CommonStockValue>
  <arwr:ValueOfCommonStockPurchasedFromMinorityShareHolders id="F_000843" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20060331" decimals="0" unitRef="U_iso4217USD">1928000</arwr:ValueOfCommonStockPurchasedFromMinorityShareHolders>
  <arwr:ValueOfCommonStockPurchasedByCash id="F_000844" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20060331" decimals="0" unitRef="U_iso4217USD">850667</arwr:ValueOfCommonStockPurchasedByCash>
  <us-gaap:CommonStockSharesIssued id="F_000845" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesEPreferredStockMember_20070420" decimals="INF" unitRef="U_shares">143122</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000846" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesEPreferredStockMember_20070420" decimals="0" unitRef="U_iso4217USD">5400000</us-gaap:CommonStockValue>
  <arwr:CommonStockPurchasedFromMinorityShareHolders id="F_000847" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20080423" decimals="INF" unitRef="U_shares">200000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <us-gaap:CommonStockSharesIssued id="F_000848" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20080423" decimals="INF" unitRef="U_shares">7054</us-gaap:CommonStockSharesIssued>
  <arwr:ValueOfCommonStockPurchasedByCash id="F_000849" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20080423" decimals="0" unitRef="U_iso4217USD">200000</arwr:ValueOfCommonStockPurchasedByCash>
  <us-gaap:CommonStockSharesIssued id="F_000850" contextRef="C_0000879407_deiLegalEntityAxis_arwrMsEnergyLlcMember_20080429" decimals="INF" unitRef="U_shares">10504</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000851" contextRef="C_0000879407_deiLegalEntityAxis_arwrMsEnergyLlcMember_20080429" decimals="0" unitRef="U_iso4217USD">310000</us-gaap:CommonStockValue>
  <arwr:ValueOfCommonStockPurchasedFromMinorityShareHolders id="F_000852" contextRef="C_0000879407_deiLegalEntityAxis_arwrMsEnergyLlcMember_20080429" decimals="0" unitRef="U_iso4217USD">560000</arwr:ValueOfCommonStockPurchasedFromMinorityShareHolders>
  <arwr:ValueOfCommonStockPurchasedByCash id="F_000853" contextRef="C_0000879407_deiLegalEntityAxis_arwrMsEnergyLlcMember_20080429" decimals="0" unitRef="U_iso4217USD">250000</arwr:ValueOfCommonStockPurchasedByCash>
  <us-gaap:CommonStockSharesIssued id="F_000854" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20080808" decimals="INF" unitRef="U_shares">11411</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000855" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20080808" decimals="0" unitRef="U_iso4217USD">250000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockSharesIssued id="F_000856" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090611" decimals="INF" unitRef="U_shares">132462</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000857" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090611" decimals="0" unitRef="U_iso4217USD">688802</us-gaap:CommonStockValue>
  <us-gaap:CommonStockSharesIssued id="F_000858" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20090625" decimals="INF" unitRef="U_shares">194444</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000859" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20090625" decimals="0" unitRef="U_iso4217USD">972222</us-gaap:CommonStockValue>
  <us-gaap:CommonStockSharesIssued id="F_000860" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090922" decimals="INF" unitRef="U_shares">9149</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000861" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090922" decimals="0" unitRef="U_iso4217USD">46662</us-gaap:CommonStockValue>
  <us-gaap:CommonStockSharesIssued id="F_000862" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20090928" decimals="INF" unitRef="U_shares">64227</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000863" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_20090928" decimals="0" unitRef="U_iso4217USD">398209</us-gaap:CommonStockValue>
  <arwr:CommonStockPurchasedFromMinorityShareHolders id="F_000864" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20090928" decimals="INF" unitRef="U_shares">5574</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <arwr:CommonStockPurchasedFromMinorityShareHolders id="F_000865" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20090928" decimals="INF" unitRef="U_shares">636699</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <us-gaap:CommonStockSharesIssued id="F_000866" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_arwrSeriesCOnePreferredStockMember_20090930" decimals="INF" unitRef="U_shares">27777</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000867" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_arwrSeriesCOnePreferredStockMember_20090930" decimals="0" unitRef="U_iso4217USD">186111</us-gaap:CommonStockValue>
  <us-gaap:CommonStockSharesIssued id="F_000868" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20091130" decimals="INF" unitRef="U_shares">15317</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000869" contextRef="C_0000879407_deiLegalEntityAxis_arwrUnidymIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_20091130" decimals="0" unitRef="U_iso4217USD">47485</us-gaap:CommonStockValue>
  <arwr:CommonStockPurchasedFromMinorityShareHolders id="F_000870" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20091130" decimals="INF" unitRef="U_shares">2850000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <us-gaap:CommonStockSharesIssued id="F_000871" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20091130" decimals="INF" unitRef="U_shares">114000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="F_000872" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20091130" decimals="0" unitRef="U_iso4217USD">706800</us-gaap:CommonStockValue>
  <arwr:WarrantsIssued id="F_000873" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20091130" decimals="INF" unitRef="U_shares">24000</arwr:WarrantsIssued>
  <arwr:WarrantsPurchased id="F_000874" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20091130" decimals="INF" unitRef="U_shares">600000</arwr:WarrantsPurchased>
  <arwr:CommonStockPurchasedFromMinorityShareHolders id="F_000875" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20100228" decimals="INF" unitRef="U_shares">200000</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <us-gaap:CommonStockSharesIssued id="F_000876" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20100228" decimals="INF" unitRef="U_shares">8000</us-gaap:CommonStockSharesIssued>
  <arwr:ValueOfCommonStockPurchasedByCash id="F_000877" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20100228" decimals="0" unitRef="U_iso4217USD">60000</arwr:ValueOfCommonStockPurchasedByCash>
  <arwr:WarrantsIssued id="F_000878" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20100228" decimals="INF" unitRef="U_shares">2400</arwr:WarrantsIssued>
  <arwr:ExercisePriceOfWarrants id="F_000879" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20100228" decimals="INF" unitRef="U_iso4217USD_shares">5.00</arwr:ExercisePriceOfWarrants>
  <arwr:WarrantsExercised id="F_000880" contextRef="C_0000879407_20100331" decimals="INF" unitRef="U_shares">24788</arwr:WarrantsExercised>
  <arwr:StockIssuedAgainstWarrants id="F_000881" contextRef="C_0000879407_20100331" decimals="INF" unitRef="U_shares">12870</arwr:StockIssuedAgainstWarrants>
  <arwr:CommonStockPurchasedFromMinorityShareHolders id="F_000882" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20100930" decimals="INF" unitRef="U_shares">1562.5</arwr:CommonStockPurchasedFromMinorityShareHolders>
  <arwr:WarrantsIssued id="F_000883" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20100930" decimals="INF" unitRef="U_shares">390625</arwr:WarrantsIssued>
  <arwr:ExercisePriceOfWarrants id="F_000884" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20100930" decimals="INF" unitRef="U_iso4217USD_shares">5.00</arwr:ExercisePriceOfWarrants>
  <us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1 id="F_000885" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20111001_20111021" decimals="INF" unitRef="U_shares">1288158</us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1>
  <arwr:BusinessCombinationConsiderationPromissoryNoteIssued id="F_000886" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20111021" decimals="0" unitRef="U_iso4217USD">50000</arwr:BusinessCombinationConsiderationPromissoryNoteIssued>
  <us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1 id="F_000887" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20120401_20120405" decimals="INF" unitRef="U_shares">315457</us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1>
  <us-gaap:CommonStockSharesIssued id="F_000888" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20121021" decimals="INF" unitRef="U_shares">239894</us-gaap:CommonStockSharesIssued>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability id="F_000889" contextRef="C_0000879407_20121001_20121021" decimals="0" unitRef="U_iso4217USD">986049</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock id="F_000890" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;NOTE 1. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt;Nature of Business &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 5pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Arrowhead Research Corporation is a biopharmaceutical company developing t&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;argeted RNAi therapeutics. The C&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ompany is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silence disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead&amp;#8217;s pipeline includes clinical programs in chronic hepatitis B virus and obesity and partner-based programs in oncology.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:18pt 0pt 0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt;Liquidity &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Historically, The Company&amp;#8217;s primary source of financing has been &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;through the sale of securities of Arrowhead&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; Research Corp.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Research and d&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;evelopment activities have required significant capital investment since the Company&amp;#8217;s inception and we expect our &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;operations &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;to continue to requir&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;e cash investment in fiscal 2014&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and beyond &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;as the C&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ompany continues its research and development efforts, as well as clinical trials, and related drug manufacturing.&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, the Company had $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;19.1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million in cash to fund operations. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In addition to its cash resources, the Company has invested excess cash in investment grade commercial bonds maturing in &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;less than 18 months&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&amp;#160; These bonds provide a source of liquidity, although the Company plans to hold them until maturity.&amp;#160; At September 30, 2013, the Company had invested $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;10.8&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million in these bonds.&amp;#160; During October 2013, the Company completed an additional financing through the sale of equity securities in the amount of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;60&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million, providing additional liquidity to the Company.&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;During the year ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, the Company&amp;#8217;s cash position &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;increased&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; by $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;15.7&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million. The Company received cash from the issuance of equity of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;44.5&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million, cash from the sale of its holdings of stock in Wisepower Co. Ltd of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1.4&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million, and&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; cash from&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;licensing revenue &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million. The C&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ompany had cash outflow of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;19.8&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million related to its continuing operating activities and capital expenditures of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;On October&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;21, 2011, Arrowhead completed the acquisition of certain RNAi assets from Hoffmann-La Roche Inc. and F. Hoffmann-La Roche Ltd., including intellectual property and a research and development facility in Madison, Wisconsin. At the time of the acquisition, the facility had &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;41&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; employees. Due to the costs associated with operating the facility, including personnel costs, rent, research and development expenses, and other costs, cash expenses have increased, and it is expected that the Company will incur higher cash expenses during the remainder of 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and beyond, relative to periods prior to the acquisition, as the Company accelerates its preclinical and clinical development efforts.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:18pt 0pt 0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt;Summary of Significant Accounting Policies &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Principles of Consolidation&amp;#8212;The consolidated financial statements include the accounts of Arrowhead and its &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Subsidiaries, Arrowhead Madison, Calando, Ablaris, Tego&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, and until its disposition in January 2011, Unidym. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In 2013, Agonn and Alvos were merged into Arrowhead.&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Prior to April 2008, Arrowhead&amp;#8217;s Subsidiaries included Insert Therapeutics, Inc. (&amp;#8220;Insert&amp;#8221;), which was merged with Calando in April 2008. The merged entity is majority-owned by Arrowhead and continues to operate under the name of Calando. In January&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2011, Arrowhead sold its interests in Unidym to Wisepower, and in December&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2009, Tego completed a sale of its assets to Luna Innovations, Inc. Unidym and Tego results are included in the Income (Loss) from Discontinued Operations. Income (Loss) from Discontinued Operations also includes Aonex Technologies, Inc., sold in May 2008, and Nanotechnica, Inc., dissolved in June 2005. All significant intercompany accounts and transactions are eliminated in consolidation, and noncontrolling interests are accounted for in the Company&amp;#8217;s financial statements. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Basis of Presentation and Use of Estimates&amp;#8212;The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&amp;#160; Actual results could differ from those estimates. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; Significant estimates made in preparing these financial statements include valuing the stock of the Subsidiaries, assumptions to calculate stock-based compensation expense, allowance for doubtful accounts, deferred tax asset valuation allowance, derivative assets and liabilities, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent consideration, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;noncontrolling interest and useful lives for depreciable and amortizable assets. Actual results could differ from those estimates. Additionally, certain reclassifications have been made to prior period financial statements to conform to the current period presentation. In the opinion of management, all adjustments, including normal recurring accruals considered necessary for a fair presentation, have been included. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Cash and Cash Equivalents&amp;#8212;The Company considers all liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; The Company had &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;no&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; restricted cash at September 30, 2012 and 2013&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Concentration of Credit Risk&amp;#8212;The Company maintains checking accounts for Arrowhead and separate accounts for&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; each Subsidiary at two&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; financial institutions. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;250,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per account. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institution&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;s&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; in which these deposits are held.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Investments&amp;#8212;the Company invests excess cash balances in short-term and long-term marketable debt securities. Investments may consist of certificates of deposits, money market accounts, government-sponsored enterprise securities, corporate bonds and/or commercial paper. The Company accounts for its investment in marketable securities in accordance with FASB ASC 320, Investments &amp;#8211; Debt and Equity Securities.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;This statement requires certain securities to be classified into three categories: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt 24.45pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Held-to-maturity&amp;#8212;Debt securities that the entity has the positive intent and ability to hold to maturity are reported at amortized cost. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt 24.45pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Trading Securities&amp;#8212;Debt and equity securities that are bought and held primarily for the purpose of selling in the near term are reported at fair value, with unrealized gains and losses included in earnings. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt 24.45pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Available-for-Sale&amp;#8212;Debt and equity securities not classified as either securities held-to-maturity or trading securities are reported at fair value with unrealized gains or losses excluded from earnings and reported as a separate component of shareholders&amp;#8217; equity. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The Company classifies its investments in marketable debt securities based on the facts and circumstances present at the time of purchase of the securities. At &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2013, the Company classified all of its investments as held-to-maturity. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Held-to-maturity investments are measured and recorded at amortized cost on the Company&amp;#8217;s Consolidated Balance Sheet. Discounts and premiums to par value of the debt securities are amortized to interest income/expense over the term of the security. No gains or losses on investment securities are realized until they are sold or a decline in fair value is determined to be other-than-temporary. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2013, all short-term investments were comprised of corporate bonds with maturity dates of less than one year. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Certain investments maturing in excess of twelve months, but &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;less than 24 months&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; are classified as long-term investments.&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of September 30, 2013, t&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;he amortized cost of such bonds was $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;10,732,414&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;For the year ended September 30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, g&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ross unrealized &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;losses were $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;41,643&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;gross unrealized gains&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; were &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;7,500&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. The to&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;tal fair value of the&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; investments &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;at September 30, 2013 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;was $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;10,698,271&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;See further information regarding fair market value of marketabl&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;e debt securities in Note 11&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &amp;#8211; Fair Value Measu&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;rements&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, such fair market data is obtained from independent pricing services. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Property and Equipment&amp;#8212;Property and equipment are recorded at cost, which may equal fair market value in the case of property and equipment acquired in conjunction with a business acquisition. Depreciation of property and equipment is recorded using the straight-line method over the respective useful lives of the assets ranging from &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;three&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; to &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;seven&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; years. Leasehold improvements are amortized over the lesser of the expected useful life or the remaining lease term. Long-lived assets, including property and equipment are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Intangible Assets Subject to A&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;mortization&amp;#8212;At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, intangible assets subject to amortization included patents and certain license agreements. Intangible assets subject to amortization are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In-Process Research&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;amp; Development (IPR&amp;amp;D)&amp;#8212;IPR&amp;amp;D assets represent capitalized on-going research projects that Arrowhead acquired through business combinations. Such assets are initially measured at their acquisition date fair values. The amounts capitalized are being accounted for as indefinite-lived intangible assets, subject to impairment testing until completion or abandonment of R&amp;amp;D efforts associated with the project. Upon successful completion of a project, Arrowhead will make a determination as to the then remaining useful life of the intangible asset and begin amortization. Based on early adoption of ASU 2012-02, Arrowhead tests its indefinite-lived assets for impairment at least annually, through a two-step process. The first step is a qualitative assessment to determine if it is more likely than not that the indefinite lived assets are impaired. Arrowhead considers relevant events and circumstances that could affect the inputs used to determine the fair value of the intangible assets. If the qualitative assessment indicates that it is more likely than not that the intangible assets is impaired, a second step is performed which is a quantitative test to determine the fair value of the intangible asset. If the carrying amount of the intangible assets exceeds its fair value, an impairment loss is recorded in the amount of that excess. If circumstances determine that it is appropriate, the Company may also elect to bypass step one, and proceed directly to the second step. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Contingent Consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; - &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The consideration for our acquisitions often includes future payments that are contingent upon the occurrence of a particular event.&amp;#160; For example, milestone payments might be based on the achievement of various regulatory approvals or future sales milestones, and royalty payments might be based on drug product sales levels. We record a &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligation for such contingent payments at fair value on the acquisition date. We estimate the fair value of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligations through valuation models designed to estimate the probability of such contingent payments based on various assumptions and incorporating estimated success rates.&amp;#160; Estimated payments are discounted using present value techniques to arrive at estimated fair value at the balance sheet date.&amp;#160; We revalue these &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligations each reporting period. Changes in the fair value of our &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligations are recognized within our consolidated statements of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;operations&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. Changes in the fair value of the &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligations can result from changes to one or multiple inputs, including adjustments to the discount rates, changes in the amount or timing of expected expenditures associated with product development, changes in the amount or timing of cash flows from products upon commercialization, changes in the assumed achievement or timing of any development milestones, changes in the probability of certain clinical events and changes in the assumed probability associated with regulatory approval. These fair value measurements are based on significant inputs not observable in the market. Significant judgment is employed in determining the appropriateness of these assumptions as of the acquisition date and for each subsequent period. Accordingly, changes in assumptions could have a material impact on the amount of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; expense we record in any given period.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Equity Investments&amp;#8212;Arrowhead had&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; a noncontrolling equity investment in Nanotope, a privately held biotechnology company, which is recorded in Other Assets. Historically, this investment was carried at cost less Arrowhead&amp;#8217;s proportionate share of Nanotope&amp;#8217;s operating loss for the period since investment. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The investment was fully reserved in 2012.&amp;#160; During 2013, Nanotope was dissolved&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Minority Equity Investments&amp;#8212;The Company&amp;#8217;s minority equity investment in Leonardo, a privately&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; held biotechnology company, had&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; been recorded in Other Assets, howeve&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;r, an impairment charge was&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; recorded in 2012, and its net book value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; is &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$0&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. This investment has been accounted for under the cost method of accounting. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Noncontrolling Interests in Majority-Owned Subsidiaries&amp;#8212;Operating losses applicable to majority-owned Calando, Ablaris and, prior to its disposal, Unidym have periodically exceeded the noncontrolling interests in the equity capital of either Subsidiary. Such excess losses applicable to the noncontrolling interests have been and are borne by the Company as there is no obligation of the noncontrolling interests to fund any losses in excess of their original investment. There is also no obligation or commitment on the part of the Company to fund operating losses of any Subsidiary whether wholly-owned or majority-owned. The Company allocates the noncontrolling interest&amp;#8217;s share of net loss in excess of the noncontrolling interest&amp;#8217;s initial investment in accordance with FASB ASC 810-10. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;When there is a change in the Company&amp;#8217;s proportionate share of a development-stage Subsidiary resulting from additional equity transactions in a Subsidiary, the change is accounted for as an equity transaction in consolidation. To the extent that the increase in the calculated value of the Company&amp;#8217;s interest in the equity of the Subsidiary exceeds the Company&amp;#8217;s investment in the offering, that increase in value is referred to as the Company&amp;#8217;s &amp;#8220;increase in its proportionate share of the Subsidiary&amp;#8217;s equity&amp;#8221; and the amount is recorded as an increase in the Company&amp;#8217;s Additional Paid-in Capital. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Revenue Recognition&amp;#8212;Revenue from license fees are recorded when persuasive evidence of an arrangement exists, title has passed or services have been rendered, a price is fixed and determinable, and collection is reasonably assured. We may generate revenue from product sales, technology licenses, collaborative research and development arrangements, and research grants. Revenue under technology licenses and collaborative agreements typically consists of nonrefundable and/or guaranteed technology license fees, collaborative research funding and various milestone and future product royalty or profit-sharing payments. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Revenue associated with research and development funding payments under collaborative agreements, is recognized ratably over the relevant periods specified in the agreement, generally the research and development period. Revenue from up-front license fees, milestones and product royalties are recognized as earned based on the completion of the milestones and product sales, as defined in the respective agreements. Payments received in advance of recognition as revenue are recorded as deferred revenue. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Allowance for Doubtful Accounts&amp;#8212;The Company accrues an allowance for doubtful accounts based on estimates of uncollectible revenues by analyzing historical collections, accounts receivable aging and other factors. Accounts receivable are written off when all collection attempts have failed. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Research and Development&amp;#8212;Costs and expenses that can be clearly identified as research and development are charged to expense as incurred in accordance with FASB ASC 730-10. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Earnings (Loss) per Share&amp;#8212;Basic earnings (loss) per share is computed using the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share are computed using the weighted-average number of common shares and dilutive potential common shares outstanding during the period. Dilutive potential common shares primarily consist of stock options issued to employees and consultants and warrants to purchase Common Stock of the Company.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Stock-Based Compensation&amp;#8212;The Company accounts for share-based compensation arrangements in accordance with FASB ASC 718, which requires the measurement and recognition of compensation expense for all share-based payment awards to be based on estimated fair values. We use the Black-Scholes option valuation model to estimate the fair value of our stock options at the date of grant. The Black-Scholes option valuation model requires the input of subjective assumptions to calculate the value of stock options. We use historical data among other information to estimate the expected price volatility and the expected forfeiture rate. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Derivative Assets and Liabilities -&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;We account for warrants and other derivative financial instruments as either equity or assets/liabilities based upon the characteristics and provisions of each instrument. Warrants classified as equity are recorded as additional paid-in capital on our consolidated balance sheet and no further adjustments to their valuation are made. Some of our warrants were determined to be ineligible for equity classification because of provisions that may result in an adjustment to their exercise price. Warrants classified as derivative liabilities and other derivative financial instruments that require separate accounting as assets or liabilities are recorded on our consolidated balance sheet at their fair value on the date of issuance and are revalued on each subsequent balance sheet date until such instruments are exercised or expire, with any changes in the fair value between reporting periods recorded as other income or expense. We estimate the fair value of these assets/liabilities using option pricing models that are based on the individual characteristics of the warrants or instruments on the valuation date, as well as assumptions for expected volatility, expected life and risk-free interest rate&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Income Taxes&amp;#8212;The Company accounts for income taxes under the liability method, which requires the recognition of deferred income tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred income tax assets to the amount expected to be realized. The provision for income taxes, if any, represents the tax payable for the period and the change in deferred income tax assets and liabilities during the period. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:18pt 0pt 0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;Recently Issued Accounting Standards &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In July 2012, the FASB issued ASU 2012-02, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt;Testing Indefinite-Lived Intangible Assets for Impairment,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; which amended the guidance in ASU 2011-08 to simplify the testing of indefinite-lived intangible assets other than goodwill for impairment. ASU 2012-02 becomes effective for annual and interim impairment tests performed for fiscal years beginning on or after September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;15, 2012 and earlier adoption is permitted. We adopted this standard in the third quarter of fiscal year 2012. We believe adoption did not have a material effect on our financial statements. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In September 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2011-08, Intangibles&amp;#8212;Goodwill and Other (Topic 350)&amp;#8212;Testing Goodwill for Impairment (ASU 2011-08), to allow entities to use a qualitative approach to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If after performing the qualitative assessment an entity determines it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step goodwill impairment test is unnecessary. However, if an entity concludes otherwise, then it is required to perform the first step of the two-step goodwill impairment test. ASU 2011-08 is effective for us in fiscal 2013 and earlier adoption is permitted. The adoption of ASU 2011-08 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;did not have a material&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; impact on our financial position, results of operations or cash flows. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In May 2011, the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued ASU 2011-04, Fair Value Measurement (&amp;#8220;ASU 2011-04&amp;#8221;), which amended ASC 820, Fair Value Measurements (&amp;#8220;ASC 820&amp;#8221;), providing a consistent definition and measurement of fair value, as well as similar disclosure requirements between U.S. GAAP and International Financial Reporting Standards. ASU 2011-04 changes certain fair value measurement principles, clarifies the application of existing fair value measurement and expands the disclosure requirements. ASU 2011-04 was effective for us beginning January&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1, 2012. The adoption of ASU 2011-04 did not have a material effect on our consolidated financial statements or disclosures.&amp;#160; &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
  <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock id="F_000891" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;NOTE 2. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;NOTE RECEIVABLE&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As part of the proceeds from the sale of Unidym in January 2011, Arrowhead received a Note Receivable from Wisepower (the &amp;#8220;Wisepower Note&amp;#8221;) in the face amount of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2.5&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million. On January&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;24, 2013, the Company entered into an agreement to sell the Wisepower Note. As consideration for selling the Wisepower Note the Company received &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1,570,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Wisepower stock, (the &amp;#8220;First Tranche&amp;#8221;). Per the terms of the agreement, the Company was entitled to receive additional consideration (the &amp;#8220;Second Tranche&amp;#8221;) based on the proceeds realized from the First Tranche, at which time the Company would deliver the Wisepower Note to the Purchaser. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2013, the Company sold &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;all&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Wisepower from the First Tranche,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and realized approximately $1.4 million in proceeds&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. It is unclear when or if the Company will receive the Second Tranche. The Company recorded the $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1.4&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million proceeds realized from the First Tranche against the $2.5 million value of the Wisepower Note, and has recorded a reserve for the &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;balance of the receivable of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1.1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, which is presented as a part of other expense on the Company&amp;#8217;s Statement of Operations&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
  <us-gaap:CostAndEquityMethodInvestmentsDisclosureTextBlock id="F_000892" contextRef="C_0000879407_20121001_20130930">&lt;div style="text-align: left;"&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;NOTE 3. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;INVESTMENTS&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:27pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The Company invests its excess cash balances in short-term and long-term debt securities.&amp;#160; Investments at September 30, 2013 consisted of corporate bonds with maturities remaining of less than two years at the time of purchase.&amp;#160; The Company may also invest excess cash balances in certificates of deposit, money market accounts, US Treasuries, US government agency obligations, corporate debt securities, and/or commercial paper.&amp;#160; The Company accounts for its investments in accordance with FASB ASC 320, Investments &amp;#8211; Debt and Equity Securities.&amp;#160; At September 30, 2013, all investments were classified as held-to-maturity securities.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:27pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following table summarizes the Company&amp;#8217;s short and long-term investments as of September 30, 2013.&amp;#160; There were no comparable investments as of September 30, 2012.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
				&lt;tr&gt;
					&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="28" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;30, 2013&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr&gt;
					&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="3" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Amortized Cost&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="4" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Gross Unrealized Gains&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="3" style="border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="4" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Gross Unrealized Losses&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="3" style="border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="4" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Fair Value&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr&gt;
					&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
						&lt;p style="margin:0pt 0pt 0pt 12.25pt; text-indent:-12.25pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Commercial notes (due within one year)&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;9,030,261&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;7,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(39,281&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;8,998,480&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr&gt;
					&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
						&lt;p style="margin:0pt 0pt 0pt 12.25pt; text-indent:-12.25pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Commercial notes (due after one year through two years)&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,702,153&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(2,362&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,699,791&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td colspan="3" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr&gt;
					&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
						&lt;p style="margin:0pt 0pt 0pt 12.25pt; text-indent:-12.25pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Total&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;10,732,414&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;7,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(41,643&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;10,698,271&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;&lt;/table&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:CostAndEquityMethodInvestmentsDisclosureTextBlock>
  <us-gaap:BusinessCombinationDisclosureTextBlock id="F_000893" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;NOTE 4.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;ACQUISITIONS&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;Roche Madison &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;On October&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;21, 2011, the Company entered into a Stock and Asset Purchase Agreement (the &amp;#8220;RNAi Purchase Agreement&amp;#8221;) with Hoffmann-La Roche Inc. and F Hoffmann-La Roche Ltd (collectively, &amp;#8220;Roche&amp;#8221;), pursuant to which the Company purchased from Roche (&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;i&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;all of the outstanding common stock of Roche Madison Inc. (&amp;#8220;Roche Madison&amp;#8221;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, now &amp;#8220;Arrowhead Madison&amp;#8221;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;) and (ii)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;the intellectual property rights then held by Roche related to its RNAi business and identified in the RNAi Purchase Agreement (the &amp;#8220;Transaction&amp;#8221;). In consideration for the purchase of Roche Madison and the Roche RNAi assets, the Company issued to Roche a promissory note with a principal value of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;50,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1,288,158&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Common Stock&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Pursuant to the RNAi Purchase Agreement, Roche has a right of first negotiation on certain product candidates developed by the Company and its affiliates relating to the purchased assets. If the Company proposes to out-license or enters into substantive negotiations to out-license, any Clinical Candidate or Existing Candidate (as such terms are defined in the RNAi Purchase Agreement), the Company must give notice of the Candidate it proposes to out-license and negotiate exclusively and in good faith with Roche for 90 days regarding the applicable out-license. This right of first negotiation applies to all Existing Candidates (as defined in the RNAi Purchase Agreement) and the first five Clinical Candidates for which the Company delivers notice to Roche and subsequently enters into an out-license. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In addition to the consideration paid by the Company as per the closing terms, the Company is obligated to make certain royalty and milestone payments to Roche upon the occurrence of certain events. For certain product candidates that are developed by the Company that are covered by a valid claim by the patent rights transferred in the Transaction for which the Company and Roche do not enter into a licensing arrangement, the Company will be obligated to pay a 3% royalty on Net Sales (as defined in the RNAi Purchase Agreement), provided that the royalty rate may be reduced or offset in certain circumstances. The obligation to pay royalties on such candidates will last until the &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;later of (&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;i&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;the expiration of the last to expire patent right related to such product candidate that was transferred in the Transaction and (ii)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ten years after the first commercial sale of such product candidate.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The Company will also be obligated to make cash payments to Roche upon the achievement of various milestones&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; for certain clinical candidates&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;for which the Company and Roche do not enter into a licensing arrangement, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;including the first regulatory approval in certain jurisdictions&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and upon certain annual sales mi&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;lestones&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;for candidates that&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; receive regulatory approval. The potential payments range from $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2,500,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; to $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;6,000,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per milestone. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;At the time of acquisition, the &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Compan&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;y&amp;#8217;s estimate of future payments for potential royalties and milestones had&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; a net present value of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;84,935&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; w&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;hich was recorded&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; as contingen&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;t consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; as a part of other noncurrent liabilities. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; Contingent consideration is calculated by modeling research and development activities for clinical candidates, forecasting timelines to market, and using &amp;#8220;peak sales&amp;#8221; estimate modeling, cash flows and potential milestone and royalty payments are calculated.&amp;#160; The modeling assumes certain success rates, and discount factors related to riskiness of projects and the time value of money to calculate a net present value of future consideration payments to Roche.&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;These estimates are based on many unknown variables that are difficult to estimate, and due to the extended process of drug development prior to marketing of drug candidates, the models must extend many years into the future.&amp;#160; Such predictions are inherently uncertain.&amp;#160; Each year, the Company re-evaluates its contingent consideration, and if material, makes adjustments to the recorded liability.&amp;#160; Any adjustment to the contingent consideration liability is reflected in the Company&amp;#8217;s Statement of Operations.&amp;#160; As of September 30, 2013, the contingent consideration liability had been increased by $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1.4&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million, which is recorded as a part of other noncurrent liabilities on the Company&amp;#8217;s Consolidated Balance Sheet.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; For additional information related to our valuation of this obligation, see &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt;Note 11, Fair Value Measurements&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following table summarizes the estimated fair values at the date of acquisition: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Current assets&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;432,709&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Property and equipment&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;7,215,206&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Intangible assets&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,174,935&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Other noncurrent assets&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;6,264&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Current liabilities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(414,122&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Noncurrent liabilities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(1,570,072&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Gain on purchase&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(1,576,106&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Total purchase consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5,268,814&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The purchase consideration was composed of the following: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Promissory note due Roche&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;50,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Contingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;84,935&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Shares issued to Roche&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5,133,879&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Total purchase consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5,268,814&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;We estimated the fair value of the assets and liabilities acquired through various valuation techniques including a market approach and an income approach. Because the net identifiable tangible and intangible assets and liabilities were in excess of the purchase price, a gain on the purchase of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1.6&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million was recorded. The most significant assets capitalized were research equipment and certain in-process research and development. We believe that we were able to acquire these assets at a reasonable purchase price and generate a gain on the transaction due in part from the seller&amp;#8217;s desire to exit the relatively early stage of the RNAi business, as compared to the seller&amp;#8217;s other business operations, as well as the seller&amp;#8217;s desire to dispose of certain on-going costs associated with the facility, primarily lease costs and personnel costs, which were synergistic to the Company&amp;#8217;s strategy to establish a research facility to advance development efforts for its drug product candidates. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:18pt 0pt 0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;Alvos Therapeutics &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;On April&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5, 2012, the Company entered into a Stock Purchase Agreement to purchase all of the outstanding shares of Alvos Therapeutics, Inc., (&amp;#8220;Alvos&amp;#8221;), a privately held company that licensed a large platform of proprietary human-derived Homing Peptides, and the method for their discovery, from MD Anderson Cancer Center. In conjunction with the acquisition, Arrowhea&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;d hired one employee from Alvos&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. In exchange for all of the outstanding shares of Alvos, Arrowhead issued an upfront payment of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;315,4&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;7&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Common Stock. The former Alvos stockholders are also eligible to receive additional issuances of stock valued at up to $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;23.5&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million at the time of issuance based on the future achievement of clinical, regulatory and sales milestones. Based on the Company&amp;#8217;s estimate of future payments, a net present value of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;88,686&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; was calculated as contingent consideration, and is recorded as a part &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;of other noncurrent liabilities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160; Similar to contingent consideration related to the Roche Madison acquisition, a forecasting model was used to determine potential future payments to the former shareholders of Alvos. Each year, the Company re-evaluates its contingent consideration, and if material, makes adjustments to the recorded liability.&amp;#160; Any adjustment to the contingent consideration liability is reflected in the Company&amp;#8217;s Statement of Operations. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;No adjustments to this contingent consideration have been made since the date of acquisition.&amp;#160; For additional information related to our valuation of this obligation, see &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt;Note 11, Fair Value Measurements&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following table summarizes the estimated fair values at the date of acquisition: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Current assets&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;29,332&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In-process R&amp;amp;D&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,172,387&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Current liabilities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(113,033&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Total purchase consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,088,686&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:12pt 0pt 0pt 24.45pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The purchase consideration was comprised solely of shares of Arrowhead Common Stock issued to the former shareholders of Alvos Therapeutics, Inc. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Shares issued&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;315,457&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Price per share&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;6.34&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Share consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,000,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Contingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;88,686&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Total purchase consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,088,686&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
  <us-gaap:IntangibleAssetsDisclosureTextBlock id="F_000894" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;NOTE 5. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;INTANGIBLE ASSETS&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Intangible assets consist of in-process research and development (IPR&amp;amp;D) not subject to amortization, and patents and other intangible assets subject to amortization, which were capitalized as a part of a business combination. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;IPR&amp;amp;D represents projects that have not yet received regulatory approval and are required to be classified as indefinite assets until the successful completion or the abandonment of the associated R&amp;amp;D efforts. Accordingly, during the development period after the date of acquisition, these assets will not be amortized until approval is obtained in one or more jurisdictions which, individually or combined, are expected to generate a significant portion of the total revenue expected to be earned by an IPR&amp;amp;D project. At that time, we will determine the useful life of the asset, reclassify the asset out of IPR&amp;amp;D and begin amortization. If the associated R&amp;amp;D effort is abandoned the related IPR&amp;amp;D assets will likely be written off and we would record an impairment loss. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Intangible assets subject to amortization include patents capitalized as part of a business combination as well as license agreements capitalized as part of a business combination from the acquisition of Roche Madison. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The license agreements are being amortized over the estimated life remaining at the time of acquisition which was &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;4&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; years. Patents are amortized over a period of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;three&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; years to &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;twenty&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; years. The weighted average original amortization period is &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;twelve&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; years. Amortization of license agreements and patents is expected to be approximately $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;55&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; for fiscal years 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;4 and &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;13&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; in 2016,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and zero thereafter. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;On August 5, 2013, Calando terminated a License Agreement with the California Institute of Technology (the &amp;#8220;License&amp;#8221;).&amp;#160; The License provided Calando with exclusive rights to develop and commercialize therapeutics based on the linear cyclodextrin drug delivery technology invented at Caltech.&amp;#160; The drug delivery technology platforms, Cyclosert&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:6.67pt; vertical-align:super"&gt;TM&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and RONDEL&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:6.67pt; vertical-align:super"&gt;TM&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, as well as the drug candidates IT-101 and CALAA-01, were developed based on the licensed technology.&amp;#160; Calando was responsible to direct and pay for the prosecution of the patents and patent applications covered by the License and to progress the technology. In conjunction with a previous business acquisition, the patents covered by this license agreement had been capitalized, and had a net book value of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million at June 30, 2013.&amp;#160; Management has determined that the value of the patents was impaired as of June 30, 2013, and the Company recorded an impairment charge of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million, and is presented as a part of operating expenses for the year ended September 30, 2013.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;We review amounts capitalized as&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; IPR&amp;amp;D&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; for impairment at least annually in the fourth quarter, and whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In the event the carrying value of the assets is not expected to be recovered, the assets are written down to their estimated fair values. We continue to test our indefinite-lived IPR&amp;amp;D assets for potential impairment until the projects are completed or abandoned. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The below table provides details on our intangible asset balances: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Intangible&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;assets&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;not subject to&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;amortization&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Intangible&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;assets&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;subject to&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;amortization&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Total&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Intangible&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;assets&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Balance at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2011&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,731,211&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,731,211&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Additions&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Madison acquisition&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;944,935&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;230,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,174,935&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Additions&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Alvos acquisition&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,172,387&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,172,387&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Amortization&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(293,964&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(293,964&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Balance at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2012&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3,117,322&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,667,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;247&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4,784,569&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Impairment&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(1,308,047&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(1,308,047&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Amortization&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(236,009&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; (236,009&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Balance at September 30, 2013&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3,117,322&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;123,191&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3,240,513&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
					&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
  <us-gaap:EquityMethodInvestmentsDisclosureTextBlock id="F_000895" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;NOTE 6. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;INVESTMENT IN SUBSIDIARIES&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In addition to &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;100&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;% ownership interest in Arrowhead Madison Inc., Arrowhead also maintains majority ownership in Calando Pharmaceuticals, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Ablaris&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; Therapeutics, Inc., and &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;a minority investment in&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; Leonardo &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Biosystems&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, Inc. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:18pt 0pt 0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt;Calando Pharmaceuticals, Inc. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Calando is a clinical stage &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;RNAi&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; therapeutics company. On April&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;17, 2008, Calando merged with and into Insert, with Insert as the surviving company. Prior to the merger, Arrowhead invested an aggregate of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;23.2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million in Calando through equity and debt financings. As a condition of the merger, the Preferred Stock of each of Calando and Insert was converted into common stock and the loans were converted to equity. As a result of the merger, shares of Insert common stock were issued to the stockholders of the former Calando, and Insert changed its name to Calando Pharmaceuticals, Inc. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;On November&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;26, 2008, Calando entered into Unsecured Convertible Promissory Note Agreements (&amp;#8220;Notes&amp;#8221;) for $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2.5&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million with accredited investors and Arrowhead, which invested $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;200,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; in the Notes offering. Arrowhead subsequently invested an additional $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;600,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; in the same offering. Except for one Note in the principal amount of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;500,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, all Notes and accrued interest were converted into a total of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2,950&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Calando Series A Preferred Stock on June&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;23, 2009. The remaining Note is due November&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;26, 2013; see Note 4 for further information. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, Calando owed to Arrowhead $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;4.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million under a series of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;8&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;% simple interest notes and advances. It is expected that these loans will either be repaid or converted to equity in the future. The balance of the notes and advances is eliminated in consolidation. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, Arrowhead owned &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;79&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;% of the outstanding shares of Calando and &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;76&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;% on a fully diluted basis. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:18pt 0pt 0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt;Ablaris&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt; Therapeutics, Inc. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Ablaris&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; was formed and began op&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;erations in&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; fiscal 2011, based on the license of certain anti-obesity technology developed at the MD Anderson Cancer Center at the University of Texas. During &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;fiscal 2011&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Ablaris&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; raised $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2.9&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million in cash, of which $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million was invested by Arrowhead and $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1.6&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million was invested by outside investors, through the issuance of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Ablaris&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; Series A Preferred stock. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, Arrowhead owned &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;64&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;% of the outstanding shares of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Ablaris&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;64&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;% on a fully diluted basis. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:18pt 0pt 0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt;Leonardo &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt;Biosystems&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt;, Inc. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Leonardo is developing a drug-delivery platform technology based on novel methods of designing porous silicon &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;microparticles&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; that selectively accumulate in tumor vasculature. Arrowhead accounts for its investment in Leonardo using the cost method of accounting. As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, Leonardo owed to Arrowhead $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1.1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million, which is fully reserved due to the uncertainty of whether such amount will be repaid&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, Arrowhead&amp;#8217;s ownership interest in Leonardo was&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
  <us-gaap:DebtDisclosureTextBlock id="F_000896" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;NOTE 7. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;NOTES PAYABLE&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;On November&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;26, 2008, Calando entered into Unsecured Convertible Promissory Note Agreements (&amp;#8220;Notes&amp;#8221;) for $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2.5&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million with accredited investors and Arrowhead, which invested $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;200,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; in the Notes offering. Arrowhead subsequently invested an additional $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;600,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; in the same offering. Except for one Note in the principal amount of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;500,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, all Notes and accrued interest were converted into a total of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2,950&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Calando Series A Preferred Stock on June&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;23, 2009. The remaining Note had a 10% interest rate, matured on November&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;26, 2010, and was renegotiated and extended until &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;November&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;26, 2013&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. The terms of the new note include a &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;10%&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; interest rate and require &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;two t&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;imes principal payment&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; at maturity. At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;t&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;he Note is reflected on the balance sheet at the maturity amount of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;million &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;less a discount of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;28,443&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock id="F_000897" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;NOTE 8.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;STOCKHOLDERS&amp;#8217; EQUITY&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, the Company had a total of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;150,000,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of capital stock authorized for issuance, consisting of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;145,000,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Common Stock, par value $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.001&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, and &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;5,000,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Preferred Stock, par value $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.001&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;32,489,444&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Common Stock were outstanding; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;9,900&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Preferred Stock were outstanding. At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;153,200&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares and &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3,419,285&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares were reserved for issuance upon exercise of options granted under Arrowhead&amp;#8217;s 2000 Stock Option Plan and 2004 Equity Incentive Plan, respectively. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The Preferred Stock is convertible to Common Stock by its holder at its stated conversion &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;price,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; though the Preferred Stock is not convertible to the extent the holder would beneficially own more than &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;9.99&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;% of the number of Common Stock immediately after the conversion.&amp;#160; The holders of Preferred Stock are eligible to vote with the Common Stock of the Company on an as-converted basis, but only to the extent they are eligible for conversion without exceeding the 9.99% ownership limitation. The Preferred Stock does not carry a coupon, but the Preferred Stock is entitled to receive dividends on a &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;pari&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;passu&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; basis with Common Stock, when and if declared.&amp;#160; In any liquidation or dissolution of the Company, the holders of Preferred Stock are entitled to participate in the distribution of the assets, to the extent legally available for distribution, on a &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;pari&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;passu&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; basis with the Common Stock.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;On September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2011, the Company sold &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1,191,473&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Common Stock at a price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;3.80&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per share. Cash proceeds received in fiscal 2011 were $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;4.5&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;On October&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;4, 2011, the Company completed a second closing of the offering in which the Company sold &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;138,158&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Common Stock at a price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;3.80&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per share. Cash proceeds were $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;525,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;On October&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;20, 2011, the Company and Lincoln Park Capital Fund, LLC, an Illinois limited liability company (&amp;#8220;LPC&amp;#8221;) entered into a $15 million purchase agreem&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ent (the &amp;#8220;Purchase Agreement&amp;#8221;)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, whereby LPC agreed to purchase up to $15 million of Common Stock, subject to certain limitations, from time to time during the three-year term of the Purchase Agreement. The Company has the right, in its sole discretion, over a &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;36&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-month period to sell up to $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;15&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million of Common Stock (subject to certain limitations) to LPC, depending on certain conditions as set forth in the Purchase Agreement. As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, the Company had drawn $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million from the facility. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;On October&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;21, 2011 and October&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;24, 2011, the Company entered into Subscription Agreements with certain accredited investors (the &amp;#8220;Series A Purchasers&amp;#8221;), pursuant to which the Company issued and sold an aggregate of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1,015&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Series A Preferred Convertible Stock, $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.001&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; par value per share, at a purchase price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per share. The aggregate purchase price paid for the shares of Series A Preferred was $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1,015,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. On February&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;16, 2012, upon approval by the Company&amp;#8217;s shareholders, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1,015&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Arrowhead Series A Preferred Convertible Stock, $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.001&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; par value per share, were converted to &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;275,782&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Common Stock. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;On October&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;21, 2011, the Company entered into a Subscription Agreement with an accredited investor, pursuant to which the Company issued and sold an aggregate of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;675,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Common Stock, $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.001&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; par value per share, at a purchase price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;3.70&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per share. The aggregate purchase price paid by the purchaser for the shares of Common Stock is $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2,497,500&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;On August&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;10, 2012 the Company sold &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2,260,869&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; units at a price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2.76&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per unit. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;Each unit consisted of one share of common stock and a warrant to purchase&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.75&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of common stock at an exercise price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;3.25&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. Gross proceeds from the offering were $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;6.2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million excluding offering fees and expenses. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In December 2012, the Company sold &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1,825,079&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; units at a price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2.26&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per unit. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;Each unit consisted of one share of common stock and a warrant to purchase&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.5&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of common stock. Gross proceeds from the offering were $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;4.1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million excluding offering fees and expenses. The exercise price of these warrants was $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1.83&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; as of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2013&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, and may decrease based on certain specified events.&amp;#160; As a result, the Company determined these warrants were ineligible for equity classification.&amp;#160; Refer to Note 11 for further discussion regarding these warrants&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:5pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In January 2013, the Company sold &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1,667,051&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; units at a price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2.12&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per unit. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;Each unit consisted of one share of common stock and a warrant to purchase&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.5&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of common stock. Gross proceeds from the offering were $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;3.5&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million excluding offering fees and expenses. The exercise price of these warrants was $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1.83&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; as of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3, and may decrease based on certain specified events.&amp;#160; As a result, the Company determined these warrants were ineligible for equity classification.&amp;#160; Refer to Note 11 for further discussion regarding these warrants&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:5pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In May 2013, the Company sold &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;14.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;million shares of Arrowhead common stock at a price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1.83&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per share and &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;9,900&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Arrowhead series B convertible preferred stock at a price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per share. The series B preferred stock is convertible into common stock at a conversion price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1.83&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. Gross proceeds were $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;36&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million. No warrants were issued in the May 2013 financing&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of November&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;17, 2011, the &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;Company effected a 1 for 10 reverse stock split&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. As a result of the reverse stock split, each ten shares of the Company&amp;#8217;s Common Stock issued and outstanding immediately prior to the reverse stock split was combined into one share of Common Stock. Also, as a result of the reverse stock split, the per share exercise price, and the number of shares of Common Stock underlying Company stock options, warrants, and any Common Stock based equity grants outstanding immediately prior to the reverse stock split was proportionally adjusted, based on the one-for-ten split ratio, in accordance with the terms of such options, warrants or other Common Stock based equity grants as the case may be. No fractional shares of Common Stock were issued in connection with the reverse split. Stockholders received a cash payment in lieu of any fractional shares. All share and per share amounts in these financial statements have been retrospectively adjusted to reflect the reverse stock split. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following table summarizes information about warrants outstanding at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th colspan="5" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Exercise&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;prices&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Number&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;of&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Warrants&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="5" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Remaining&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Life&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;in&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Years&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;70.60&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;94,897&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3.6&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5.00&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,155,023&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;461,024&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.38&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;187,313&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4.16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3.25&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,685,870&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2.9&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2.12&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;75,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.83&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;742,396&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td colspan="5" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Total warrants outstanding&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4,402,523&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
					&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:LeasesOfLesseeDisclosureTextBlock id="F_000898" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;NOTE 9. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;LEASES&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In May 2012, the Company signed a lease for new office space for its corporate headquarters, and moved into the new location in August 2012. The lease has a &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;five&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-year term; rental costs are approximately $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;13,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per month, increasing &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;3%&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; annually&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The Company&amp;#8217;s research facility in Madison, Wisconsin is leased through February&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;28, 2019. Monthly rental expense is approximately $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;22,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. Other monthly rental expenses include common area maintenance and real estate taxes totaling approximately $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;13,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per month. Utilities costs are approximately $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;15&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per month. Including monthly payments recorded under a capital lease of approximately $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;21,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, total monthly costs are approximately $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;71&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per month. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Facility and equipment rent expense, related to continuing operations, for the year ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; was $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;534,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;480,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, respectively. From inception to date, rent expense was $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;4,660,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, future minimum lease payments due in fiscal years under capitalized leases are as follows: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;4 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;256,846&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;256,846&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;6 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;256,846&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;7 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;256,846&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;8 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;256,846&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;9 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;and thereafter&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;107,019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Less interest&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;108,79&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Principal&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,282,458&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Less current portion&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;221,345&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Noncurrent portion&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,061,113&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, future minimum lease payments due in fiscal years under operating leases are as follows: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;4 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;434,229&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;445,921&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;6 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;457,961&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;7 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;470,154&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;8 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;359,370&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;9 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;and thereafter&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;125,415&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Total&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,293,050&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:LeasesOfLesseeDisclosureTextBlock>
  <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock id="F_000899" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;NOTE 10. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;STOCK-BASED COMPENSATION&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Arrowhead has two plans that provide for equity-based compensation. Under the 2000 Stock Option Plan, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;153,200&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Arrowhead&amp;#8217;s Common Stock are reserved for issuance upon exercise of non-qualified stock options. No further grants can be made under the 2000 Stock Option Plan. The 2004 Equity Incentive Plan reserves &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;,965,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;185&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares for the grant of stock options, stock appreciation rights, restricted stock awards and performance unit/share awards by the Board of Directors to employees, consultants and others. As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, there were options granted and outstanding to purchase &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;15&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2,900&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2,965,185&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Common Stock under the 2000 Stock Option Plan and the 2004 Equity Incentive Plan, respectively. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Also, as of September 30, 2013, there were 301,200 shares reserved for options issued outside of equity compensation plans, as inducement grants to new employees. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;During the year ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1,459,166&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; options were granted under the 2004 Equity Incentive Plan, and &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;50,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; o&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ptions were granted outside of equity i&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ncentive plans as inducement&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; stock options to new employees&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following tables summarize i&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;nformation about stock options:&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Number&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;of&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Options&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Outstanding&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Weighted-&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Average&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Exercise&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Price&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Per&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Share&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Weighted-&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Average&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Remaining&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Contractual&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Term&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Aggregate&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Intrinsic&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Value&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Balance At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;729,096&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;9.03&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Granted&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,229,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4.40&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Cancelled&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;42,919&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;11.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Exercised&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;4,883&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5.2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;0&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:middle"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:middle"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Balance At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,910,794&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;6.10&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Granted&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,509,166&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;0&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Cancelled&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Exercised&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(675&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;93&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:middle"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:middle"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Balance At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3,419,285&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4.68&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;8.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;years&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5,811,926&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Exercisable At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,306,306&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;6.55&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;6.7&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; years&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,127,819&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
					&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Stock-based compensation expense for the year ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; was $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1,536,271&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1,241,404&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, respectively&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. There i&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;s no income tax benefit as the C&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ompany is currently operating at a loss and an actual income tax benefit may not be realized. The loss creates a timing difference, resulting in a deferred tax asset, which is fully reserved by a valuation allowance. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The fair value of the options granted by Arrowhead for the years ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; is estimated at $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2,843,575&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;4,091,117&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, respectively. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;No&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; Calando stock options were issued in fiscal 2013; t&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;he aggregate fair value of options granted by Calando during the years ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; is estimated at&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;33,690&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The intrinsic value of the options exercised during the years ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; was $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;554&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, respectively. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, the pre-tax compensation expense for all unvested stock options at Arrowhead in the amount of approximately $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;5,072,252&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; will be recognized in our results of operations over a weighted average period of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;3.1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;years. As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, the pre-tax compensation expense for all unvested stock options at Calando in the amount of approximately $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;32,952&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; will be recognized in our results of operations over a weighted average period of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;years. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The fair value of each stock option award is estimated on the date of grant using the Black-Scholes option pricing model. The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options, which do not have vesting restrictions and are fully transferable. The determination of the fair value of each stock option is affected by our stock price on the date of grant, as well as assumptions regarding a number of highly complex and subjective variables. Because the Company&amp;#8217;s employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management&amp;#8217;s opinion, the existing models do not necessarily provide a reliable single measure of the fair value of its employee stock options. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The assumptions used to value stock options are as follows: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="6" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Year&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;ended&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;30,&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom" colspan="3"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt; &lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt; &lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Dividend yield&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Risk-free interest rate&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="3"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;0.7&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;to&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;0.9%&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; to&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1.7%&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Volatility&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:center; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;69&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;p style="text-align:center; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;90% - 100%&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Expected life (in years)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="3"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5.5 to 6.25&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5.5 to 6.25&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Weighted average grant date fair value per share of options granted&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:center; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:center; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.88&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:center; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:center; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3.32&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;/tr&gt;
					&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The dividend yield is &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;zero&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; as the Company currently does not pay a dividend. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The risk-free interest rate is based on the U.S. Treasury bond. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Volatility is estimated based on volatility average of the Company&amp;#8217;s Common Stock price. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock id="F_000900" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;NOTE 11.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;FAIR VALUE MEASU&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;REMENTS&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The Company measures its financial assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., exit price) in an orderly transaction between market participants at the measurement date. Additionally, the Company is required to provide disclosure and categorize assets and liabilities measured at fair value into one of three different levels depending on the assumptions (i.e., inputs) used in the valuation. Level&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1 provides the most reliable measure of fair value while Level&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3 generally requires significant management judgment. Financial assets and liabilities are classified in their entirety based on the lowest level of input significant to the fair value measurement. The fair value hierarchy is defined as follows: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Level&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1&amp;#8212;Valuations are based on unadjusted quoted prices in active markets for identical assets or liabilities. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Level&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&amp;#8212;Valuations are based on quoted prices for similar assets or liabilities in active markets, or quoted prices in markets that are not active for which significant inputs are observable, either directly or indirectly. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Level&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&amp;#8212;Valuations are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. Inputs reflect management&amp;#8217;s best estimate of what market participants would use in valuing the asset or liability at the measurement date. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following table summarizes fair value measurements at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; for assets and liabilities measured at fair value on a recurring basis: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Level 1&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Level 2&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Level 3&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Total&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Cash and cash equivalents&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;19,114,444&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;19,114,444&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Marketable securities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;10,698,271&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;0&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;,698,271&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Derivative assets&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Derivative liabilities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4,096,363&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4,096,363&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Acquisition related c&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ontingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligations&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
					&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:12pt 0pt 0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Level 1&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Level 2&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Level 3&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Total&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Cash and cash equivalents&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3,377,288&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3,377,288&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Marketable securities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;106,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;106,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Derivative assets&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;250,250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;250,250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Derivative liabilities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;647,213&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;647,213&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Acquisition related c&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ontingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligations&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;173,621&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;173,621&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
					&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The Company invests its excess cash balances in short and long-term corporate bonds, generally with remaining maturities of less than two years.&amp;#160; At September 30, 2013, the Company had short-term investment&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;s&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;$9,030&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;261&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, and long-term investments of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;$1,702,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;153&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, for a total of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;$10,732,414&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&amp;#160; The fair value of its investment at September 30, 2013 was &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;$10,698,271&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&amp;#160; The Company expects to hold such investments until maturity, and thus unrealized gains and losses from the fluctuations in the fair value of the securities are not likely to be realized.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As part of the proceeds from the sale of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Unidym&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; in January 2011, Arrowhead received a bond from &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Wisepower&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; in the face amount of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;$2.5&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million. The bond is convertible to &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Wisepower&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; common stock at a price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2.00&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per share. The conversion feature is subject to derivative accounting as prescribed under ASC 815. Accordingly, the fair value of the conversion feature on the date of issuance was estimated using an option pricing model and recorded on the Company&amp;#8217;s consolidated balance sheet as a derivative asset. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;This was offset somewhat by the portion of the bond that was owed to a third party in the amount of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;10,646&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; as of September 30, 2012, reduced to &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;zero&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; at September 30, 2013.&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The fair value of the conversion feature is estimated at the end of each reporting period and the change in the fair value of the conversion feature is recorded as a &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;nonoperating&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; gain/loss as change in value of derivatives in Company&amp;#8217;s Consolidated Statement of Operations. During the quarter ended March&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;31, 2013, the trading of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Wisepower&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; stock was halted. Trading resumed in July 2013, but the trading price is significantly below the conversion price.&amp;#160; The Company determined that the probability of realizing value from the conversion feature was remote, and the derivative asset value has been reduced to &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;zero&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;During th&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;e year ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, the Company recorded a gain from the change in fair value of the derivative asset of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;250,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;250&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:9pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The assumptions used in valuing the derivative asset as of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; were as follows: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:9pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:9pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;30,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt; 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;3&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;30,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt; 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;2&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Risk free interest rate&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:right; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;0.23&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;p style="text-align:right; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Expected life&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Years&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Dividend yield&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;none&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Volatility&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:right; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;72&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;p style="text-align:right; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;/tr&gt;

				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following is a reconciliation of the derivative asset for the years ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:9pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:9pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;61,125&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Receipt of instruments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Increase &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;in value&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;89,125&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Net settlements&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at October&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;250,250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Receipt of instruments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Dec&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;rease in value&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(250,25&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;0&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Net settlements&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; widows:0; orphans:0; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As part of an equity financing in June 2010, Arrowhead issued warrants to acquire up to &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;329,649&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Common Stock (the &amp;#8220;2010 Warrants&amp;#8221;), of which &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;187,313&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; warrants were outstanding at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2013, which contain a mechanism to adjust the strike price upon the issuance of certain dilutive equity securities. If during the term of the 2010 Warrants, the Company issues Common Stock at a price lower than the exercise price of the 2010 Warrants, the exercise price of the 2010 Warrants would be reduced to the amount equal to the issuance price of the Common Stock. Similarly, as part of a financing in December 2012, Arrowhead issued warrants to acquire up to &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;912,543&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Common Stock (the &amp;#8220;2012 Warrants&amp;#8221;) of which &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;415,761&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; warrants were outstanding at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2013, which contain a mechanism to adjust the strike price upon the issuance of certain dilutive equity securities. If during the term of the 2012 Warrants, the Company issues Common Stock at a price lower than the exercise price of the 2012 Warrants, the exercise price of the 2012 Warrants would be reduced to the amount equal to the issuance price of the Common Stock. Further, as part of a financing in January 2013, Arrowhead issued warrants to acquire up to &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;833,530&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Common Stock (the &amp;#8220;2013 Warrants&amp;#8221;) of which &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;326,635&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; warrants were outstanding at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2013 which contain a mechanism to adjust the strike price upon the issuance of certain dilutive equity securities. If during the term of the 2013 Warrants, the Company issues Common Stock at a price lower than the exercise price of the 2013 Warrants, the exercise price of the 2013 Warrants would be reduced to the amount equal to the issuance price of the Common Stock.&amp;#160; As a result of these features, the 2010 Warrants, the 2012 Warrants, and the 2013 Warrants are subject to derivative accounting as prescribed under ASC 815. Accordingly, the fair value of the Warrants on the date of issuance was estimated using an option pricing model and recorded on the Company&amp;#8217;s consolidated balance sheet as a derivative liability. The fair value of the Warrants is estimated at the end of each reporting period and the change in the fair value of the Warrants is recorded as a &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;nonoperating&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; gain or loss in the Company&amp;#8217;s consolidated statement of operations. During the year ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2013, the Company recorded a non-cash loss from the change in fair value of the derivative liability of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;5,066,591&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The assumptions used in valuing the derivative liability as of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; were as follows: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;2010 Warrants&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;30,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;2013&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;30,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;2012&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;0.33&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;0.31&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Expected life&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt 0pt 0pt 36pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2.2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Years&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt 0pt 0pt 36pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3.2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Years&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;one&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;one&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Volatility&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;69&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;100&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;2012 Warrants&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt; 30, 2013&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;September 30, 2012&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;39&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Expected life&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt 0pt 0pt 36pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;4.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Years&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;none&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Volatility&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;69&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;2013 Warrants&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt; 30, 2013&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;September 30, 2012&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.39&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Expected life&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt 0pt 0pt 36pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;4.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Years&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;none&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Volatility&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;69&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:1pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following is a reconciliation of the derivative liability related to these warrants for the years ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;907,233&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Receipt of instruments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Change in value&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;281&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;038&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Net settlements&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;6&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;26,195&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Issuance&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; of instruments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,153,819&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Change in value&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5,066,591&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Net settlements&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(3,754,808&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4,091&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;797&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; widows:0; orphans:0; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In conjunction with the financing of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Ablaris&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;in fiscal&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; 2011, Arrowhead sold exchange rights to certain investors whereby the investors have the right to exchange their shares of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Ablaris&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; for a prescribed number of Arrowhead shares based upon a predefined ratio. The exchange rights have a &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;seven&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-year term. During the first year, the exchange right allows the holder to exchange one &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Ablaris&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; share for &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.06&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; Arrowhead shares (as adjusted for a subsequent reverse stock split). This ratio declines to &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.04&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; in the second year, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.03&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; in the third year and &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.02&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; in the fourth year. In the fifth year and beyond the exchange ratio is &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.01&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. Exchange rights for &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;675,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Ablaris&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares were sold &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;in fiscal&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; 2011, and remain outstanding at Septembe&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;r&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2013&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. The exchange rights are subject to derivative accounting as prescribed under ASC 815. Accordingly, the fair value of the exchange rights on the date of issuance was estimated using an option pricing model and recorded on the Company&amp;#8217;s consolidated balance sheet as a derivative liability. The fair value of the exchange rights is estimated at the end of each reporting period and the change in the fair value of the exchange rights is recorded as a &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;nonoperating&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; gain or loss in the Company&amp;#8217;s Consolidated Statement of Operations. During the year ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, the Company recorded a non-cash loss from the change in fair value of the derivative liability of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;$&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;5,806&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The assumptions used in valuing the derivative liability as of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; were as follows: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;30,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt; 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;3&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;30,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt; 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;2&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Risk free interest rate&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.39&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;0.62&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Expected life&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;4.3 Years&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Years&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Dividend yield&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;None&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;one&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Volatility&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;100&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;100&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;/tr&gt;

				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:1pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following is a reconciliation of the derivative liability related to these exchange rights for the years ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;30,89&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Issuance of instruments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Change in value&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;20,520&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;10,375&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Issuance of instruments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Change in value&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(5,806&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Net settlements&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4,569&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:5pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The derivative assets/liabilities are estimated &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;using option pricing models that are based on the individual characteristics of the warrants or instruments on the valuation date, as well as assumptions for expected volatility, expected life and risk-free interest rate. Changes in the assumptions used could have a material impact on the resulting fair value. The primary input affecting the value of our derivatives liabilities is the Company&amp;#8217;s stock price. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Other inputs have a comparatively insignificant effect&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;During the year ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, contingent consideration was recorded upon th&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;e acquisitions of Roche Madison&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; Inc. and &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Alvos&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; Therapeutics, Inc., totaling &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;$&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;173,621&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; The fair value measurement of the contingent consideration obligations is determined using Level 3 inputs. The fair value of contingent consideration obligations is based on a discounted cash flow model using a probability-weighted income approach. The measurement is based upon unobservable inputs supported by little or no market activity based on our own assumptions and experience. Estimating timing to complete the development, and obtain approval of products is difficult, and there are inherent uncertainties in developing a product candidate, such as obtaining U.S. Food and Drug Administration (FDA) and other regulatory approvals. In determining the probability of regulatory approval and commercial success, we utilize data regarding similar milestone events from several sources, including industry studies and our own experience. These fair value measurements represent Level 3 measurements as they are based on significant inputs not observable in the market. Significant judgment is employed in determining the appropriateness of these assumptions as of the acquisition date and for each subsequent period. Accordingly, changes in assumptions could have a material impact on the amount of contingent consideration expense we record in any given period. Changes in the fair value of the contingent consideration obligations are recorded in our consolidated statement of operations. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;T&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;he following is a reconciliation of contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; consideration fair value&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; during the years ended &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 2012&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Purchase price contingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;173,621&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Contingent consideration payments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Change in fair value of contingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;173,621&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Purchase price contingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Contingent consideration payments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Change in fair value of contingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,421,652&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;fair value of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligations &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;is estimated &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;through valuation models designed to estimate the probability of such contingent payments based on various assumptions and incorporating estimated success rates.&amp;#160; Estimated payments are discounted using present value techniques to arrive at estimated fair value at the balance sheet date.&amp;#160; Changes in the fair value of the &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligations can result from changes to one or multiple inputs, including adjustments to the discount rates, changes in the amount or timing of expected expenditures associated with product development, changes in the amount or timing of cash flows from products upon commercialization, changes in the assumed achievement or timing of any development milestones, changes in the probability of certain clinical events and changes in the assumed probability associated with regulatory approval. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Each of these assumptions can have a significant impact on the calculation of contingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The carrying amounts of the Company&amp;#8217;s other financial instruments, which include accounts receivable, accounts payable, and accrued expenses approximate their respective fair values due to the relatively short-term nature of these instruments. The carrying value of the Company&amp;#8217;s debt obligations approximates fair value based on market interest rates. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:IncomeTaxDisclosureTextBlock id="F_000901" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;NOTE 12. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;INCOME TAXES&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The Company utilizes the guidance issued by the FASB for accounting for income taxes which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and the change during the period in deferred tax assets and liabilities. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;For the years ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, the Company had consolidated net book losses of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;31.7&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million and $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;22.1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million, respectively. The losses result in a deferred income tax benefit which is offset by a deferred tax provision for the valuation allowance for a net deferred provision of zero. Since the Company is a development stage company, management has provided a &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;100&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;% valuation allowance against its deferred tax assets until such time as management believes that its projections of future profits as well as expected future tax rates make the realization of these deferred tax assets more-likely-than-not. Significant judgment is required in the evaluation of deferred tax benefits and differences in future results from our estimates could result in material differences in the realization of these assets.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, the Company has available gross federal net operating loss (NOL) carry forwards of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;99.5&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;million and gross state NOL carry forwards of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;77.4&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;million which expire at various dates through 2032.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160; Gross federal NOL carry forwards for 2013 are estimated at $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;8.7&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million, and gross state NOL carry forwards for 2013 are estimated at $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;32.6&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;federal&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; deferred tax assets were&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; estimated to be&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;40.2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;million. The Company has recorded&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; a full valuation allowance related&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; to&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; all of its&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; net operating loss carry forwards. The Company has performed an assessment of positive and negative evidence regarding the realization of the net deferred tax asset in accordance with FASB ASC 740-10, &amp;#8220;Accounting for Income Taxes.&amp;#8221; This assessment included the evaluation of scheduled reversals of deferred tax liabilities, the availability of carry forwards and estimates of projected future taxable income. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise&amp;#8217;s financial statements and prescribes a recognition threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume that the tax position will be examined by taxing authorities. Our policy is to include interest and penalties related to unrecognized tax benefits in income tax expense. Interest and penalties totaled $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; for the years ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, respectively, and $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; for the period from May&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;7, 2003 (date of inception) through September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. The Company files income tax returns with the Internal Revenue Service (&amp;#8220;IRS&amp;#8221;), the state of California and certain other taxing jurisdictions. For jurisdictions in which tax filings are prepared,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;the Company is no longer subject to income tax examinations by state tax authorities for years through fiscal 2007, and by the IRS for the years through fiscal 2008. Our review of prior year tax positions using the criteria and provisions presented by the FASB did not result in a material impact on the Company&amp;#8217;s financial position or results of operations.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The provision for income taxes differs from the federal statutory rate due to state income taxes and changes in the valuation allowance for deferred income tax assets. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock id="F_000902" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;NOTE 13. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;EMPLOYEE BENEFIT PLANS&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In January 2005, the Company began sponsoring a defined contribution 401(k) retirement savings plan covering substantially all of its employees. The Plan was administered under the &amp;#8220;safe harbor&amp;#8221; provision of ERISA. Under the terms of the plan, an eligible employee may elect to contribute a portion of their salary on a pre-tax basis, subject to federal statutory limitations. The plan allowed for a discretionary match in an amount up to &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;100&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;% of each participant&amp;#8217;s first &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;% of compensation contributed plus &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;50&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;% of each participant&amp;#8217;s next &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;% of compensation contributed. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;For the years ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, we recorded expenses under these plans of approximately $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;191,947&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;62,495&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, respectively and $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;807,939&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; since inception of the Company. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In addition to the employee benefit plans described above, the Company participates in certain customary employee benefits plans, including those which provide health and life insurance benefits to employees. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
  <us-gaap:SubsequentEventsTextBlock id="F_000903" contextRef="C_0000879407_20021001_20030930">&lt;div&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;NOTE &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;14&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold; font-style:italic"&gt;SUBSEQUENT EVENTS&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 5pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;On October&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;11, 2013, the Company closed a securities offering with certain institutional investors (the &amp;#8220;Purchasers&amp;#8221;), pursuant to which the Company sold &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;3,071,672&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of common stock, (the &amp;#8220;Shares&amp;#8221;), at a purchase price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;5.86&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per share, and &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;46,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; shares of Series&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;C Convertible Preferred Stock (the &amp;#8220;Preferred Shares&amp;#8221;), at a purchase price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per share. The Preferred Shares are convertible into shares of common stock at a conversion price of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;5.86&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per share of common stock. The aggregate purchase price paid by the Purchasers for the Shares and Preferred Shares was $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;64&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;million &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;and the Company received net proceeds of approximately $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;60&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, after advisory fees and offering expenses. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock id="F_000904" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:6pt 0pt 0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt;Nature of Business &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 5pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Arrowhead Research Corporation is a biopharmaceutical company developing t&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;argeted RNAi therapeutics. The C&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ompany is leveraging its proprietary drug delivery technologies to develop targeted drugs based on the RNA interference mechanism that efficiently silence disease-causing genes. Arrowhead technologies also enable partners to create peptide-drug conjugates that specifically home to cell types of interest while sparing off-target tissues. Arrowhead&amp;#8217;s pipeline includes clinical programs in chronic hepatitis B virus and obesity and partner-based programs in oncology.&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
  <us-gaap:LiquidityDisclosureTextBlock id="F_000905" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:18pt 0pt 0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt;Liquidity &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Historically, The Company&amp;#8217;s primary source of financing has been &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;through the sale of securities of Arrowhead&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; Research Corp.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Research and d&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;evelopment activities have required significant capital investment since the Company&amp;#8217;s inception and we expect our &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;operations &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;to continue to requir&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;e cash investment in fiscal 2014&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and beyond &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;as the C&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ompany continues its research and development efforts, as well as clinical trials, and related drug manufacturing.&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, the Company had $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;19.1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million in cash to fund operations. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In addition to its cash resources, the Company has invested excess cash in investment grade commercial bonds maturing in &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;less than 18 months&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&amp;#160; These bonds provide a source of liquidity, although the Company plans to hold them until maturity.&amp;#160; At September 30, 2013, the Company had invested $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;10.8&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million in these bonds.&amp;#160; During October 2013, the Company completed an additional financing through the sale of equity securities in the amount of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;60&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million, providing additional liquidity to the Company.&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;During the year ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, the Company&amp;#8217;s cash position &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;increased&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; by $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;15.7&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million. The Company received cash from the issuance of equity of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;44.5&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million, cash from the sale of its holdings of stock in Wisepower Co. Ltd of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;1.4&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million, and&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; cash from&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;licensing revenue &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million. The C&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ompany had cash outflow of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;19.8&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million related to its continuing operating activities and capital expenditures of $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;0.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; million. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;On October&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;21, 2011, Arrowhead completed the acquisition of certain RNAi assets from Hoffmann-La Roche Inc. and F. Hoffmann-La Roche Ltd., including intellectual property and a research and development facility in Madison, Wisconsin. At the time of the acquisition, the facility had &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;41&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; employees. Due to the costs associated with operating the facility, including personnel costs, rent, research and development expenses, and other costs, cash expenses have increased, and it is expected that the Company will incur higher cash expenses during the remainder of 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and beyond, relative to periods prior to the acquisition, as the Company accelerates its preclinical and clinical development efforts.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:LiquidityDisclosureTextBlock>
  <us-gaap:ConsolidationPolicyTextBlock id="F_000906" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Principles of Consolidation&amp;#8212;The consolidated financial statements include the accounts of Arrowhead and its &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Subsidiaries, Arrowhead Madison, Calando, Ablaris, Tego&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, and until its disposition in January 2011, Unidym. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In 2013, Agonn and Alvos were merged into Arrowhead.&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Prior to April 2008, Arrowhead&amp;#8217;s Subsidiaries included Insert Therapeutics, Inc. (&amp;#8220;Insert&amp;#8221;), which was merged with Calando in April 2008. The merged entity is majority-owned by Arrowhead and continues to operate under the name of Calando. In January&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2011, Arrowhead sold its interests in Unidym to Wisepower, and in December&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2009, Tego completed a sale of its assets to Luna Innovations, Inc. Unidym and Tego results are included in the Income (Loss) from Discontinued Operations. Income (Loss) from Discontinued Operations also includes Aonex Technologies, Inc., sold in May 2008, and Nanotechnica, Inc., dissolved in June 2005. All significant intercompany accounts and transactions are eliminated in consolidation, and noncontrolling interests are accounted for in the Company&amp;#8217;s financial statements. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <arwr:BasisOfPresentationAndUseOfEstimatesPolicyTextBlock id="F_000907" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Basis of Presentation and Use of Estimates&amp;#8212;The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&amp;#160; Actual results could differ from those estimates. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; Significant estimates made in preparing these financial statements include valuing the stock of the Subsidiaries, assumptions to calculate stock-based compensation expense, allowance for doubtful accounts, deferred tax asset valuation allowance, derivative assets and liabilities, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent consideration, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;noncontrolling interest and useful lives for depreciable and amortizable assets. Actual results could differ from those estimates. Additionally, certain reclassifications have been made to prior period financial statements to conform to the current period presentation. In the opinion of management, all adjustments, including normal recurring accruals considered necessary for a fair presentation, have been included. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</arwr:BasisOfPresentationAndUseOfEstimatesPolicyTextBlock>
  <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy id="F_000908" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Cash and Cash Equivalents&amp;#8212;The Company considers all liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; The Company had &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;no&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; restricted cash at September 30, 2012 and 2013&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
  <us-gaap:ConcentrationRiskCreditRisk id="F_000909" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Concentration of Credit Risk&amp;#8212;The Company maintains checking accounts for Arrowhead and separate accounts for&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; each Subsidiary at two&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; financial institutions. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;250,000&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; per account. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institution&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;s&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; in which these deposits are held.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:InvestmentPolicyTextBlock id="F_000910" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Investments&amp;#8212;the Company invests excess cash balances in short-term and long-term marketable debt securities. Investments may consist of certificates of deposits, money market accounts, government-sponsored enterprise securities, corporate bonds and/or commercial paper. The Company accounts for its investment in marketable securities in accordance with FASB ASC 320, Investments &amp;#8211; Debt and Equity Securities.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;This statement requires certain securities to be classified into three categories: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt 24.45pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Held-to-maturity&amp;#8212;Debt securities that the entity has the positive intent and ability to hold to maturity are reported at amortized cost. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt 24.45pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Trading Securities&amp;#8212;Debt and equity securities that are bought and held primarily for the purpose of selling in the near term are reported at fair value, with unrealized gains and losses included in earnings. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt 24.45pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Available-for-Sale&amp;#8212;Debt and equity securities not classified as either securities held-to-maturity or trading securities are reported at fair value with unrealized gains or losses excluded from earnings and reported as a separate component of shareholders&amp;#8217; equity. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The Company classifies its investments in marketable debt securities based on the facts and circumstances present at the time of purchase of the securities. At &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2013, the Company classified all of its investments as held-to-maturity. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Held-to-maturity investments are measured and recorded at amortized cost on the Company&amp;#8217;s Consolidated Balance Sheet. Discounts and premiums to par value of the debt securities are amortized to interest income/expense over the term of the security. No gains or losses on investment securities are realized until they are sold or a decline in fair value is determined to be other-than-temporary. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2013, all short-term investments were comprised of corporate bonds with maturity dates of less than one year. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Certain investments maturing in excess of twelve months, but &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;less than 24 months&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; are classified as long-term investments.&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of September 30, 2013, t&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;he amortized cost of such bonds was $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;10,732,414&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;For the year ended September 30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, g&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ross unrealized &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;losses were $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;41,643&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;gross unrealized gains&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; were &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;7,500&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. The to&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;tal fair value of the&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; investments &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;at September 30, 2013 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;was $&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;10,698,271&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;See further information regarding fair market value of marketabl&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;e debt securities in Note 11&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &amp;#8211; Fair Value Measu&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;rements&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, such fair market data is obtained from independent pricing services. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock id="F_000911" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Property and Equipment&amp;#8212;Property and equipment are recorded at cost, which may equal fair market value in the case of property and equipment acquired in conjunction with a business acquisition. Depreciation of property and equipment is recorded using the straight-line method over the respective useful lives of the assets ranging from &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;three&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; to &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; "&gt;seven&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; years. Leasehold improvements are amortized over the lesser of the expected useful life or the remaining lease term. Long-lived assets, including property and equipment are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock id="F_000912" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Intangible Assets Subject to A&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;mortization&amp;#8212;At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, intangible assets subject to amortization included patents and certain license agreements. Intangible assets subject to amortization are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may not be recoverable. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
  <us-gaap:InProcessResearchAndDevelopmentPolicy id="F_000913" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In-Process Research&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;amp; Development (IPR&amp;amp;D)&amp;#8212;IPR&amp;amp;D assets represent capitalized on-going research projects that Arrowhead acquired through business combinations. Such assets are initially measured at their acquisition date fair values. The amounts capitalized are being accounted for as indefinite-lived intangible assets, subject to impairment testing until completion or abandonment of R&amp;amp;D efforts associated with the project. Upon successful completion of a project, Arrowhead will make a determination as to the then remaining useful life of the intangible asset and begin amortization. Based on early adoption of ASU 2012-02, Arrowhead tests its indefinite-lived assets for impairment at least annually, through a two-step process. The first step is a qualitative assessment to determine if it is more likely than not that the indefinite lived assets are impaired. Arrowhead considers relevant events and circumstances that could affect the inputs used to determine the fair value of the intangible assets. If the qualitative assessment indicates that it is more likely than not that the intangible assets is impaired, a second step is performed which is a quantitative test to determine the fair value of the intangible asset. If the carrying amount of the intangible assets exceeds its fair value, an impairment loss is recorded in the amount of that excess. If circumstances determine that it is appropriate, the Company may also elect to bypass step one, and proceed directly to the second step. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:InProcessResearchAndDevelopmentPolicy>
  <arwr:ContingentConsiderationPolicyTextBlock id="F_000914" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Contingent Consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; - &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The consideration for our acquisitions often includes future payments that are contingent upon the occurrence of a particular event.&amp;#160; For example, milestone payments might be based on the achievement of various regulatory approvals or future sales milestones, and royalty payments might be based on drug product sales levels. We record a &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligation for such contingent payments at fair value on the acquisition date. We estimate the fair value of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligations through valuation models designed to estimate the probability of such contingent payments based on various assumptions and incorporating estimated success rates.&amp;#160; Estimated payments are discounted using present value techniques to arrive at estimated fair value at the balance sheet date.&amp;#160; We revalue these &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligations each reporting period. Changes in the fair value of our &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligations are recognized within our consolidated statements of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;operations&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. Changes in the fair value of the &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligations can result from changes to one or multiple inputs, including adjustments to the discount rates, changes in the amount or timing of expected expenditures associated with product development, changes in the amount or timing of cash flows from products upon commercialization, changes in the assumed achievement or timing of any development milestones, changes in the probability of certain clinical events and changes in the assumed probability associated with regulatory approval. These fair value measurements are based on significant inputs not observable in the market. Significant judgment is employed in determining the appropriateness of these assumptions as of the acquisition date and for each subsequent period. Accordingly, changes in assumptions could have a material impact on the amount of &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; expense we record in any given period.&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</arwr:ContingentConsiderationPolicyTextBlock>
  <us-gaap:EquityMethodInvestmentsPolicy id="F_000915" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Equity Investments&amp;#8212;Arrowhead had&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; a noncontrolling equity investment in Nanotope, a privately held biotechnology company, which is recorded in Other Assets. Historically, this investment was carried at cost less Arrowhead&amp;#8217;s proportionate share of Nanotope&amp;#8217;s operating loss for the period since investment. &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The investment was fully reserved in 2012.&amp;#160; During 2013, Nanotope was dissolved&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
  <us-gaap:EquityAndCostMethodInvestmentsPolicy id="F_000916" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Minority Equity Investments&amp;#8212;The Company&amp;#8217;s minority equity investment in Leonardo, a privately&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; held biotechnology company, had&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; been recorded in Other Assets, howeve&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;r, an impairment charge was&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; recorded in 2012, and its net book value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; is &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$0&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. This investment has been accounted for under the cost method of accounting. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:EquityAndCostMethodInvestmentsPolicy>
  <arwr:NoncontrollingInterestsPolicyTextBlock id="F_000917" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Noncontrolling Interests in Majority-Owned Subsidiaries&amp;#8212;Operating losses applicable to majority-owned Calando, Ablaris and, prior to its disposal, Unidym have periodically exceeded the noncontrolling interests in the equity capital of either Subsidiary. Such excess losses applicable to the noncontrolling interests have been and are borne by the Company as there is no obligation of the noncontrolling interests to fund any losses in excess of their original investment. There is also no obligation or commitment on the part of the Company to fund operating losses of any Subsidiary whether wholly-owned or majority-owned. The Company allocates the noncontrolling interest&amp;#8217;s share of net loss in excess of the noncontrolling interest&amp;#8217;s initial investment in accordance with FASB ASC 810-10. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;When there is a change in the Company&amp;#8217;s proportionate share of a development-stage Subsidiary resulting from additional equity transactions in a Subsidiary, the change is accounted for as an equity transaction in consolidation. To the extent that the increase in the calculated value of the Company&amp;#8217;s interest in the equity of the Subsidiary exceeds the Company&amp;#8217;s investment in the offering, that increase in value is referred to as the Company&amp;#8217;s &amp;#8220;increase in its proportionate share of the Subsidiary&amp;#8217;s equity&amp;#8221; and the amount is recorded as an increase in the Company&amp;#8217;s Additional Paid-in Capital. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</arwr:NoncontrollingInterestsPolicyTextBlock>
  <us-gaap:RevenueRecognitionPolicyTextBlock id="F_000918" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Revenue Recognition&amp;#8212;Revenue from license fees are recorded when persuasive evidence of an arrangement exists, title has passed or services have been rendered, a price is fixed and determinable, and collection is reasonably assured. We may generate revenue from product sales, technology licenses, collaborative research and development arrangements, and research grants. Revenue under technology licenses and collaborative agreements typically consists of nonrefundable and/or guaranteed technology license fees, collaborative research funding and various milestone and future product royalty or profit-sharing payments. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Revenue associated with research and development funding payments under collaborative agreements, is recognized ratably over the relevant periods specified in the agreement, generally the research and development period. Revenue from up-front license fees, milestones and product royalties are recognized as earned based on the completion of the milestones and product sales, as defined in the respective agreements. Payments received in advance of recognition as revenue are recorded as deferred revenue. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:TradeAndOtherAccountsReceivablePolicy id="F_000919" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Allowance for Doubtful Accounts&amp;#8212;The Company accrues an allowance for doubtful accounts based on estimates of uncollectible revenues by analyzing historical collections, accounts receivable aging and other factors. Accounts receivable are written off when all collection attempts have failed. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
  <us-gaap:ResearchAndDevelopmentExpensePolicy id="F_000920" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Research and Development&amp;#8212;Costs and expenses that can be clearly identified as research and development are charged to expense as incurred in accordance with FASB ASC 730-10. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:EarningsPerSharePolicyTextBlock id="F_000921" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Earnings (Loss) per Share&amp;#8212;Basic earnings (loss) per share is computed using the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share are computed using the weighted-average number of common shares and dilutive potential common shares outstanding during the period. Dilutive potential common shares primarily consist of stock options issued to employees and consultants and warrants to purchase Common Stock of the Company.&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy id="F_000922" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Stock-Based Compensation&amp;#8212;The Company accounts for share-based compensation arrangements in accordance with FASB ASC 718, which requires the measurement and recognition of compensation expense for all share-based payment awards to be based on estimated fair values. We use the Black-Scholes option valuation model to estimate the fair value of our stock options at the date of grant. The Black-Scholes option valuation model requires the input of subjective assumptions to calculate the value of stock options. We use historical data among other information to estimate the expected price volatility and the expected forfeiture rate. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:DerivativesPolicyTextBlock id="F_000923" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Derivative Assets and Liabilities -&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;We account for warrants and other derivative financial instruments as either equity or assets/liabilities based upon the characteristics and provisions of each instrument. Warrants classified as equity are recorded as additional paid-in capital on our consolidated balance sheet and no further adjustments to their valuation are made. Some of our warrants were determined to be ineligible for equity classification because of provisions that may result in an adjustment to their exercise price. Warrants classified as derivative liabilities and other derivative financial instruments that require separate accounting as assets or liabilities are recorded on our consolidated balance sheet at their fair value on the date of issuance and are revalued on each subsequent balance sheet date until such instruments are exercised or expire, with any changes in the fair value between reporting periods recorded as other income or expense. We estimate the fair value of these assets/liabilities using option pricing models that are based on the individual characteristics of the warrants or instruments on the valuation date, as well as assumptions for expected volatility, expected life and risk-free interest rate&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
  <us-gaap:IncomeTaxPolicyTextBlock id="F_000924" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Income Taxes&amp;#8212;The Company accounts for income taxes under the liability method, which requires the recognition of deferred income tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred income tax assets to the amount expected to be realized. The provision for income taxes, if any, represents the tax payable for the period and the change in deferred income tax assets and liabilities during the period. &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="F_000925" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:18pt 0pt 0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;Recently Issued Accounting Standards &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In July 2012, the FASB issued ASU 2012-02, &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-style:italic"&gt;Testing Indefinite-Lived Intangible Assets for Impairment,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; which amended the guidance in ASU 2011-08 to simplify the testing of indefinite-lived intangible assets other than goodwill for impairment. ASU 2012-02 becomes effective for annual and interim impairment tests performed for fiscal years beginning on or after September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;15, 2012 and earlier adoption is permitted. We adopted this standard in the third quarter of fiscal year 2012. We believe adoption did not have a material effect on our financial statements. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In September 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2011-08, Intangibles&amp;#8212;Goodwill and Other (Topic 350)&amp;#8212;Testing Goodwill for Impairment (ASU 2011-08), to allow entities to use a qualitative approach to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If after performing the qualitative assessment an entity determines it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step goodwill impairment test is unnecessary. However, if an entity concludes otherwise, then it is required to perform the first step of the two-step goodwill impairment test. ASU 2011-08 is effective for us in fiscal 2013 and earlier adoption is permitted. The adoption of ASU 2011-08 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;did not have a material&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; impact on our financial position, results of operations or cash flows. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In May 2011, the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued ASU 2011-04, Fair Value Measurement (&amp;#8220;ASU 2011-04&amp;#8221;), which amended ASC 820, Fair Value Measurements (&amp;#8220;ASC 820&amp;#8221;), providing a consistent definition and measurement of fair value, as well as similar disclosure requirements between U.S. GAAP and International Financial Reporting Standards. ASU 2011-04 changes certain fair value measurement principles, clarifies the application of existing fair value measurement and expands the disclosure requirements. ASU 2011-04 was effective for us beginning January&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1, 2012. The adoption of ASU 2011-04 did not have a material effect on our consolidated financial statements or disclosures.&amp;#160; &lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:HeldToMaturitySecuritiesTextBlock id="F_000926" contextRef="C_0000879407_20121001_20130930">&lt;div style="text-align: left;"&gt;
			&lt;p style="margin:6pt 0pt 0pt; text-indent:27pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following table summarizes the Company&amp;#8217;s short and long-term investments as of September 30, 2013.&amp;#160; There were no comparable investments as of September 30, 2012.&lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:6pt 0pt 0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
				&lt;tr&gt;
					&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="28" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;30, 2013&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr&gt;
					&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="3" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Amortized Cost&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="4" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Gross Unrealized Gains&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="3" style="border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="4" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Gross Unrealized Losses&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="3" style="border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="4" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Fair Value&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr&gt;
					&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
						&lt;p style="margin:0pt 0pt 0pt 12.25pt; text-indent:-12.25pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Commercial notes (due within one year)&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;9,030,261&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;7,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(39,281&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;8,998,480&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr&gt;
					&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
						&lt;p style="margin:0pt 0pt 0pt 12.25pt; text-indent:-12.25pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Commercial notes (due after one year through two years)&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,702,153&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(2,362&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,699,791&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td colspan="3" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr&gt;
					&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
						&lt;p style="margin:0pt 0pt 0pt 12.25pt; text-indent:-12.25pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Total&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;10,732,414&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;7,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(41,643&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;10,698,271&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;td colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
						&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;&lt;/table&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:HeldToMaturitySecuritiesTextBlock>
  <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock id="F_000927" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonIncMember_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following table summarizes the estimated fair values at the date of acquisition: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Current assets&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;432,709&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Property and equipment&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;7,215,206&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Intangible assets&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,174,935&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Other noncurrent assets&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;6,264&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Current liabilities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(414,122&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Noncurrent liabilities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(1,570,072&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Gain on purchase&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(1,576,106&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Total purchase consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5,268,814&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
  <arwr:PurchaseConsiderationTableTextBlock id="F_000928" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonIncMember_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The purchase consideration was composed of the following: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Promissory note due Roche&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;50,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Contingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;84,935&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Shares issued to Roche&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5,133,879&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Total purchase consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5,268,814&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</arwr:PurchaseConsiderationTableTextBlock>
  <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock id="F_000929" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following table summarizes the estimated fair values at the date of acquisition: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Current assets&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;29,332&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;In-process R&amp;amp;D&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,172,387&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Current liabilities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(113,033&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Total purchase consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,088,686&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
  <arwr:PurchaseConsiderationTableTextBlock id="F_000930" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt 24.45pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The purchase consideration was comprised solely of shares of Arrowhead Common Stock issued to the former shareholders of Alvos Therapeutics, Inc. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Shares issued&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;315,457&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Price per share&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;6.34&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Share consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,000,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Contingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;88,686&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Total purchase consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,088,686&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</arwr:PurchaseConsiderationTableTextBlock>
  <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock id="F_000931" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The below table provides details on our intangible asset balances: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Intangible&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;assets&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;not subject to&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;amortization&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Intangible&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;assets&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;subject to&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;amortization&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Total&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Intangible&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;assets&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Balance at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2011&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,731,211&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,731,211&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Additions&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Madison acquisition&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;944,935&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;230,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,174,935&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Additions&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Alvos acquisition&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,172,387&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,172,387&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Amortization&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(293,964&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(293,964&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Balance at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 2012&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3,117,322&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,667,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;247&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4,784,569&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Impairment&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(1,308,047&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(1,308,047&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Amortization&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(236,009&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; (236,009&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Balance at September 30, 2013&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3,117,322&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;123,191&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3,240,513&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
					&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
  <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock id="F_000932" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following table summarizes information about warrants outstanding at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th colspan="5" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Exercise&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;prices&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Number&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;of&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Warrants&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="5" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Remaining&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Life&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;in&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Years&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;70.60&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;94,897&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3.6&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5.00&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,155,023&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;461,024&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.38&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;187,313&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4.16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3.25&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,685,870&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2.9&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2.12&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;75,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-bottom:5pt; margin-left:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:5pt; margin-right:5pt; margin-bottom:5pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.83&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;742,396&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="3" style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td colspan="5" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Total warrants outstanding&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4,402,523&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
					&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
  <us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock id="F_000933" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, future minimum lease payments due in fiscal years under capitalized leases are as follows: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;4 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;256,846&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;256,846&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;6 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;256,846&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;7 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;256,846&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;8 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;256,846&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;9 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;and thereafter&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;107,019&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Less interest&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;108,79&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Principal&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,282,458&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Less current portion&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;221,345&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Noncurrent portion&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,061,113&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock>
  <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock id="F_000934" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;As of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;, future minimum lease payments due in fiscal years under operating leases are as follows: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;4 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;434,229&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;445,921&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;6 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;457,961&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;7 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;470,154&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;8 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;359,370&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;9 &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;and thereafter&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;125,415&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Total&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,293,050&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock id="F_000935" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Number&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;of&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Options&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Outstanding&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Weighted-&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Average&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Exercise&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Price&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Per&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Share&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Weighted-&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Average&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Remaining&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Contractual&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Term&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Aggregate&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Intrinsic&lt;/font&gt;&lt;br /&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Value&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Balance At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;729,096&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;9.03&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Granted&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,229,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4.40&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Cancelled&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;42,919&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;11.77&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Exercised&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;4,883&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5.2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;0&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:middle"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:middle"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Balance At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,910,794&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;6.10&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Granted&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,509,166&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;0&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Cancelled&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Exercised&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(675&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;93&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:middle"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:middle"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Balance At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3,419,285&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4.68&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;8.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;years&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5,811,926&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Exercisable At September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,306,306&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;6.55&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;6.7&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; years&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:double; border-top-width:1.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,127,819&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
					&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock id="F_000936" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The assumptions used to value stock options are as follows: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="6" style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Year&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;ended&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;30,&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom" colspan="3"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt; &lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt; &lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Dividend yield&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Risk-free interest rate&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="3"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;0.7&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;to&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;0.9%&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; to&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1.7%&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Volatility&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:center; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;69&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;p style="text-align:center; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;90% - 100%&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Expected life (in years)&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="3"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5.5 to 6.25&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5.5 to 6.25&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Weighted average grant date fair value per share of options granted&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:center; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:center; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.88&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:center; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:center; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3.32&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;/tr&gt;
					&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
  <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock id="F_000937" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following table summarizes fair value measurements at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; for assets and liabilities measured at fair value on a recurring basis: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Level 1&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Level 2&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Level 3&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Total&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Cash and cash equivalents&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;19,114,444&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;19,114,444&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Marketable securities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;10,698,271&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;0&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;,698,271&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Derivative assets&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Derivative liabilities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4,096,363&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4,096,363&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Acquisition related c&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ontingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligations&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
					&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:12pt 0pt 0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Level 1&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Level 2&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Level 3&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="3" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th colspan="4" style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;Total&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Cash and cash equivalents&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3,377,288&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;3,377,288&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Marketable securities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;106,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;106,500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Derivative assets&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;250,250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;250,250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Derivative liabilities&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;647,213&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;647,213&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Acquisition related c&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;ontingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; obligations&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;173,621&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right" colspan="2"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;173,621&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td colspan="2" style="background-color:#ffffff; padding-right:0.7pt; padding-top:0.7pt; vertical-align:top"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
					&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
  <arwr:FairValueAssumptionsAndMethodologyForAssetsTableTextBlock id="F_000938" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:9pt 0pt 0pt; text-indent:24.5pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The assumptions used in valuing the derivative asset as of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; were as follows: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:9pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:9pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;30,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt; 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;3&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:center; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;30,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt; 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;2&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Risk free interest rate&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:right; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;0.23&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;p style="text-align:right; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Expected life&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Years&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Dividend yield&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;none&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Volatility&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:right; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;72&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;p style="text-align:right; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;/tr&gt;

				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</arwr:FairValueAssumptionsAndMethodologyForAssetsTableTextBlock>
  <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock id="F_000939" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following is a reconciliation of the derivative asset for the years ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:9pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:9pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;61,125&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Receipt of instruments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Increase &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;in value&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;89,125&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Net settlements&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at October&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;250,250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Receipt of instruments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Dec&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;rease in value&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(250,25&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;0&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Net settlements&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
  <arwr:FairValueAssumptionsAndMethodologyForLiabilitiesTableTextBlock id="F_000940" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The assumptions used in valuing the derivative liability as of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; were as follows: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;2010 Warrants&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;30,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;2013&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;30,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;2012&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;0.33&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;0.31&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Expected life&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt 0pt 0pt 36pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2.2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Years&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt 0pt 0pt 36pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3.2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Years&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;one&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;one&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Volatility&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;69&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;100&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;2012 Warrants&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt; 30, 2013&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;September 30, 2012&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;39&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Expected life&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt 0pt 0pt 36pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;4.&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Years&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;none&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Volatility&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;69&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:bold"&gt;2013 Warrants&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt; 30, 2013&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; text-decoration:underline"&gt;September 30, 2012&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Risk free interest rate&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.39&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Expected life&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt 0pt 0pt 36pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;4.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Years&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Dividend yield&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;none&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#ffffff; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:5pt 0pt 5pt 12pt; text-indent:-12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Volatility&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:right"&gt;&lt;p style="text-align:right; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;69&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; vertical-align:top; text-align:left"&gt;&lt;p style="text-align:right; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top"&gt;
							&lt;p style="margin:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; vertical-align:top" colspan="2"&gt;
							&lt;p style="margin:0pt; text-align:right"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N/A&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:1pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</arwr:FairValueAssumptionsAndMethodologyForLiabilitiesTableTextBlock>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock id="F_000941" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following is a reconciliation of the derivative liability related to these warrants for the years ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;907,233&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Receipt of instruments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Change in value&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;281&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;038&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Net settlements&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;6&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;26,195&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Issuance&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; of instruments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;2,153,819&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Change in value&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;5,066,591&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Net settlements&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(3,754,808&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:1.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4,091&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;797&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
  <arwr:FairValueAssumptionsAndMethodologyForLiabilitiesTableTextBlock id="F_000942" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The assumptions used in valuing the derivative liability as of September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; were as follows: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;

						&lt;tr&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;30,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt; 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;3&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
							&lt;th style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:1pt; padding-left:0.7pt; padding-right:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:center; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:8pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;30,&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt; 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:8pt; font-weight:bold"&gt;2&lt;/font&gt;&lt;/p&gt;
							&lt;/th&gt;
						&lt;/tr&gt;


						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Risk free interest rate&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1.39&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;0.62&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Expected life&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;4.3 Years&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5.3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Years&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Dividend yield&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;None&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
								&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;N&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;one&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
						&lt;/tr&gt;
						&lt;tr&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Volatility&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;100&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
							&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
								&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt; font-weight:normal; font-style:normal"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
							&lt;/td&gt;
							&lt;td style="padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;100&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:left"&gt;&lt;p style="text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;/tr&gt;

				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</arwr:FairValueAssumptionsAndMethodologyForLiabilitiesTableTextBlock>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock id="F_000943" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;The following is a reconciliation of the derivative liability related to these exchange rights for the years ended September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;: &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;30,89&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;5&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Issuance of instruments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Change in value&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;20,520&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;10,375&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Issuance of instruments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Change in value&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;(5,806&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;)&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Net settlements&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="page-break-inside:avoid; line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;4,569&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; page-break-inside:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
  <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock id="F_000944" contextRef="C_0000879407_20121001_20130930">&lt;div&gt;
			&lt;p style="margin:12pt 0pt 0pt; text-indent:24.5pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;T&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;he following is a reconciliation of contingent&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; consideration fair value&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; during the years ended &lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt; and 2012&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;. &lt;/font&gt;&lt;/p&gt;
			&lt;p style="margin:0pt; page-break-after:avoid; line-height:115%; font-size:12pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:12pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
			&lt;div style="text-align: left;"&gt;
				&lt;table cellspacing="0" cellpadding="0" style="display: block; text-align: left; border: 0"&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;1&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Purchase price contingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;173,621&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Contingent consideration payments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Change in fair value of contingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;2&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;173,621&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Purchase price contingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Contingent consideration payments&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#8212;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12.25pt; text-indent:-12.25pt; page-break-after:avoid; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Change in fair value of contingent consideration&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom" colspan="2"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.75pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,421,652&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
					&lt;tr&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:5pt 0pt 0pt 12pt; text-indent:-12pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;Value at September&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;30, 201&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;3&lt;/font&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-bottom:0pt; margin-left:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="line-height:115%; font-size:10pt; margin-top:0pt; margin-right:0pt; margin-bottom:0pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; border-bottom-color:#000000; border-bottom-style:double; border-bottom-width:2.25pt; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom; text-align:right"&gt;&lt;p style="margin:0pt; text-align:right; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&amp;#160;1,595,273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
						&lt;td style="background-color:#cff0fc; padding-right:0.7pt; padding-top:0.7pt; vertical-align:bottom"&gt;
							&lt;p style="margin:0pt; line-height:115%; font-size:10pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
						&lt;/td&gt;
					&lt;/tr&gt;
				&lt;/table&gt;
			&lt;/div&gt;
			&lt;p style="margin:0pt 0pt 10pt; line-height:115%; font-size:11pt"&gt;&lt;font style="font-family:&amp;apos;Times New Roman&amp;apos;; font-size:11pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
		&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
  <us-gaap:DebtInstrumentMaturityDateDescription id="F_000945" contextRef="C_0000879407_us-gaapSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesByTypeAxis_us-gaapBondsMember_20121001_20130930">less than 18 months</us-gaap:DebtInstrumentMaturityDateDescription>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="F_000946" contextRef="C_0000879407_20121001_20130930" decimals="-5" unitRef="U_iso4217USD">44500000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <arwr:OperatingCashOutflow id="F_000947" contextRef="C_0000879407_20121001_20130930" decimals="-5" unitRef="U_iso4217USD">19800000</arwr:OperatingCashOutflow>
  <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments id="F_000948" contextRef="C_0000879407_deiLegalEntityAxis_arwrWisePowerMember_20121001_20130930" decimals="-5" unitRef="U_iso4217USD">1400000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
  <us-gaap:ProceedsFromCustomers id="F_000949" contextRef="C_0000879407_20121001_20130930" decimals="-5" unitRef="U_iso4217USD">200000</us-gaap:ProceedsFromCustomers>
  <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment id="F_000950" contextRef="C_0000879407_20121001_20130930" decimals="-5" unitRef="U_iso4217USD">300000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
  <us-gaap:Investments id="F_000951" contextRef="C_0000879407_us-gaapSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesByTypeAxis_us-gaapBondsMember_20130930" decimals="-5" unitRef="U_iso4217USD">10800000</us-gaap:Investments>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="F_000952" contextRef="C_0000879407_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131001_20131031" decimals="-6" unitRef="U_iso4217USD">60000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <arwr:NumberOfEmployeesAtTimeOfAcquisition id="F_000953" contextRef="C_0000879407_20111021" decimals="INF" unitRef="U_arwrEmployee">41</arwr:NumberOfEmployeesAtTimeOfAcquisition>
  <us-gaap:CashFDICInsuredAmount id="F_000954" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">250000</us-gaap:CashFDICInsuredAmount>
  <us-gaap:DebtInstrumentMaturityDateDescription id="F_000955" contextRef="C_0000879407_20121001_20130930">less than 24 months</us-gaap:DebtInstrumentMaturityDateDescription>
  <us-gaap:MarketableSecurities id="F_000956" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">10732414</us-gaap:MarketableSecurities>
  <us-gaap:UnrealizedLossOnSecurities id="F_000957" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">41643</us-gaap:UnrealizedLossOnSecurities>
  <us-gaap:UnrealizedGainOnSecurities id="F_000958" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">7500</us-gaap:UnrealizedGainOnSecurities>
  <us-gaap:InvestmentsFairValueDisclosure id="F_000959" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">10698271</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000960" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMinimumMember_20121001_20130930">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000961" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMaximumMember_20121001_20130930">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <arwr:CostMethodInvestmentAttributableToNoncontrollingInterest id="F_000962" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">0</arwr:CostMethodInvestmentAttributableToNoncontrollingInterest>
  <us-gaap:RestrictedCashAndCashEquivalents id="F_000963" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">0</us-gaap:RestrictedCashAndCashEquivalents>
  <us-gaap:RestrictedCashAndCashEquivalents id="F_000964" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">0</us-gaap:RestrictedCashAndCashEquivalents>
  <us-gaap:ReceivableWithImputedInterestFaceAmount id="F_000965" contextRef="C_0000879407_us-gaapScheduleOfReceivablesWithImputedInterestNameOfReceivableWithImputedInterestAxis_arwrWisepowerMember_20110131" decimals="-5" unitRef="U_iso4217USD">2500000</us-gaap:ReceivableWithImputedInterestFaceAmount>
  <arwr:SaleOfNoteConsiderationReceivedShares id="F_000966" contextRef="C_0000879407_us-gaapScheduleOfReceivablesWithImputedInterestNameOfReceivableWithImputedInterestAxis_arwrWisepowerMember_20130124" decimals="INF" unitRef="U_shares">1570000</arwr:SaleOfNoteConsiderationReceivedShares>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="F_000967" contextRef="C_0000879407_us-gaapScheduleOfReceivablesWithImputedInterestNameOfReceivableWithImputedInterestAxis_arwrWisepowerMember_20121001_20130930" decimals="-5" unitRef="U_iso4217USD">1400000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <arwr:NoteReceivableFuturePaymentReserve id="F_000968" contextRef="C_0000879407_20130930" decimals="-5" unitRef="U_iso4217USD">1100000</arwr:NoteReceivableFuturePaymentReserve>
  <us-gaap:UnrealizedGainOnSecurities id="F_000969" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">7500</us-gaap:UnrealizedGainOnSecurities>
  <us-gaap:UnrealizedGainOnSecurities id="F_000970" xsi:nil="true" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueAfterOneYearThroughTwoYearsMember_20121001_20130930" unitRef="U_iso4217USD" />
  <us-gaap:UnrealizedLossOnSecurities id="F_000971" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">39281</us-gaap:UnrealizedLossOnSecurities>
  <us-gaap:UnrealizedLossOnSecurities id="F_000972" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueAfterOneYearThroughTwoYearsMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">2362</us-gaap:UnrealizedLossOnSecurities>
  <us-gaap:InvestmentsFairValueDisclosure id="F_000973" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueWithinOneYearMember_20130930" decimals="0" unitRef="U_iso4217USD">8998480</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure id="F_000974" contextRef="C_0000879407_us-gaapMajorTypesOfDebtAndEquitySecuritiesAxis_arwrCommercialNotesDueAfterOneYearThroughTwoYearsMember_20130930" decimals="0" unitRef="U_iso4217USD">1699791</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:MarketableSecuritiesNoncurrent id="F_000975" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">1702153</us-gaap:MarketableSecuritiesNoncurrent>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssets id="F_000976" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20130930" decimals="0" unitRef="U_iso4217USD">432709</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssets>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment id="F_000977" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20130930" decimals="0" unitRef="U_iso4217USD">7215206</us-gaap:BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets id="F_000978" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20130930" decimals="0" unitRef="U_iso4217USD">1174935</us-gaap:BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationOtherNoncurrentAssets id="F_000979" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20130930" decimals="0" unitRef="U_iso4217USD">6264</us-gaap:BusinessAcquisitionPurchasePriceAllocationOtherNoncurrentAssets>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities id="F_000980" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20130930" decimals="0" unitRef="U_iso4217USD">414122</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationNoncurrentLiabilities id="F_000981" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20130930" decimals="0" unitRef="U_iso4217USD">1570072</us-gaap:BusinessAcquisitionPurchasePriceAllocationNoncurrentLiabilities>
  <arwr:GainLossOnPurchaseOfBusiness id="F_000982" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1576106</arwr:GainLossOnPurchaseOfBusiness>
  <us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice id="F_000983" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20130930" decimals="0" unitRef="U_iso4217USD">5268814</us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssets id="F_000984" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20130930" decimals="0" unitRef="U_iso4217USD">29332</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentAssets>
  <us-gaap:DevelopmentInProcess id="F_000985" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20130930" decimals="0" unitRef="U_iso4217USD">2172387</us-gaap:DevelopmentInProcess>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities id="F_000986" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20130930" decimals="0" unitRef="U_iso4217USD">113033</us-gaap:BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities>
  <us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice id="F_000987" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20130930" decimals="0" unitRef="U_iso4217USD">2088686</us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice>
  <us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue id="F_000988" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20111021" decimals="0" unitRef="U_iso4217USD">84935</us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue>
  <us-gaap:BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable id="F_000989" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20111021" decimals="0" unitRef="U_iso4217USD">5133879</us-gaap:BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable>
  <us-gaap:BusinessCombinationConsiderationTransferred id="F_000990" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20111021" decimals="0" unitRef="U_iso4217USD">5268814</us-gaap:BusinessCombinationConsiderationTransferred>
  <arwr:BusinessAcquisitionEquityInterestsIssuedNumberOfSharesIssued id="F_000991" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20120405" decimals="INF" unitRef="U_shares">315457</arwr:BusinessAcquisitionEquityInterestsIssuedNumberOfSharesIssued>
  <us-gaap:SaleOfStockPricePerShare id="F_000992" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20120405" decimals="INF" unitRef="U_iso4217USD_shares">6.34</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable id="F_000993" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20120405" decimals="0" unitRef="U_iso4217USD">2000000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityEquityInterestsIssuedAndIssuable>
  <us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue id="F_000994" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20120405" decimals="0" unitRef="U_iso4217USD">88686</us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue>
  <us-gaap:BusinessCombinationConsiderationTransferred id="F_000995" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20120405" decimals="0" unitRef="U_iso4217USD">2088686</us-gaap:BusinessCombinationConsiderationTransferred>
  <arwr:BusinessAcquisitionEquityInterestsIssuedNumberOfSharesIssued id="F_000996" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20111021" decimals="INF" unitRef="U_shares">1288158</arwr:BusinessAcquisitionEquityInterestsIssuedNumberOfSharesIssued>
  <arwr:ApplicableOutLicenseTerm id="F_000997" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20130930">P90D</arwr:ApplicableOutLicenseTerm>
  <arwr:PercentageOfRoyaltyLiability id="F_000998" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20130930" decimals="2" unitRef="U_pure">0.03</arwr:PercentageOfRoyaltyLiability>
  <arwr:ObligationToPayRoyalties id="F_000999" contextRef="C_0000879407_20121001_20130930">later of (i) the expiration of the last to expire patent right related to such product candidate that was transferred in the Transaction and (ii) ten years after the first commercial sale of such product candidate.</arwr:ObligationToPayRoyalties>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow id="F_001000" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_us-gaapRangeAxis_us-gaapMinimumMember_20130930" decimals="INF" unitRef="U_iso4217USD">2500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh id="F_001001" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_us-gaapRangeAxis_us-gaapMaximumMember_20130930" decimals="INF" unitRef="U_iso4217USD">6000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
  <arwr:PresentValueOfContingentAcquisitionConsideration id="F_001002" contextRef="C_0000879407_20111001_20111021" decimals="0" unitRef="U_iso4217USD">84935</arwr:PresentValueOfContingentAcquisitionConsideration>
  <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned id="F_001003" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20120405" decimals="-5" unitRef="U_iso4217USD">23500000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill id="F_001004" xsi:nil="true" contextRef="C_0000879407_20110930" unitRef="U_iso4217USD" />
  <us-gaap:AcquiredIndefiniteLivedIntangibleAssetAmount id="F_001005" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20120930" decimals="0" unitRef="U_iso4217USD">944935</us-gaap:AcquiredIndefiniteLivedIntangibleAssetAmount>
  <us-gaap:AcquiredIndefiniteLivedIntangibleAssetAmount id="F_001006" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20120930" decimals="0" unitRef="U_iso4217USD">2172387</us-gaap:AcquiredIndefiniteLivedIntangibleAssetAmount>
  <arwr:IndefiniteLivedIntangibleAssetsAccumulatedAmortization id="F_001007" xsi:nil="true" contextRef="C_0000879407_20120930" unitRef="U_iso4217USD" />
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill id="F_001008" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">3117322</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:ImpairmentOfIntangibleAssetsFinitelived id="F_001009" xsi:nil="true" contextRef="C_0000879407_20111001_20120930" unitRef="U_iso4217USD" />
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill id="F_001010" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">3117322</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:FiniteLivedIntangibleAssetsNet id="F_001011" contextRef="C_0000879407_20110930" decimals="0" unitRef="U_iso4217USD">1731211</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsAcquired id="F_001012" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">230000</us-gaap:FiniteLivedIntangibleAssetsAcquired>
  <us-gaap:AmortizationOfIntangibleAssets id="F_001013" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">293964</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:FiniteLivedIntangibleAssetsNet id="F_001014" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">1667247</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:ImpairmentOfIntangibleAssetsFinitelived id="F_001015" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1308047</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
  <us-gaap:AmortizationOfIntangibleAssets id="F_001016" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">236009</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:FiniteLivedIntangibleAssetsNet id="F_001017" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">123191</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="F_001018" contextRef="C_0000879407_20110930" decimals="0" unitRef="U_iso4217USD">1731211</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <arwr:IntangibleAssetsAdditions id="F_001019" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMadisonMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1174935</arwr:IntangibleAssetsAdditions>
  <arwr:IntangibleAssetsAdditions id="F_001020" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrAlvosTherapeuticsMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">2172387</arwr:IntangibleAssetsAdditions>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="F_001021" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">4784569</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="F_001022" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">3240513</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="F_001023" contextRef="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapLicensingAgreementsMember_20121001_20130930">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="F_001024" contextRef="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapPatentsMember_us-gaapRangeAxis_us-gaapMinimumMember_20121001_20130930">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="F_001025" contextRef="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapPatentsMember_us-gaapRangeAxis_us-gaapMaximumMember_20121001_20130930">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="F_001026" contextRef="C_0000879407_20121001_20130930">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths id="F_001027" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">55000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo id="F_001028" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">55000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree id="F_001029" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">13000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive id="F_001030" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
  <us-gaap:FiniteLivedIntangibleAssetsNet id="F_001031" contextRef="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapPatentsMember_20130630" decimals="-5" unitRef="U_iso4217USD">1300000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:ImpairmentOfIntangibleAssetsFinitelived id="F_001032" contextRef="C_0000879407_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapPatentsMember_20121001_20130930" decimals="-5" unitRef="U_iso4217USD">1300000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
  <arwr:OwnershipPercentageInSubsidiary id="F_001033" contextRef="C_0000879407_20121001_20130930" decimals="INF" unitRef="U_pure">1.00</arwr:OwnershipPercentageInSubsidiary>
  <arwr:AggregateInvestmentInSubsidiaryThroughEquityAndDebt id="F_001034" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20080417" decimals="-5" unitRef="U_iso4217USD">23200000</arwr:AggregateInvestmentInSubsidiaryThroughEquityAndDebt>
  <arwr:UnsecuredConvertiblePromissoryNoteAgreements id="F_001035" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20081126" decimals="-5" unitRef="U_iso4217USD">2500000</arwr:UnsecuredConvertiblePromissoryNoteAgreements>
  <arwr:InvestInNotesOffering id="F_001036" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20081126" decimals="0" unitRef="U_iso4217USD">200000</arwr:InvestInNotesOffering>
  <arwr:AdditionalInvestInNotesOffering id="F_001037" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20081126" decimals="0" unitRef="U_iso4217USD">600000</arwr:AdditionalInvestInNotesOffering>
  <arwr:PrincipalAmountOfNoteWhichNotConvertedIntoShares id="F_001038" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20090623" decimals="0" unitRef="U_iso4217USD">500000</arwr:PrincipalAmountOfNoteWhichNotConvertedIntoShares>
  <arwr:ConversionOfNotesAndAccruedInterestIntoShare id="F_001039" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20090623" decimals="INF" unitRef="U_shares">2950</arwr:ConversionOfNotesAndAccruedInterestIntoShare>
  <arwr:AmountOwedBySubsidiary id="F_001040" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20130930" decimals="-5" unitRef="U_iso4217USD">4300000</arwr:AmountOwedBySubsidiary>
  <arwr:StatedPercentageOfNotesAndAdvances id="F_001041" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20130930" decimals="INF" unitRef="U_pure">0.08</arwr:StatedPercentageOfNotesAndAdvances>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage id="F_001042" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20130930" decimals="2" unitRef="U_pure">0.79</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <arwr:EquityMethodInvestmentOwnershipPercentageOnDilutiveBasis id="F_001043" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoPharmaceuticalsIncMember_20130930" decimals="2" unitRef="U_pure">0.76</arwr:EquityMethodInvestmentOwnershipPercentageOnDilutiveBasis>
  <arwr:InvestmentInPreferredStock id="F_001044" contextRef="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20110930" decimals="-5" unitRef="U_iso4217USD">1300000</arwr:InvestmentInPreferredStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_001045" contextRef="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20101001_20110930" decimals="-5" unitRef="U_iso4217USD">2900000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <arwr:InvestmentInPreferredStockByOutsider id="F_001046" contextRef="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20110930" decimals="-5" unitRef="U_iso4217USD">1600000</arwr:InvestmentInPreferredStockByOutsider>
  <arwr:AmountOwedBySubsidiary id="F_001047" contextRef="C_0000879407_deiLegalEntityAxis_arwrLeonardoBiosystemsIncMember_20130930" decimals="-5" unitRef="U_iso4217USD">1100000</arwr:AmountOwedBySubsidiary>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage id="F_001048" contextRef="C_0000879407_deiLegalEntityAxis_arwrLeonardoBiosystemsIncMember_20130930" decimals="2" unitRef="U_pure">0.03</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage id="F_001049" contextRef="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20130930" decimals="2" unitRef="U_pure">0.64</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <arwr:EquityMethodInvestmentOwnershipPercentageOnDilutiveBasis id="F_001050" contextRef="C_0000879407_deiLegalEntityAxis_arwrAblarisTherapeuticsMember_20130930" decimals="2" unitRef="U_pure">0.64</arwr:EquityMethodInvestmentOwnershipPercentageOnDilutiveBasis>
  <arwr:UnsecuredConvertiblePromissoryNoteAgreements id="F_001051" contextRef="C_0000879407_20081126" decimals="-5" unitRef="U_iso4217USD">2500000</arwr:UnsecuredConvertiblePromissoryNoteAgreements>
  <arwr:InvestInNotesOffering id="F_001052" contextRef="C_0000879407_20081126" decimals="0" unitRef="U_iso4217USD">200000</arwr:InvestInNotesOffering>
  <arwr:AdditionalInvestmentInNotesOffering id="F_001053" contextRef="C_0000879407_20081126" decimals="0" unitRef="U_iso4217USD">600000</arwr:AdditionalInvestmentInNotesOffering>
  <arwr:PrincipalAmountOfNoteNotConvertedInToShares id="F_001054" contextRef="C_0000879407_20081126" decimals="0" unitRef="U_iso4217USD">500000</arwr:PrincipalAmountOfNoteNotConvertedInToShares>
  <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 id="F_001055" contextRef="C_0000879407_deiLegalEntityAxis_arwrCalandoMember_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20121001_20130930" decimals="INF" unitRef="U_shares">2950</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
  <us-gaap:DebtInstrumentMaturityDate id="F_001056" contextRef="C_0000879407_20121001_20130930">2013-11-26</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:DebtInstrumentPaymentTerms id="F_001057" contextRef="C_0000879407_20121001_20130930">Two times principal payment upon certain events</us-gaap:DebtInstrumentPaymentTerms>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="F_001058" contextRef="C_0000879407_20081126" decimals="INF" unitRef="U_pure">0.1</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount id="F_001059" contextRef="C_0000879407_20130930" decimals="-5" unitRef="U_iso4217USD">1000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentUnamortizedDiscount id="F_001060" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">28443</us-gaap:DebtInstrumentUnamortizedDiscount>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001061" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantOneMember_20130930" decimals="2" unitRef="U_iso4217USD_arwrWarrant">70.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001062" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantTwoMember_20130930" decimals="2" unitRef="U_iso4217USD_arwrWarrant">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001063" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantThreeMember_20130930" decimals="2" unitRef="U_iso4217USD_arwrWarrant">5.09</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001064" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFourMember_20130930" decimals="2" unitRef="U_iso4217USD_arwrWarrant">1.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001065" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFiveMember_20130930" decimals="2" unitRef="U_iso4217USD_arwrWarrant">4.16</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001066" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSixMember_20130930" decimals="2" unitRef="U_iso4217USD_arwrWarrant">3.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001067" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSevenMember_20130930" decimals="2" unitRef="U_iso4217USD_arwrWarrant">2.12</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001068" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantEightMember_20130930" decimals="2" unitRef="U_iso4217USD_arwrWarrant">1.83</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001069" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantOneMember_20130930" decimals="INF" unitRef="U_shares">94897</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001070" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantTwoMember_20130930" decimals="INF" unitRef="U_shares">1155023</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001071" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantThreeMember_20130930" decimals="INF" unitRef="U_shares">461024</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001072" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFourMember_20130930" decimals="INF" unitRef="U_shares">187313</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001073" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFiveMember_20130930" decimals="INF" unitRef="U_shares">1000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001074" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSixMember_20130930" decimals="INF" unitRef="U_shares">1685870</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001075" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSevenMember_20130930" decimals="INF" unitRef="U_shares">75000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001076" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantEightMember_20130930" decimals="INF" unitRef="U_shares">742396</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001077" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">4402523</us-gaap:ClassOfWarrantOrRightOutstanding>
  <arwr:RemainingLifeOfWarrant id="F_001078" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantOneMember_20121001_20130930">P3Y7M6D</arwr:RemainingLifeOfWarrant>
  <arwr:RemainingLifeOfWarrant id="F_001079" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantTwoMember_20121001_20130930">P1Y2M12D</arwr:RemainingLifeOfWarrant>
  <arwr:RemainingLifeOfWarrant id="F_001080" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantThreeMember_20121001_20130930">P1Y2M12D</arwr:RemainingLifeOfWarrant>
  <arwr:RemainingLifeOfWarrant id="F_001081" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFourMember_20121001_20130930">P2Y2M12D</arwr:RemainingLifeOfWarrant>
  <arwr:RemainingLifeOfWarrant id="F_001082" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantFiveMember_20121001_20130930">P3Y2M12D</arwr:RemainingLifeOfWarrant>
  <arwr:RemainingLifeOfWarrant id="F_001083" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSixMember_20121001_20130930">P2Y10M24D</arwr:RemainingLifeOfWarrant>
  <arwr:RemainingLifeOfWarrant id="F_001084" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantSevenMember_20121001_20130930">P4Y2M12D</arwr:RemainingLifeOfWarrant>
  <arwr:RemainingLifeOfWarrant id="F_001085" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrWarrantEightMember_20121001_20130930">P4Y2M12D</arwr:RemainingLifeOfWarrant>
  <us-gaap:CapitalUnitsAuthorized id="F_001086" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">150000000</us-gaap:CapitalUnitsAuthorized>
  <us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance id="F_001087" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandStockOptionPlanMember_20130930" decimals="INF" unitRef="U_shares">153200</us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance>
  <us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance id="F_001088" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandFourEquityIncentivePlanMember_20130930" decimals="INF" unitRef="U_shares">3419285</us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance>
  <arwr:ThresholdPercentageOfCommonStockOwnershipUponPreferredStockConversion id="F_001089" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_pure">0.0999</arwr:ThresholdPercentageOfCommonStockOwnershipUponPreferredStockConversion>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001090" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110901_20110930" decimals="INF" unitRef="U_shares">1191473</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SaleOfStockPricePerShare id="F_001091" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110930" decimals="INF" unitRef="U_iso4217USD_shares">3.80</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_001092" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110901_20110930" decimals="-5" unitRef="U_iso4217USD">4500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001093" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20111031" decimals="INF" unitRef="U_shares">138158</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SaleOfStockPricePerShare id="F_001094" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111004" decimals="INF" unitRef="U_iso4217USD_shares">3.80</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_001095" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20111031" decimals="0" unitRef="U_iso4217USD">525000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <arwr:MaximumEquityCommitmentAmountUnderAgreement id="F_001096" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_us-gaapLimitedLiabilityCompanyMember_20130930" decimals="-6" unitRef="U_iso4217USD">15000000</arwr:MaximumEquityCommitmentAmountUnderAgreement>
  <arwr:EquityCommitmentAgreementPeriod id="F_001097" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_us-gaapLimitedLiabilityCompanyMember_20121001_20130930">P36M</arwr:EquityCommitmentAgreementPeriod>
  <arwr:CashDrawnFromFacility id="F_001098" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_us-gaapLimitedLiabilityCompanyMember_20130930" decimals="-6" unitRef="U_iso4217USD">1000000</arwr:CashDrawnFromFacility>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001099" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_us-gaapStatementScenarioAxis_arwrSubscriptionAgreementMember_20111001_20111031" decimals="INF" unitRef="U_shares">1015</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_001100" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20120229" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_001101" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20111021" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:SaleOfStockPricePerShare id="F_001102" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20111021" decimals="INF" unitRef="U_iso4217USD_shares">1000</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_001103" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20111001_20111031" decimals="0" unitRef="U_iso4217USD">1015000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ConversionOfStockSharesConverted1 id="F_001104" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20120201_20120229" decimals="INF" unitRef="U_shares">1015</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ConversionOfStockSharesConverted1 id="F_001105" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20111001_20111031" decimals="INF" unitRef="U_shares">1015</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities id="F_001106" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesAPreferredStockMember_20120201_20120229" decimals="INF" unitRef="U_shares">275782</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:CommonStockParOrStatedValuePerShare id="F_001107" contextRef="C_0000879407_20111021" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001108" contextRef="C_0000879407_us-gaapStatementScenarioAxis_arwrSubscriptionAgreementMember_20111001_20111031" decimals="INF" unitRef="U_shares">675000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SaleOfStockPricePerShare id="F_001109" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111021" decimals="INF" unitRef="U_iso4217USD_shares">3.70</us-gaap:SaleOfStockPricePerShare>
  <arwr:AggregatePurchasePriceOnIssuanceOfCommonStockToBeReceived id="F_001110" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111001_20111031" decimals="0" unitRef="U_iso4217USD">2497500</arwr:AggregatePurchasePriceOnIssuanceOfCommonStockToBeReceived>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001111" contextRef="C_0000879407_20120710_20120810" decimals="INF" unitRef="U_shares">2260869</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SaleOfStockPricePerShare id="F_001112" contextRef="C_0000879407_20120810" decimals="INF" unitRef="U_iso4217USD_shares">2.76</us-gaap:SaleOfStockPricePerShare>
  <arwr:UnitSoldDescription id="F_001113" contextRef="C_0000879407_20120710_20120810">Each unit consisted of one share of common stock and a warrant to purchase</arwr:UnitSoldDescription>
  <arwr:WarrantToPurchaseShareOfCommonStock id="F_001114" contextRef="C_0000879407_20120810" decimals="INF" unitRef="U_shares">0.75</arwr:WarrantToPurchaseShareOfCommonStock>
  <arwr:CommonStockExercisePrice id="F_001115" contextRef="C_0000879407_20120710_20120810" decimals="INF" unitRef="U_iso4217USD_shares">3.25</arwr:CommonStockExercisePrice>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_001116" contextRef="C_0000879407_20120710_20120810" decimals="-5" unitRef="U_iso4217USD">6200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockholdersEquityNoteStockSplitConversionRatio id="F_001117" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20111101_20111117" decimals="1" unitRef="U_pure">0.1</us-gaap:StockholdersEquityNoteStockSplitConversionRatio>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001118" contextRef="C_0000879407_20121201_20121231" decimals="INF" unitRef="U_shares">1825079</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SaleOfStockPricePerShare id="F_001119" contextRef="C_0000879407_20121231" decimals="INF" unitRef="U_iso4217USD_shares">2.26</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_001120" contextRef="C_0000879407_20121201_20121231" decimals="-5" unitRef="U_iso4217USD">4100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_001121" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_iso4217USD_shares">1.83</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <arwr:UnitSoldDescription id="F_001122" contextRef="C_0000879407_20121201_20121231">Each unit consisted of one share of common stock and a warrant to purchase</arwr:UnitSoldDescription>
  <arwr:WarrantToPurchaseShareOfCommonStock id="F_001123" contextRef="C_0000879407_20121231" decimals="INF" unitRef="U_shares">0.5</arwr:WarrantToPurchaseShareOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001124" contextRef="C_0000879407_20130101_20130131" decimals="INF" unitRef="U_shares">1667051</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SaleOfStockPricePerShare id="F_001125" contextRef="C_0000879407_20130131" decimals="INF" unitRef="U_iso4217USD_shares">2.12</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_001126" contextRef="C_0000879407_20130101_20130131" decimals="-5" unitRef="U_iso4217USD">3500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <arwr:UnitSoldDescription id="F_001127" contextRef="C_0000879407_20130101_20130131">Each unit consisted of one share of common stock and a warrant to purchase</arwr:UnitSoldDescription>
  <arwr:WarrantToPurchaseShareOfCommonStock id="F_001128" contextRef="C_0000879407_20130131" decimals="INF" unitRef="U_shares">0.5</arwr:WarrantToPurchaseShareOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001129" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130501_20130531" decimals="INF" unitRef="U_shares">14300000.0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SaleOfStockPricePerShare id="F_001130" contextRef="C_0000879407_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130531" decimals="INF" unitRef="U_iso4217USD_shares">1.83</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001131" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrConvertiblePreferredStockSeriesBMember_20130501_20130531" decimals="INF" unitRef="U_shares">9900</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:SaleOfStockPricePerShare id="F_001132" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_arwrConvertiblePreferredStockSeriesBMember_20130531" decimals="INF" unitRef="U_iso4217USD_shares">1000</us-gaap:SaleOfStockPricePerShare>
  <arwr:ConversionPricePerShare id="F_001133" contextRef="C_0000879407_20130531" decimals="INF" unitRef="U_iso4217USD_shares">1.83</arwr:ConversionPricePerShare>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="F_001134" contextRef="C_0000879407_20130501_20130531" decimals="-6" unitRef="U_iso4217USD">36000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent id="F_001135" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">256846</us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears id="F_001136" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">256846</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears id="F_001137" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">256846</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears id="F_001138" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">256846</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFourYears>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFiveYears id="F_001139" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">256846</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInFiveYears>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueThereafter id="F_001140" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">107019</us-gaap:CapitalLeasesFutureMinimumPaymentsDueThereafter>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments id="F_001141" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">108791</us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments id="F_001142" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">1282458</us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent id="F_001143" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">434229</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears id="F_001144" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">445921</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears id="F_001145" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">457961</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears id="F_001146" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">470154</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears id="F_001147" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">359370</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter id="F_001148" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">125415</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue id="F_001149" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">2293050</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:LeaseAndRentalExpense id="F_001150" contextRef="C_0000879407_20120801_20120831" decimals="0" unitRef="U_iso4217USD">13000</us-gaap:LeaseAndRentalExpense>
  <arwr:CapitalLeaseTermOfLease id="F_001151" contextRef="C_0000879407_20120801_20120831">P5Y</arwr:CapitalLeaseTermOfLease>
  <arwr:PercentageOfIncreaseInAnnualRentalCost id="F_001152" contextRef="C_0000879407_20120801_20120831" decimals="2" unitRef="U_pure">0.03</arwr:PercentageOfIncreaseInAnnualRentalCost>
  <us-gaap:LeaseAndRentalExpense id="F_001153" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">22000</us-gaap:LeaseAndRentalExpense>
  <arwr:PaymentsUnderCapitalLease id="F_001154" contextRef="C_0000879407_us-gaapBusinessAcquisitionAxis_arwrRocheMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">21000</arwr:PaymentsUnderCapitalLease>
  <arwr:OtherRentalExpenses id="F_001155" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">13000</arwr:OtherRentalExpenses>
  <us-gaap:UtilitiesCosts id="F_001156" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">15000</us-gaap:UtilitiesCosts>
  <arwr:IncreaseInMonthlyExpenditureDueToUtilitiesCosts id="F_001157" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">71000</arwr:IncreaseInMonthlyExpenditureDueToUtilitiesCosts>
  <us-gaap:LeaseAndRentalExpense id="F_001158" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">4660000</us-gaap:LeaseAndRentalExpense>
  <arwr:FacilityAndEquipmentRentExpense id="F_001159" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">534000</arwr:FacilityAndEquipmentRentExpense>
  <arwr:FacilityAndEquipmentRentExpense id="F_001160" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">480000</arwr:FacilityAndEquipmentRentExpense>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_001161" contextRef="C_0000879407_20110930" decimals="INF" unitRef="U_shares">729096</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="F_001162" contextRef="C_0000879407_20111001_20120930" decimals="INF" unitRef="U_shares">1229500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod id="F_001163" contextRef="C_0000879407_20111001_20120930" decimals="INF" unitRef="U_shares">42919</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_001164" contextRef="C_0000879407_20111001_20120930" decimals="INF" unitRef="U_shares">4883</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_001165" contextRef="C_0000879407_20120930" decimals="INF" unitRef="U_shares">1910794</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="F_001166" contextRef="C_0000879407_20121001_20130930" decimals="INF" unitRef="U_shares">1509166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod id="F_001167" xsi:nil="true" contextRef="C_0000879407_20121001_20130930" unitRef="U_shares" />
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_001168" contextRef="C_0000879407_20121001_20130930" decimals="INF" unitRef="U_shares">675</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_001169" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">3419285</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber id="F_001170" contextRef="C_0000879407_20130930" decimals="INF" unitRef="U_shares">1306306</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="F_001171" contextRef="C_0000879407_20110930" decimals="2" unitRef="U_iso4217USD_shares">9.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="F_001172" contextRef="C_0000879407_20111001_20120930" decimals="2" unitRef="U_iso4217USD_shares">4.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice id="F_001173" contextRef="C_0000879407_20111001_20120930" decimals="2" unitRef="U_iso4217USD_shares">11.77</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="F_001174" contextRef="C_0000879407_20111001_20120930" decimals="2" unitRef="U_iso4217USD_shares">5.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="F_001175" contextRef="C_0000879407_20120930" decimals="2" unitRef="U_iso4217USD_shares">6.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="F_001176" contextRef="C_0000879407_20121001_20130930" decimals="2" unitRef="U_iso4217USD_shares">2.03</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice id="F_001177" xsi:nil="true" contextRef="C_0000879407_20121001_20130930" unitRef="U_iso4217USD_shares" />
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="F_001178" contextRef="C_0000879407_20121001_20130930" decimals="2" unitRef="U_iso4217USD_shares">3.93</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="F_001179" contextRef="C_0000879407_20130930" decimals="2" unitRef="U_iso4217USD_shares">4.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice id="F_001180" contextRef="C_0000879407_20130930" decimals="2" unitRef="U_iso4217USD_shares">6.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="F_001181" contextRef="C_0000879407_20121001_20130930">P8Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 id="F_001182" contextRef="C_0000879407_20121001_20130930">P6Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue id="F_001183" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">5811926</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 id="F_001184" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">1127819</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="F_001185" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum id="F_001186" contextRef="C_0000879407_20121001_20130930" decimals="3" unitRef="U_pure">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum id="F_001187" contextRef="C_0000879407_20111001_20120930" decimals="3" unitRef="U_pure">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum id="F_001188" contextRef="C_0000879407_20121001_20130930" decimals="3" unitRef="U_pure">0.023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum id="F_001189" contextRef="C_0000879407_20111001_20120930" decimals="3" unitRef="U_pure">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum id="F_001190" contextRef="C_0000879407_20111001_20120930" decimals="1" unitRef="U_pure">0.9</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum id="F_001191" contextRef="C_0000879407_20111001_20120930" decimals="1" unitRef="U_pure">1.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="F_001192" contextRef="C_0000879407_20121001_20130930" decimals="2" unitRef="U_pure">0.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="F_001193" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMinimumMember_20121001_20130930">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="F_001194" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMinimumMember_20111001_20120930">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="F_001195" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMaximumMember_20121001_20130930">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="F_001196" contextRef="C_0000879407_us-gaapRangeAxis_us-gaapMaximumMember_20111001_20120930">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_001197" contextRef="C_0000879407_20121001_20130930" decimals="2" unitRef="U_iso4217USD_shares">1.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_001198" contextRef="C_0000879407_20111001_20120930" decimals="2" unitRef="U_iso4217USD_shares">3.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance id="F_001199" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsStockOptionPlanMember_20130930" decimals="INF" unitRef="U_shares">153200</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance id="F_001200" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsFourEquityIncentivePlanMember_20130930" decimals="INF" unitRef="U_shares">2965185</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_001201" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsStockOptionPlanMember_20130930" decimals="INF" unitRef="U_shares">152900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_001202" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsFourEquityIncentivePlanMember_20130930" decimals="INF" unitRef="U_shares">2965185</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="F_001203" contextRef="C_0000879407_us-gaapPlanNameAxis_arwrTwoThousandsFourEquityIncentivePlanMember_20121001_20130930" decimals="INF" unitRef="U_shares">1459166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted id="F_001204" contextRef="C_0000879407_20121001_20130930" decimals="INF" unitRef="U_shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_001205" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">1536271</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_001206" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">1241404</us-gaap:AllocatedShareBasedCompensationExpense>
  <arwr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue id="F_001207" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">2843575</arwr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue>
  <arwr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue id="F_001208" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">4091117</arwr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue>
  <arwr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue id="F_001209" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrCalandoPharmaceuticalsIncMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">33690</arwr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="F_001210" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">554</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="F_001211" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <arwr:PreTaxCompensationExpense id="F_001212" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrArrowheadMember_20130930" decimals="0" unitRef="U_iso4217USD">5072252</arwr:PreTaxCompensationExpense>
  <arwr:PreTaxCompensationExpense id="F_001213" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrCalandoPharmaceuticalsIncMember_20130930" decimals="0" unitRef="U_iso4217USD">32952</arwr:PreTaxCompensationExpense>
  <arwr:WeightedAveragePeriodToRecognizePreTaxCompensationExpense id="F_001214" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrArrowheadMember_20121001_20130930">P3Y1M6D</arwr:WeightedAveragePeriodToRecognizePreTaxCompensationExpense>
  <arwr:WeightedAveragePeriodToRecognizePreTaxCompensationExpense id="F_001215" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrCalandoPharmaceuticalsIncMember_20121001_20130930">P2Y3M18D</arwr:WeightedAveragePeriodToRecognizePreTaxCompensationExpense>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="F_001216" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" decimals="0" unitRef="U_iso4217USD">19114444</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="F_001217" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" decimals="0" unitRef="U_iso4217USD">19114444</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure id="F_001218" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" decimals="0" unitRef="U_iso4217USD">10698271</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure id="F_001219" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" decimals="0" unitRef="U_iso4217USD">10698271</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:DerivativeAssetsNoncurrent id="F_001220" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" unitRef="U_iso4217USD" />
  <us-gaap:DerivativeAssetsNoncurrent id="F_001221" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" unitRef="U_iso4217USD" />
  <us-gaap:DerivativeAssetsNoncurrent id="F_001222" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" unitRef="U_iso4217USD" />
  <us-gaap:DerivativeAssetsNoncurrent id="F_001223" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" unitRef="U_iso4217USD" />
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="F_001224" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" decimals="0" unitRef="U_iso4217USD">4096363</us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure>
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="F_001225" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" decimals="0" unitRef="U_iso4217USD">4096363</us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure>
  <us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue id="F_001226" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" decimals="0" unitRef="U_iso4217USD">1595273</us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue>
  <us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue id="F_001227" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20130930" decimals="0" unitRef="U_iso4217USD">1595273</us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="F_001228" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20120930" decimals="0" unitRef="U_iso4217USD">3377288</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure id="F_001229" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20120930" decimals="0" unitRef="U_iso4217USD">3377288</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure id="F_001230" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20120930" decimals="0" unitRef="U_iso4217USD">106500</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure id="F_001231" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20120930" decimals="0" unitRef="U_iso4217USD">106500</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:DerivativeAssetsNoncurrent id="F_001232" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20120930" decimals="0" unitRef="U_iso4217USD">250250</us-gaap:DerivativeAssetsNoncurrent>
  <us-gaap:DerivativeAssetsNoncurrent id="F_001233" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20120930" decimals="0" unitRef="U_iso4217USD">250250</us-gaap:DerivativeAssetsNoncurrent>
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="F_001234" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20120930" decimals="0" unitRef="U_iso4217USD">647213</us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure>
  <us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure id="F_001235" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20120930" decimals="0" unitRef="U_iso4217USD">647213</us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure>
  <us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue id="F_001236" contextRef="C_0000879407_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20120930" decimals="0" unitRef="U_iso4217USD">173621</us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue>
  <us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue id="F_001237" contextRef="C_0000879407_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20120930" decimals="0" unitRef="U_iso4217USD">173621</us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001238" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20111001_20120930" decimals="4" unitRef="U_pure">0.0023</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001239" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20121001_20130930">P0Y</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001240" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20111001_20120930">P1Y3M18D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001241" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20121001_20130930" unitRef="U_pure" />
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001242" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20111001_20120930" unitRef="U_pure" />
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001243" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20111001_20120930" decimals="2" unitRef="U_pure">0.72</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue id="F_001244" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20110930" decimals="0" unitRef="U_iso4217USD">161125</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases id="F_001245" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20111001_20120930" unitRef="U_iso4217USD" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 id="F_001246" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">89125</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements id="F_001247" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20111001_20120930" unitRef="U_iso4217USD" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue id="F_001248" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20120930" decimals="0" unitRef="U_iso4217USD">250250</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases id="F_001249" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20121001_20130930" unitRef="U_iso4217USD" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 id="F_001250" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-250250</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements id="F_001251" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20121001_20130930" unitRef="U_iso4217USD" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue id="F_001252" contextRef="C_0000879407_us-gaapFairValueByAssetClassAxis_us-gaapDerivativeFinancialInstrumentsAssetsMember_20130930" decimals="0" unitRef="U_iso4217USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="F_001253" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20110930" decimals="0" unitRef="U_iso4217USD">907233</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases id="F_001254" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20111001_20120930" unitRef="U_iso4217USD" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings id="F_001255" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-281038</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements id="F_001256" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20111001_20120930" unitRef="U_iso4217USD" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="F_001257" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20120930" decimals="0" unitRef="U_iso4217USD">626195</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases id="F_001258" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">2153819</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings id="F_001259" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">5066591</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements id="F_001260" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">3754808</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="F_001261" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_us-gaapWarrantMember_20130930" decimals="0" unitRef="U_iso4217USD">4091797</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001262" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930" decimals="4" unitRef="U_pure">0.0139</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001263" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20111001_20120930" decimals="4" unitRef="U_pure">0.0062</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001264" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930">P4Y3M18D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001265" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20111001_20120930">P5Y3M18D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001266" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930" unitRef="U_pure" />
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001267" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20111001_20120930" unitRef="U_pure" />
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001268" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930" decimals="0" unitRef="U_pure">1</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001269" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20111001_20120930" decimals="0" unitRef="U_pure">1</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="F_001270" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20110930" decimals="0" unitRef="U_iso4217USD">30895</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues id="F_001271" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20111001_20120930" unitRef="U_iso4217USD" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings id="F_001272" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20111001_20120930" decimals="0" unitRef="U_iso4217USD">-20520</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="F_001273" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20120930" decimals="0" unitRef="U_iso4217USD">10375</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues id="F_001274" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930" unitRef="U_iso4217USD" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings id="F_001275" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">-5806</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements id="F_001276" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20121001_20130930" unitRef="U_iso4217USD" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue id="F_001277" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrExchangeRightsMember_20130930" decimals="0" unitRef="U_iso4217USD">4569</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue id="F_001278" xsi:nil="true" contextRef="C_0000879407_20110930" unitRef="U_iso4217USD" />
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationPreacquisitionContingencyAccrual id="F_001279" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">173621</us-gaap:BusinessAcquisitionPurchasePriceAllocationPreacquisitionContingencyAccrual>
  <us-gaap:BusinessAcquisitionContingentConsiderationPotentialCashPayment id="F_001280" xsi:nil="true" contextRef="C_0000879407_20120930" unitRef="U_iso4217USD" />
  <arwr:BusinessAcquisitionNetChangeInFairValueOfContingentConsideration id="F_001281" xsi:nil="true" contextRef="C_0000879407_20120930" unitRef="U_iso4217USD" />
  <us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue id="F_001282" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">173621</us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationPreacquisitionContingencyAccrual id="F_001283" xsi:nil="true" contextRef="C_0000879407_20130930" unitRef="U_iso4217USD" />
  <us-gaap:BusinessAcquisitionContingentConsiderationPotentialCashPayment id="F_001284" xsi:nil="true" contextRef="C_0000879407_20130930" unitRef="U_iso4217USD" />
  <arwr:BusinessAcquisitionNetChangeInFairValueOfContingentConsideration id="F_001285" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">-1421652</arwr:BusinessAcquisitionNetChangeInFairValueOfContingentConsideration>
  <us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue id="F_001286" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">1595273</us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue>
  <arwr:NonCashConsiderationReceivedInSaleOfInterestInSubsidiaryBonds id="F_001287" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrUnidymIncMember_20110101_20110131" decimals="-5" unitRef="U_iso4217USD">2500000</arwr:NonCashConsiderationReceivedInSaleOfInterestInSubsidiaryBonds>
  <arwr:BondConvertibleConversionPrice id="F_001288" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrUnidymIncMember_20110101_20110131" decimals="INF" unitRef="U_iso4217USD_shares">2.00</arwr:BondConvertibleConversionPrice>
  <us-gaap:DerivativeGainLossOnDerivativeNet id="F_001289" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">0</us-gaap:DerivativeGainLossOnDerivativeNet>
  <us-gaap:DerivativeFairValueOfDerivativeLiability id="F_001290" contextRef="C_0000879407_20120930" decimals="0" unitRef="U_iso4217USD">10646</us-gaap:DerivativeFairValueOfDerivativeLiability>
  <us-gaap:DerivativeFairValueOfDerivativeLiability id="F_001291" contextRef="C_0000879407_20130930" decimals="0" unitRef="U_iso4217USD">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 id="F_001292" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrUnidymIncMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">250250</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
  <arwr:WarrantsIssuedToAcquireCommonStock id="F_001293" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandTenWarrantMember_20100630" decimals="INF" unitRef="U_shares">329649</arwr:WarrantsIssuedToAcquireCommonStock>
  <arwr:WarrantsIssuedToAcquireCommonStock id="F_001294" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandTwelveWarrantMember_20121231" decimals="INF" unitRef="U_shares">912543</arwr:WarrantsIssuedToAcquireCommonStock>
  <arwr:WarrantsIssuedToAcquireCommonStock id="F_001295" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandThirteenWarrantMember_20130930" decimals="INF" unitRef="U_shares">833530</arwr:WarrantsIssuedToAcquireCommonStock>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings id="F_001296" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">5066591</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001297" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandTenWarrantMember_20130930" decimals="INF" unitRef="U_shares">187313</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001298" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandTwelveWarrantMember_20130930" decimals="INF" unitRef="U_shares">415761</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_001299" contextRef="C_0000879407_us-gaapClassOfWarrantOrRightAxis_arwrTwoThousandThirteenWarrantMember_20130930" decimals="INF" unitRef="U_shares">326635</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings id="F_001300" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20121001_20130930" decimals="0" unitRef="U_iso4217USD">5806</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <arwr:TermOfExchangeRights id="F_001301" contextRef="C_0000879407_20121001_20130930">P7Y</arwr:TermOfExchangeRights>
  <arwr:ExchangeRightConvertibleConversionRatioForFirstYear id="F_001302" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20121001_20130930" decimals="2" unitRef="U_pure">0.06</arwr:ExchangeRightConvertibleConversionRatioForFirstYear>
  <arwr:ExchangeRightConvertibleConversionRatioForTwoYear id="F_001303" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20121001_20130930" decimals="2" unitRef="U_pure">0.04</arwr:ExchangeRightConvertibleConversionRatioForTwoYear>
  <arwr:ExchangeRightConvertibleConversionRatioForThreeYear id="F_001304" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20121001_20130930" decimals="2" unitRef="U_pure">0.03</arwr:ExchangeRightConvertibleConversionRatioForThreeYear>
  <arwr:ExchangeRightConvertibleConversionRatioForFourYear id="F_001305" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20121001_20130930" decimals="2" unitRef="U_pure">0.02</arwr:ExchangeRightConvertibleConversionRatioForFourYear>
  <arwr:ExchangeRightConvertibleConversionRatioForFiveYear id="F_001306" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20121001_20130930" decimals="2" unitRef="U_pure">0.01</arwr:ExchangeRightConvertibleConversionRatioForFiveYear>
  <arwr:NumberOfExchangeRightAreSold id="F_001307" contextRef="C_0000879407_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_arwrAblarisTherapeuticsMember_20121001_20130930" decimals="INF" unitRef="U_shares">675000</arwr:NumberOfExchangeRightAreSold>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001308" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20121001_20130930" decimals="4" unitRef="U_pure">0.0033</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001309" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20111001_20120930" decimals="4" unitRef="U_pure">0.0031</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001310" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20121001_20130930">P2Y2M12D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001311" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20111001_20120930">P3Y2M12D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001312" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20121001_20130930" unitRef="U_pure" />
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001313" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20111001_20120930" unitRef="U_pure" />
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001314" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20121001_20130930" decimals="2" unitRef="U_pure">0.69</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001315" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandTenWarrantsMember_20111001_20120930" decimals="0" unitRef="U_pure">1</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001316" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20121001_20130930" decimals="4" unitRef="U_pure">0.0139</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001317" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20121001_20130930">P4Y2M12D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001318" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20121001_20130930" unitRef="U_pure" />
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001319" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20111001_20120930" unitRef="U_pure" />
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001320" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandsTwelveWarrantsMember_20121001_20130930" decimals="2" unitRef="U_pure">0.69</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:FairValueAssumptionsRiskFreeInterestRate id="F_001321" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20121001_20130930" decimals="4" unitRef="U_pure">0.0139</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:FairValueAssumptionsExpectedTerm id="F_001322" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20121001_20130930">P4Y3M18D</us-gaap:FairValueAssumptionsExpectedTerm>
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001323" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20121001_20130930" unitRef="U_pure" />
  <us-gaap:FairValueAssumptionsExpectedDividendRate id="F_001324" xsi:nil="true" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20111001_20120930" unitRef="U_pure" />
  <us-gaap:FairValueAssumptionsExpectedVolatilityRate id="F_001325" contextRef="C_0000879407_us-gaapFairValueByLiabilityClassAxis_arwrTwoThousandThirteenWarrantsMember_20121001_20130930" decimals="2" unitRef="U_pure">0.69</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
  <arwr:PercentageOfValuationAllowance id="F_001326" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_pure">1</arwr:PercentageOfValuationAllowance>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic id="F_001327" contextRef="C_0000879407_20120930" decimals="-5" unitRef="U_iso4217USD">99500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic id="F_001328" contextRef="C_0000879407_20130930" decimals="-5" unitRef="U_iso4217USD">18700000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal id="F_001329" contextRef="C_0000879407_20120930" decimals="-5" unitRef="U_iso4217USD">77400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal id="F_001330" contextRef="C_0000879407_20130930" decimals="-5" unitRef="U_iso4217USD">32600000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
  <us-gaap:DeferredTaxAssetsLiabilitiesNet id="F_001331" contextRef="C_0000879407_20130930" decimals="-5" unitRef="U_iso4217USD">40200000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense id="F_001332" contextRef="C_0000879407_20121001_20130930" decimals="0" unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense id="F_001333" contextRef="C_0000879407_20111001_20120930" decimals="0" unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense id="F_001334" contextRef="C_0000879407_20030501_20130930" decimals="0" unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
  <us-gaap:DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent id="F_001335" contextRef="C_0000879407_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_arwrDiscretionaryContributionsMember_20121001_20130930" decimals="INF" unitRef="U_pure">1.00</us-gaap:DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent>
  <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent id="F_001336" contextRef="C_0000879407_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_arwrEmployeeContributionsUpToThreePercentMember_20121001_20130930" decimals="2" unitRef="U_pure">0.03</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
  <us-gaap:DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent id="F_001337" contextRef="C_0000879407_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_arwrFiftyPercentageOfMatchingContributionMember_20121001_20130930" decimals="INF" unitRef="U_pure">0.50</us-gaap:DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent>
  <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent id="F_001338" contextRef="C_0000879407_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_arwrEmployeeContributionUpToFirstTwoPercentageMember_20121001_20130930" decimals="2" unitRef="U_pure">0.02</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
  <us-gaap:EmployeeBenefitsAndShareBasedCompensation id="F_001339" contextRef="C_0000879407_20121001_20130930" decimals="-3" unitRef="U_iso4217USD">191947000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
  <us-gaap:EmployeeBenefitsAndShareBasedCompensation id="F_001340" contextRef="C_0000879407_20111001_20120930" decimals="-3" unitRef="U_iso4217USD">162495000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
  <us-gaap:EmployeeBenefitsAndShareBasedCompensation id="F_001341" contextRef="C_0000879407_20030501_20130930" decimals="-3" unitRef="U_iso4217USD">807939000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001342" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131001_20131011" decimals="INF" unitRef="U_shares">3071672</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_001343" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131001_20131011" decimals="INF" unitRef="U_shares">46000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:CommonStockParOrStatedValuePerShare id="F_001344" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapCommonStockMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131011" decimals="INF" unitRef="U_iso4217USD_shares">5.86</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:SaleOfStockPricePerShare id="F_001345" contextRef="C_0000879407_us-gaapStatementClassOfStockAxis_us-gaapSeriesCPreferredStockMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131011" decimals="INF" unitRef="U_iso4217USD_shares">1000</us-gaap:SaleOfStockPricePerShare>
  <arwr:ConversionPricePerShare id="F_001346" contextRef="C_0000879407_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131011" decimals="INF" unitRef="U_iso4217USD_shares">5.86</arwr:ConversionPricePerShare>
  <arwr:AggregatePriceOnIssuanceOrSaleOfEquity id="F_001347" contextRef="C_0000879407_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131001_20131011" decimals="-6" unitRef="U_iso4217USD">64000000</arwr:AggregatePriceOnIssuanceOrSaleOfEquity>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="F_001348" contextRef="C_0000879407_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20131001_20131011" decimals="-6" unitRef="U_iso4217USD">60000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
</xbrl>
